Sentence,class,file
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ae/51/ndt-13-803.PMC5359139.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/51/ndt-13-803.PMC5359139.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/38/96/imcrj-10-087.PMC5359140.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/38/96/imcrj-10-087.PMC5359140.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 87–91International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 87 Case seRIes open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S129239syringomyelia presenting with unilateral optic  neuropathy: a case report Qi Zhe Ngoo evelyn Li Min Tai Wan Hazabbah Wan Hitam Department of Ophthalmology,   school of Medical sciences, Universiti  sains Malaysia, Kubang Kerian,  MalaysiaPurpose: In this case report, we present two cases of syringomyelia with optic neuropathy.",Non-OADS,/arxiv_data1/oa_pdf/38/96/imcrj-10-087.PMC5359140.pdf
"Patients’ consent Both patients signed the written consent for the publication of this case report.Correspondence: Wan Hazabbah Wan  HitamDepartment of Ophthalmology, school of Medical sciences, Health Campus, Universiti sains Malaysia, 16150 Kubang Kerian, Kelantan, MalaysiaTel +60 9 767 6362email hazabbah@usm.myJournal name: International Medical Case Reports Journal Article Designation: Case SeriesY ear: 2017V olume: 10Running head verso: Ngoo et alRunning head recto: Syringomyelia with unilateral optic neuropathyDOI: http://dx.doi.org/10.2147/IMCRJ.S129239",Non-OADS,/arxiv_data1/oa_pdf/38/96/imcrj-10-087.PMC5359140.pdf
Available from: https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Syringomyelia-Fact-Sheet.,Non-OADS,/arxiv_data1/oa_pdf/38/96/imcrj-10-087.PMC5359140.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/38/96/imcrj-10-087.PMC5359140.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 91 syringomyelia with unilateral optic neuropathy  9.,Non-OADS,/arxiv_data1/oa_pdf/38/96/imcrj-10-087.PMC5359140.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4f/fd/10029_2017_Article_1577.PMC5359377.pdf
J Clin Epidemiol 62(10):e1–e34 18.http://www.cebm.net/ocebm-levels-of-evidence/ 19.,Non-OADS,/arxiv_data1/oa_pdf/4f/fd/10029_2017_Article_1577.PMC5359377.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/2a/c0/10029_2017_Article_1585.PMC5359381.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.2.100",Non-OADS,/arxiv_data1/oa_pdf/7f/fe/kjod-47-100.PMC5359628.pdf
Akyalcin et al • Changes in transverse dimension of smile www.e-kjo.org 101 https://doi.org/10.4041/kjod.2017.47.2.100 INTRODUCTION   The presence of a narrow smile and dark buccal  corridors has been the main area of interest when evaluating the esthetic outcome of orthodontic treat - ment.,Non-OADS,/arxiv_data1/oa_pdf/7f/fe/kjod-47-100.PMC5359628.pdf
"Akyalcin et al • Changes in transverse dimension of smile www.e-kjo.org 102 https://doi.org/10.4041/kjod.2017.47.2.100 For the first molars, the longitudinal axis of the crown  was represented by the mesiobuccal groove.",Non-OADS,/arxiv_data1/oa_pdf/7f/fe/kjod-47-100.PMC5359628.pdf
"Akyalcin et al • Changes in transverse dimension of smile www.e-kjo.org 103 https://doi.org/10.4041/kjod.2017.47.2.100 equation: , where d is the difference  between duplicated measurements and n is the number  of replications.",OADS,/arxiv_data1/oa_pdf/7f/fe/kjod-47-100.PMC5359628.pdf
"Akyalcin et al • Changes in transverse dimension of smile www.e-kjo.org 104 https://doi.org/10.4041/kjod.2017.47.2.100 for all measurements between all possible time-period  pair comparisons ( p < 0.05), except for the T2-T3  comparison of the MDW/SW ratio.",OADS,/arxiv_data1/oa_pdf/7f/fe/kjod-47-100.PMC5359628.pdf
"Akyalcin et al • Changes in transverse dimension of smile www.e-kjo.org 105 https://doi.org/10.4041/kjod.2017.47.2.100 DISCUSSION   With esthetic outcome being the foremost concern  in current orthodontic practice, broad smiles and small buccal corridors have become a commonly desired treatment goal.",Non-OADS,/arxiv_data1/oa_pdf/7f/fe/kjod-47-100.PMC5359628.pdf
"Akyalcin et al • Changes in transverse dimension of smile www.e-kjo.org 106 https://doi.org/10.4041/kjod.2017.47.2.100 components, lighting, and the vertical position of the  teeth and gingiva.",Non-OADS,/arxiv_data1/oa_pdf/7f/fe/kjod-47-100.PMC5359628.pdf
Akyalcin et al • Changes in transverse dimension of smile www.e-kjo.org 107 https://doi.org/10.4041/kjod.2017.47.2.100 in extraction versus non-extraction orthodontic  treatment.,Non-OADS,/arxiv_data1/oa_pdf/7f/fe/kjod-47-100.PMC5359628.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.2.108",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/kjod-47-108.PMC5359629.pdf
Choi et al • Preferred chin projection and facial form www.e-kjo.org 109 https://doi.org/10.4041/kjod.2017.47.2.108 INTRODUCTION   One of the main objectives of orthodontic treatment  and/or orthognathic surgery is to improve facial harmony and beauty.,Non-OADS,/arxiv_data1/oa_pdf/ed/1b/kjod-47-108.PMC5359629.pdf
"Choi et al • Preferred chin projection and facial form www.e-kjo.org 110 https://doi.org/10.4041/kjod.2017.47.2.108 limitations in terms of evaluating the esthetic chin  position, such as unrealistic impression and distortion of the facial images.",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/kjod-47-108.PMC5359629.pdf
"Choi et al • Preferred chin projection and facial form www.e-kjo.org 111 https://doi.org/10.4041/kjod.2017.47.2.108 MATERIALS AND METHODS Determination of the FFT    The FFT was determined using the facial index, which  is the ratio between the height of the middle and lower face (soft-tissue nasion–soft-tissue gnathion) and the interzygomatic width (soft-tissue zy on the right side–soft-tissue zy on the left side).",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/kjod-47-108.PMC5359629.pdf
"Choi et al • Preferred chin projection and facial form www.e-kjo.org 112 https://doi.org/10.4041/kjod.2017.47.2.108 years), who were asked to rate the five chin projections  (6o, 8o, 10o, 12o, and 14o) from the most to least  esthetically preferred in each 3D image.",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/kjod-47-108.PMC5359629.pdf
"Choi et al • Preferred chin projection and facial form www.e-kjo.org 113 https://doi.org/10.4041/kjod.2017.47.2.108 (Eury-FFT male < [Meso-FFT male, Eury-FFT female,  Meso-FFT female, Lepto-FFT male] < [Meso-FFT female, Lepto-FFT male, Lepto-FFT female];  p < 0.001; Table 3).",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/kjod-47-108.PMC5359629.pdf
"Choi et al • Preferred chin projection and facial form www.e-kjo.org 114 https://doi.org/10.4041/kjod.2017.47.2.108 that middle-aged (40–54 years; mean age, 47 years) as  well as older individuals (55–70 years; mean age, 62 years) preferred a slightly retrusive chin as an esthetically pleasing one.",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/kjod-47-108.PMC5359629.pdf
"Choi et al • Preferred chin projection and facial form www.e-kjo.org 115 https://doi.org/10.4041/kjod.2017.47.2.108 addition, this finding may be related to a mature and  responsible impression that is conveyed by a normal or slightly protrusive chin projection in males.",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/kjod-47-108.PMC5359629.pdf
Choi et al • Preferred chin projection and facial form www.e-kjo.org 116 https://doi.org/10.4041/kjod.2017.47.2.108 treatment of Class II malocclusion in adults.,Non-OADS,/arxiv_data1/oa_pdf/ed/1b/kjod-47-108.PMC5359629.pdf
Choi et al • Preferred chin projection and facial form www.e-kjo.org 117 https://doi.org/10.4041/kjod.2017.47.2.108 6.,Non-OADS,/arxiv_data1/oa_pdf/ed/1b/kjod-47-108.PMC5359629.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.2.118",Non-OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
"Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 119 https://doi.org/10.4041/kjod.2017.47.2.118 INTRODUCTION   In skeletal Class III patients with maxillary hypoplasia,  facemasks have been widely used to stimulate the protraction of the maxilla during the growth period.",Non-OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
"Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 120 https://doi.org/10.4041/kjod.2017.47.2.118 the prepubertal growth period) and MP3cap (i.e., the  diaphysis of the middle phalanx of the middle finger is covered by the cap-shaped epiphysis; this stage indicates the peak of the pubertal growth spurt), as evaluated using hand-wrist radiographs; and (5) no craniofacial anomalies or previous orthodontic treatment.",Non-OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
"Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 121 https://doi.org/10.4041/kjod.2017.47.2.118 the buccal vestibule side, a mucoperiosteal flap was  elevated between the maxillary canine and the distal border of the first molar under local anesthesia to expose the maxillary zygomatic buttress.",Non-OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 122 https://doi.org/10.4041/kjod.2017.47.2.118 the observation period in the control group.,Non-OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 123 https://doi.org/10.4041/kjod.2017.47.2.118 examined using the Shapiro-Wilk test.,Non-OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 124 https://doi.org/10.4041/kjod.2017.47.2.118 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 125 https://doi.org/10.4041/kjod.2017.47.2.118 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 126 https://doi.org/10.4041/kjod.2017.47.2.118 differences between the two groups at T0 (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 127 https://doi.org/10.4041/kjod.2017.47.2.118 control group.,Non-OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 128 https://doi.org/10.4041/kjod.2017.47.2.118 showed similar results.,OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
Bozkaya et al • Bone anchored maxillary protraction therapy www.e-kjo.org 129 https://doi.org/10.4041/kjod.2017.47.2.118 report.,OADS,/arxiv_data1/oa_pdf/2c/8b/kjod-47-118.PMC5359630.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSCase Report pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.2.130",Non-OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 131 https://doi.org/10.4041/kjod.2017.47.2.130 INTRODUCTION   The main goal of effective orthodontic treatment is to  improve a patient’s esthetic and dentofacial function.,Non-OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
"Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 132 https://doi.org/10.4041/kjod.2017.47.2.130 resulted in the patients as well as the dental community  showing reluctance in employing such methods.5   This report describes a specific intervention to solve moderate crowding of both the arches by combining the use of an innovative, computer-guided 6,7 piezocision procedure and esthetic clear aligners.",Non-OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
"Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 133 https://doi.org/10.4041/kjod.2017.47.2.130 referred to the Department of Orthodontics of Sapienza  University of Rome, Italy, to undergo evaluation for the possibility of a short and esthetic orthodontic treatment for crowding.",Non-OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 134 https://doi.org/10.4041/kjod.2017.47.2.130 Figure 5.,OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
"Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 135 https://doi.org/10.4041/kjod.2017.47.2.130 thin gingival biotype with Miller Class I defects on the  maxillary left lateral incisor, canine and first premolar, and also on maxillary right lateral incisor and canine (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 136 https://doi.org/10.4041/kjod.2017.47.2.130 · The first option was orthodontic treatment with  conventional brackets.,Non-OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 137 https://doi.org/10.4041/kjod.2017.47.2.130 · The third alternative consisted of an esthetic  treatment plan using esthetic clear aligners combined  with selective alveolar corticotomies to reduce the treatment time.,Non-OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 138 https://doi.org/10.4041/kjod.2017.47.2.130 RESULTS   The total treatment duration was 8 months (1 month  for the maxillary arch and 8 months for the mandibular arch).,Non-OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 139 https://doi.org/10.4041/kjod.2017.47.2.130 significant reduction in the radiographic height of the  crestal bone and no evidence of any significant apical root resorption.,Non-OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
"Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 140 https://doi.org/10.4041/kjod.2017.47.2.130 of corticotomy can be based on direct visualization  of the crown (as well as the corresponding imaginary longitudinal axis of the tooth), together with the tactile sensation of the interdental concavity between the root prominence.",Non-OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
Cassetta et al • The combined use of computer-guided corticotomy and clear aligners www.e-kjo.org 141 https://doi.org/10.4041/kjod.2017.47.2.130 bination of computer-guided piezocision and clear  removable aligners.,OADS,/arxiv_data1/oa_pdf/6a/c5/kjod-47-130.PMC5359631.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSBrief Report pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.2.142",Non-OADS,/arxiv_data1/oa_pdf/05/5f/kjod-47-142.PMC5359632.pdf
"Kang et al • Molar distalization, mandibular dentition, CBCT-generated cephalograms www.e-kjo.org 143 https://doi.org/10.4041/kjod.2017.47.2.142 INTRODUCTION   Maxillary molar distalization with skeletal anchorage  is an efficient and noncompliance-dependent treatment modality for patients with a Class II molar relationship.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/kjod-47-142.PMC5359632.pdf
"Kang et al • Molar distalization, mandibular dentition, CBCT-generated cephalograms www.e-kjo.org 144 https://doi.org/10.4041/kjod.2017.47.2.142 adjusted during appointments scheduled every 4 weeks.",OADS,/arxiv_data1/oa_pdf/05/5f/kjod-47-142.PMC5359632.pdf
"Kang et al • Molar distalization, mandibular dentition, CBCT-generated cephalograms www.e-kjo.org 145 https://doi.org/10.4041/kjod.2017.47.2.142 measurements.",OADS,/arxiv_data1/oa_pdf/05/5f/kjod-47-142.PMC5359632.pdf
"Kang et al • Molar distalization, mandibular dentition, CBCT-generated cephalograms www.e-kjo.org 146 https://doi.org/10.4041/kjod.2017.47.2.142 molar may be contributing factors.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/kjod-47-142.PMC5359632.pdf
"Kang et al • Molar distalization, mandibular dentition, CBCT-generated cephalograms www.e-kjo.org 147 https://doi.org/10.4041/kjod.2017.47.2.142 Orthod 2011;17:124-37.",OADS,/arxiv_data1/oa_pdf/05/5f/kjod-47-142.PMC5359632.pdf
- Korean J Orthod 2017;47:31-38 https://doi.org/10.4041/kjod.2017.47.2.7575www.e-kjo.orgpISSN 2234-7518 eISSN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/8c/10/kjod-47-75.PMC5359633.pdf
"76 www.e-kjo.org https://doi.org/10.4041/kjod.2017.47.2.75This is an Open Access article distributed under the terms of the  Creative Commons Attribution n on-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Table 1.",Non-OADS,/arxiv_data1/oa_pdf/8c/10/kjod-47-75.PMC5359633.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.2.77 77",Non-OADS,/arxiv_data1/oa_pdf/b4/34/kjod-47-77.PMC5359634.pdf
Park et al • Changes after MARPE in young adults www.e-kjo.org 78 https://doi.org/10.4041/kjod.2017.47.2.77 INTRODUCTION   Rapid palatal expansion (RPE) has been widely used  in the field of orthodontics since the mid-1960s for increasing the transverse dimensions of the maxilla in growing patients.,Non-OADS,/arxiv_data1/oa_pdf/b4/34/kjod-47-77.PMC5359634.pdf
Park et al • Changes after MARPE in young adults www.e-kjo.org 79 https://doi.org/10.4041/kjod.2017.47.2.77 required expansion was achieved.,Non-OADS,/arxiv_data1/oa_pdf/b4/34/kjod-47-77.PMC5359634.pdf
"Park et al • Changes after MARPE in young adults www.e-kjo.org 80 https://doi.org/10.4041/kjod.2017.47.2.77 defined as the distances between the right and left  buccal/mesiobuccal cusp tips of the first premolars and first molars, respectively, were measured on 3D tooth images (Figure 2).",OADS,/arxiv_data1/oa_pdf/b4/34/kjod-47-77.PMC5359634.pdf
Park et al • Changes after MARPE in young adults www.e-kjo.org 81 https://doi.org/10.4041/kjod.2017.47.2.77 and T2 were superimposed using a point-to-point  and volumetric registration method with specifically normalized mutual data based on the anterior cranial base (Figure 4).,OADS,/arxiv_data1/oa_pdf/b4/34/kjod-47-77.PMC5359634.pdf
Park et al • Changes after MARPE in young adults www.e-kjo.org 82 https://doi.org/10.4041/kjod.2017.47.2.77   A single examiner performed all measurements.,OADS,/arxiv_data1/oa_pdf/b4/34/kjod-47-77.PMC5359634.pdf
"Park et al • Changes after MARPE in young adults www.e-kjo.org 83 https://doi.org/10.4041/kjod.2017.47.2.77 increase in IMW width (5.4 mm) accounted for 37.0% of  the skeletal expansion at the J-point (2.0 mm), 22.2% of the alveolar expansion at the cementoenamel junction (1.2 mm), and 40.7% of the dental expansion at the cusp tip (2.2 mm).",Non-OADS,/arxiv_data1/oa_pdf/b4/34/kjod-47-77.PMC5359634.pdf
"Park et al • Changes after MARPE in young adults www.e-kjo.org 84 https://doi.org/10.4041/kjod.2017.47.2.77 would have resulted in increased air flow and improved  nasal breathing.2,24 Thus, in the coronal plane, maxillary  expansion followed a pyramidal pattern, similar to the expansion pattern reported with conventional RPE or SARPE.",Non-OADS,/arxiv_data1/oa_pdf/b4/34/kjod-47-77.PMC5359634.pdf
"Park et al • Changes after MARPE in young adults www.e-kjo.org 85 https://doi.org/10.4041/kjod.2017.47.2.77 REFERENCES 1. da Silva Filho OG, Montes LA, Torelly LF.",OADS,/arxiv_data1/oa_pdf/b4/34/kjod-47-77.PMC5359634.pdf
Park et al • Changes after MARPE in young adults www.e-kjo.org 86 https://doi.org/10.4041/kjod.2017.47.2.77 2001;59:994-1000; discussion 1001.,Non-OADS,/arxiv_data1/oa_pdf/b4/34/kjod-47-77.PMC5359634.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2017.47.2.87",Non-OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 88 http://dx.doi.org/10.4041/kjod.2017.47.2.87 INTRODUCTION   Facial esthetics plays an inherent role in social behavior  and perception worldwide.,OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
"Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 89 http://dx.doi.org/10.4041/kjod.2017.47.2.87 consent form to participate in this study, which was  approved by the institutional review board of The Catholic University of Korea (KC140ISE0057).",OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 90 http://dx.doi.org/10.4041/kjod.2017.47.2.87 parameter that minimizes the distance between the  points.27 The same software was used for analyzing the  3D models.,OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
"Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 91 http://dx.doi.org/10.4041/kjod.2017.47.2.87   Canon 5: endocanthal width/eye width = 1   Canon 6: mouth width/nasal width = 3/2  Moreover, several proportion indexes (PIs) were cal-culated (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
"Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 92 http://dx.doi.org/10.4041/kjod.2017.47.2.87 Statistics, version 20.0 (IBM Corp., Armonk, NY, USA).",OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 93 http://dx.doi.org/10.4041/kjod.2017.47.2.87 The nose was also more protruded in the MK group than  in the GP group.,Non-OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 94 http://dx.doi.org/10.4041/kjod.2017.47.2.87 Table 4.,OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 95 http://dx.doi.org/10.4041/kjod.2017.47.2.87 AB Figure 6.,OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
"Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 96 http://dx.doi.org/10.4041/kjod.2017.47.2.87 width, nasal width/height, and upper lip/nasal height  than did the GP group.",OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
"Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 97 http://dx.doi.org/10.4041/kjod.2017.47.2.87 demonstrated no significant differences between their  groups in lower-facial height and lower-lip-and-chin volume, which were significantly lesser in our MK group.",OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 98 http://dx.doi.org/10.4041/kjod.2017.47.2.87 beneficial for treatment planning of orthognathic and  plastic surgery as well as orthodontic treatment.,OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
Jang et al • 3D analysis of preferred facial esthetics www.e-kjo.org 99 http://dx.doi.org/10.4041/kjod.2017.47.2.87 22.,OADS,/arxiv_data1/oa_pdf/c2/94/kjod-47-87.PMC5359635.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 19, Number 3, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/dia.2016.0349 173",Non-OADS,/arxiv_data1/oa_pdf/82/a0/dia.2016.0349.PMC5359639.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS PATIENT CARE and STDs Volume 31, Number 3, 2017Mary Ann Liebert, Inc.DOI: 10.1089/apc.2016.0286 105",Non-OADS,/arxiv_data1/oa_pdf/c5/9e/apc.2016.0286.PMC5359640.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/44/e1/main.PMC5359675.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.12.007Abbreviation used: SPTCL: Subcutaneous panniculitis-like T-cell lymphoma 87,Non-OADS,/arxiv_data1/oa_pdf/44/e1/main.PMC5359675.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 19, Number 3, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/dia.2016.0421 155",Non-OADS,/arxiv_data1/oa_pdf/34/18/dia.2016.0421.PMC5359676.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c9/06/main.PMC5359677.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.005 100,OADS,/arxiv_data1/oa_pdf/c9/06/main.PMC5359677.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e2/e5/main.PMC5359678.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.10.006 98,OADS,/arxiv_data1/oa_pdf/e2/e5/main.PMC5359678.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS PATIENT CARE and STDs Volume 31, Number 3, 2017Mary Ann Liebert, Inc.DOI: 10.1089/apc.2016.0213 113",Non-OADS,/arxiv_data1/oa_pdf/05/8d/apc.2016.0213.PMC5359680.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercialuse, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ANTIOXIDANTS & REDOX SIGNALING Volume 26, Number 9, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/ars.2016.6750 462",Non-OADS,/arxiv_data1/oa_pdf/36/40/ars.2016.6750.PMC5359687.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 19, Number 3, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/dia.2016.0392 164",Non-OADS,/arxiv_data1/oa_pdf/91/5c/dia.2016.0392.PMC5359691.pdf
"2015; http://www.vgregion.se/upload/Regionservice/CLP/ Diabetes/Sortimentskatalog%20Diabetes%202017.pdf (ac- cessed February 9, 2017).",Non-OADS,/arxiv_data1/oa_pdf/91/5c/dia.2016.0392.PMC5359691.pdf
"Virulence 4:6, 494–496; August 15, 2013; © 2013 Landes Bioscience 494 Virulence Volume 4 Issue 6 AutophA gIc punctum Keywords:  Norovirus, E. coli , Vibrio   cholerae , foodborne diseases, C. elegans Submitted: 06/03/13 Revised: 06/07/13Accepted: 06/09/13http://dx.doi.org/10.4161/viru.25384 Correspondence to: Yoshikazu Nishikawa;   Email: nisikawa@life.osaka-cu.ac.jpWhen did you first get interested in  science?",Non-OADS,/arxiv_data1/oa_pdf/57/36/kvir-04-06-10925384.PMC5359718.pdf
"9 One group is formed by those  virulence factors only found in patho - genic bacteria, called pathogen-specific Toward a more systematic understanding   of bacterial virulence factors and establishing  Koch postulates in silico Xianwen r en MoH Key Laboratory of Systems Biology of Pathogens; i nstitute of Pathogen Biology; Chinese Academy of Medical Sciences and Peking Union Medical College;   Beijing, P. r. China Keywords:  bacteria, pathogenecity, virulence factor, common virulence factor, pathogen-specific virulence factor Correspondence to: Xianwen Ren; Email: renxwise@gmail.com Submitted: 08/15/2013; Accepted: 08/19/2013http://dx.doi.org/10.4161/viru.26211Comment on: Niu C, et al.",Non-OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
"Virulence 2013; 4:473-82; PMID:23863604; http://dx.doi.org/10.4161/viru.25730systematical studies, it is time to revisit the  relationship of pathogenecity and virulence factors from a “set theory” view.",Non-OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Science 2011; 331:296-302;  PMID:21252339; http://dx.doi.org/10.1126/sci- ence.11946942.,OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Science 2000; 287:443-9;  PMID:10642539; http://dx.doi.org/10.1126/sci-ence.287.5452.443 3.,OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Science 1999; 284:1311-3; PMID:10334978; http://dx.doi.org/10.1126/science.284.5418.1311 4.,Non-OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Curr Top Microbiol Immunol 2013; 358:3-32; PMID:23340801; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Nature  2007; 449:835-42; PMID:17943120; http://dx.doi.org/10.1038/nature06248 6.,Non-OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Nat Rev  Microbiol 2004; 2:91; PMID:15040257; http://dx.doi.org/10.1038/nrmicro825 7.,OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Postgrad Med J 2002; 78:216-24; PMID:11930024; http://dx.doi.org/10.1136/ pmj.78.918.216 8.,Non-OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Nat Rev Microbiol 2004; 2:67-72; PMID:15035010;  http://dx.doi.org/10.1038/nrmicro799 9.,OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Virulence 2013; 4:473-82; PMID:23863604;  http://dx.doi.org/10.4161/viru.25730.,Non-OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Science 2013; 341:514- 9; PMID:23908230; http://dx.doi.org/10.1126/sci- ence.1239401 11.,OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
Annu Rev Phytopathol 2004; 42:385- 414; PMID:15283671; http://dx.doi.org/10.1146/ annurev.phyto.42.040103.110731,Non-OADS,/arxiv_data1/oa_pdf/39/fb/kvir-04-06-10926211.PMC5359720.pdf
"This remarkable story was initiated by a 1991 paper by Kato and colleagues that applied  13C NMR to the study of antibody switch  variants to dansyl (5-dimethylaminonaph - thalene-1-sulfonyl).3 Most significantly,  their data on antigen binding by switch variants with or without C region deletions The interdependence of antibody C and V regions  on specificity and affinity Significant implications for the engineering of therapeutic  antibodies Joshua d  Nosanchuk departments of Medicine and Microbiology & i mmunology; Albert Einstein College of Medicine; Bronx, NY USA Keywords:  antibody, isotope, therapeutics, Bacillus anthracis , C region, V region Correspondence to: Joshua D Nosanchuk; Email: josh.nosanchuk@einstein.yu.edu Submitted: 08/14/2013; Accepted: 08/14/2013http://dx.doi.org/10.4161/viru.26153Comment on: Hubbard MA, et al.",Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
"Virulence 2013; 4:483-8; PMID:23863605; http://dx.doi.org/10.4161/viru.25711Moreover, this work has provided a key  mechanistic insight into the impact of isotype switched, V region identical anti - bodies.",Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
Dtsch Med  Wochenschr 1891; 17:1218-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
Biochemistry  1991; 30:6604-10; PMID:2054358; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
Biochem Soc T rans 2003; 31:1032-5; PMID:14505474; http://dx.doi.org/10.1042/ BST0311032 6.,OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
PLoS One 2009; 4:e5392;  PMID:19399183; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
Proc Natl Acad Sci U S A  2012; 109:12680-5; PMID:22723360; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
Eur J Immunol  2000; 30:3387-95; PMID:11093156; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
J Biol Chem 2008; 283:31366-70; PMID:18806257; http://dx.doi.org/10.1074/jbc.M806473200 10.,OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
Mol Immunol 2013; 56:588-98; PMID:23911417; http://dx.doi.org/10.1016/j.molimm.2013.06.006 11.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
J  Biol Chem 2012; 287:35409-17; PMID:22930758;  http://dx.doi.org/10.1074/jbc.M112.404483 16.,OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
Acta Crystallogr D Biol Crystallogr 2013; 69:388-97; PMID:23519414; http://dx.doi.org/10.1107/ S0907444912048664 17.,OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
J Autoimmun 2012; 39:398-411; PMID:22841793;  http://dx.doi.org/10.1016/j.jaut.2012.06.005 19.,OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
Virulence 2013; 4:483- 8; PMID:23863605; http://dx.doi.org/10.4161/ viru.25711 20.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
PLoS Pathog 2013; 9:e1003306; PMID:23637599; http://dx.doi.org/10.1371/journal.ppat.1003306 21.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
Immunology  1996; 88:169-73; PMID:8690447; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
Infect Immun 2007; 75:1424-35; PMID:17220317; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/kvir-04-06-10926153.PMC5359721.pdf
"If the antigenic determinants of pathogens are similar to host proteins as a result of mimicry, then the immune system reacts against its own cells and Molecular mimicry Good artists copy, great artists steal Uthaman Gowthaman1 and Veraragavan P Eswarakumar1,2 1department of o rthopaedics & r ehabilitation; Yale University School of Medicine; New Haven, C t USA; 2department of Pharmacology; Yale University School of Medicine;  New Haven, C t USA Keywords:  mimicry, proteins, pathogens, virulence factors, extracellular matrix, collagen, leucine-rich repeats, pathogenomics,  bacteria Correspondence to: Uthaman Gowthaman; Email:gowthaman.uthaman@yale.edu; Veraragavan P Eswarakumar; Email: eswar.kumar@yale.edu Submitted: 07/15/13; Accepted: 07/16/13http://dx.doi.org/10.4161/viru.25780Editorial to: Doxey AC, et al.",Non-OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
"Virulence 2013; 4:453-66; PMID:23715053; http://dx.doi.org/10.4161/viru.25180tissues, expressing that epitope resulting in  autoimmune reactions.",Non-OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
Cell 1992; 71:153-67; PMID:1394428;  http://dx.doi.org/10.1016/0092-8674(92)90274-G 13.,OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
PLoS Pathog 2013; 9:e1003183; PMID:23468625; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
Ann N Y Acad Sci 2012; 1253:16-36;  PMID:22524423; http://dx.doi.org/10.1111/j.1749- 6632.2012.06517.x 17.,OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
FEBS Lett 2010; 584:555-61; PMID:19945458;  http://dx.doi.org/10.1016/j.febslet.2009.11.087 19.,OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
Nature 2001; 412:701-5; PMID:11507631;  http://dx.doi.org/10.1038/35089000 2.,Non-OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
Nat Rev Immunol 2013; 13:321-35; PMID:23618829;  http://dx.doi.org/10.1038/nri3430 3.,Non-OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
Clin Rev Allergy Immunol 2012; 42:102-11; PMID:22095454;  http://dx.doi.org/10.1007/s12016-011-8294-7 4.,Non-OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
Immunol Rev 2012; 250:199-215; PMID:23046131;  http://dx.doi.org/10.1111/imr.12009 5.,Non-OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
BMC Immunol 2012; 13:13; PMID:22435930; http://dx.doi.org/10.1186/1471- 2172-13-13 6.,Non-OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
Nat Immunol 2010; 11:21-7; PMID:20016506; http://dx.doi.org/10.1038/ni.1817 7.,Non-OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
Autoimmunity 2004; 37:375-86;  PMID:15621561; http://dx.doi.org/10.1080/089169 30410001713089hundred of such candidates by screening  a total of 128 bacterial proteomes.19 The  authors have classified the bacteria ana - lyzed in the study into two broad groups—pathogenic and non-pathogenic species.,Non-OADS,/arxiv_data1/oa_pdf/ae/4d/kvir-04-06-10925780.PMC5359722.pdf
"10 The participants concluded that  sepsis is fundamentally a disease of inflammation-induced endo - thelial activation/dysfunction and that future sepsis research should focus on the role and regulation of endothelial activation/Special focus Endothelial activation/dysfunction W c onrad Liles department of Medicine; u niversity of Washington; Seattle, WA u SA Correspondence to: W Conrad Liles; Email: wcliles@uw.edu Submitted: 07/27/2013; Accepted: 07/28/2013http://dx.doi.org/10.4161/viru.26018dysfunction in order to guide development of new therapeutic  strategies for treatment of sepsis.",Non-OADS,/arxiv_data1/oa_pdf/38/b0/kvir-04-06-10926018.PMC5359723.pdf
Blood  2003; 101:3765-77; PMID:12543869; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/b0/kvir-04-06-10926018.PMC5359723.pdf
Drug Discov Today Dis Mech 2007; 4:215-22;  http://dx.doi.org/10.1016/j.ddmec.2008.01.002 9.,OADS,/arxiv_data1/oa_pdf/38/b0/kvir-04-06-10926018.PMC5359723.pdf
Virulence  2013; 4:507-16; PMID:23669075; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/b0/kvir-04-06-10926018.PMC5359723.pdf
Virulence 2013; 4:517- 24; PMID:23652985; http://dx.doi.org/10.4161/ viru.24906 13.,Non-OADS,/arxiv_data1/oa_pdf/38/b0/kvir-04-06-10926018.PMC5359723.pdf
Virulence  2013; 4:525-36; PMID:23841977; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/b0/kvir-04-06-10926018.PMC5359723.pdf
Virulence 2013; 4:537- 42; PMID:23863601; http://dx.doi.org/10.4161/ viru.25779 15.,Non-OADS,/arxiv_data1/oa_pdf/38/b0/kvir-04-06-10926018.PMC5359723.pdf
Virulence 2013; 4:543- 55; PMID:23924893; http://dx.doi.org/10.4161/viru.25949 16.,Non-OADS,/arxiv_data1/oa_pdf/38/b0/kvir-04-06-10926018.PMC5359723.pdf
Virulence 2013; 4:572- 82; PMID:23863603; http://dx.doi.org/10.4161/ viru.25740,Non-OADS,/arxiv_data1/oa_pdf/38/b0/kvir-04-06-10926018.PMC5359723.pdf
"Eliseo A Eugenin Public Health r esearch i nstitute and r utgers University Medical School; t he State University of New Jersey; Newark, NJ USA Keywords:  Acinetobacter baumannii , alcohol, cytokines, macrophages, phagocytosis Correspondence to: Eliseo A Eugenin; Email: eliseo.eugenin@rutgers.edu Submitted: 07/11/13; Accepted: 07/13/13http://dx.doi.org/10.4161/viru.25747Editorial to: Asplund MB, et al.",Non-OADS,/arxiv_data1/oa_pdf/24/2d/kvir-04-06-10925747.PMC5359724.pdf
"Virulence 2013; 4:467-72; PMID:23863607; http://dx.doi.org/10.4161/viru.25641commonly contaminated resulting in  35% mortality rate.7 In the context of drug resistance  acquired by Ab,  the more common resis - tances are to carbapenems, β -lactams,  rifampicin, and emerging strains against once successful colistin have been iso - lated.",Non-OADS,/arxiv_data1/oa_pdf/24/2d/kvir-04-06-10925747.PMC5359724.pdf
Clin Infect Dis 2008; 46:1254-63;  PMID:18444865; http://dx.doi.org/10.1086/529198 3.,Non-OADS,/arxiv_data1/oa_pdf/24/2d/kvir-04-06-10925747.PMC5359724.pdf
Int J Antimicrob Agents 2008; 32:106-19;  PMID:18571905; http://dx.doi.org/10.1016/j.ijan - timicag.2008.02.013 4.,OADS,/arxiv_data1/oa_pdf/24/2d/kvir-04-06-10925747.PMC5359724.pdf
J Clin Microbiol 2002; 40:685-6; PMID:11825997; http://dx.doi.org/10.1128/JCM.40.2.685-686.2002 5.,Non-OADS,/arxiv_data1/oa_pdf/24/2d/kvir-04-06-10925747.PMC5359724.pdf
Eur J Clin Microbiol Infect Dis 2007; 26:857-68; PMID:17701432; http://dx.doi.org/10.1007/s10096- 007-0365-6 7.,Non-OADS,/arxiv_data1/oa_pdf/24/2d/kvir-04-06-10925747.PMC5359724.pdf
Chest 2001; 120:1072- 7; PMID:11591541; http://dx.doi.org/10.1378/chest.120.4.1072 9.,Non-OADS,/arxiv_data1/oa_pdf/24/2d/kvir-04-06-10925747.PMC5359724.pdf
J Clin Microbiol 2002; 40:1526-9; PMID:11923388; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/2d/kvir-04-06-10925747.PMC5359724.pdf
Respirology 2009; 14:1200-5; PMID:19909464; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/2d/kvir-04-06-10925747.PMC5359724.pdf
PLoS  One 2012; 7:e40019; PMID:22768201; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/2d/kvir-04-06-10925747.PMC5359724.pdf
"For the infection experiments, cultures of each strain were grown over - night at 30 °C on YPD liquid medium before collection of yeast-cells, which were Paradoxical effect to caspofungin   in Candida species does not confer survival  advantage in a Drosophila model of candidiasis régis A Zanette1,2 and d imitrios P Kontoyiannis1,* 1department of i nfectious d iseases; i nfection Control and e mployee h ealth; t he University of t exas M d Anderson Cancer Center; h ouston, t X USA;   2Graduate Program in Pharmacology; Federal University of Santa Maria; Santa Maria, r S Brazil Keywords:  caspofungin, paradoxical effect, Candida , Drosophila melanogaster *Correspondence to: Dimitrios P Kontoyiannis; Email: dkontoyi@mdanderson.org Submitted: 05/14/13; Revised: 06/24/13; Accepted: 06/24/13http://dx.doi.org/10.4161/viru.25523counted using a hemocytometer and then  suspended in sterile phosphate buffered saline.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/kvir-04-06-10925523.PMC5359725.pdf
Clin Infect Dis  2009; 48:1676-84; PMID:19419331; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/kvir-04-06-10925523.PMC5359725.pdf
J Infect Dis 2006; 193:1014-22; PMID:16518764;  http://dx.doi.org/10.1086/5009503.,OADS,/arxiv_data1/oa_pdf/fe/fc/kvir-04-06-10925523.PMC5359725.pdf
Antimicrob Agents Chemother 2011; 55:302- 10; PMID:21060107; http://dx.doi.org/10.1128/ AAC.00633-10 4.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/kvir-04-06-10925523.PMC5359725.pdf
Antimicrob Agents Chemother 2005; 49:5146- 8; PMID:16304189; http://dx.doi.org/10.1128/ AAC.49.12.5146-5148.2005References 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/kvir-04-06-10925523.PMC5359725.pdf
Antimicrob Agents  Chemother 2007; 51:2257-9; PMID:17438060;  http://dx.doi.org/10.1128/AAC.00095-07 2.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/kvir-04-06-10925523.PMC5359725.pdf
Antimicrob Agents Chemother 2011; 55:2641- 7; PMID:21422223; http://dx.doi.org/10.1128/ AAC.00999-10 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/kvir-04-06-10925523.PMC5359725.pdf
*Correspondence to: Sanjib Bhakta; Email: s.bhakta@bbk.ac.uk Submitted: 04/30/13; Revised: 06/12/13; Accepted: 06/13/13http://dx.doi.org/10.4161/viru.25397Mycobacterium tuberculosis… Can we beat it?,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Mol Biol 2013; 2:e108;  http://dx.doi.org/10.4172/2168-9547.1000e108 2.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Immunobiology 2012; 217:363- 74; PMID:21813205; http://dx.doi.org/10.1016/j.imbio.2011.07.008 6.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
N Engl J Med 2013; 368:745- 55; PMID:23425167; http://dx.doi.org/10.1056/ NEJMra1200894 7.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Lancet Infect Dis 2003; 3:578-90;  PMID:12954564; http://dx.doi.org/10.1016/S1473- 3099(03)00741-2 8.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
T rends Microbiol 2006; 14:271-6; PMID:16675219; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Clin Infect Dis 2002; 34:365-70; PMID:11774084; http://dx.doi.org/10.1086/33814910.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Int J Infect Dis 2006; 10:93- 102; PMID:16377228; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Lancet Infect  Dis 2013; 13:529-39; PMID:23531391; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Lancet Infect Dis 2013; 13:349-61;  PMID:23531388; http://dx.doi.org/10.1016/S1473- 3099(13)70008-2 13.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
J Chromatogr A  2009; 1216:6319-25; PMID:19631943; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Int J T uberc Lung Dis 2013; 17:719-27; PMID:23541232; http://dx.doi.org/10.5588/ ijtld.12.0638 15.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Mol Microbiol  1999; 31:1561-72; PMID:10200973; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
PLoS Med 2008; 5:e75; PMID:18384229;  http://dx.doi.org/10.1371/journal.pmed.005007517.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
J Antimicrob Chemother 2009; 64:774- 81; PMID:19656786; http://dx.doi.org/10.1093/jac/ dkp279 20.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
J Antimicrob Chemother 2012; 67:1380- 91; PMID:22398649; http://dx.doi.org/10.1093/jac/ dks056 22.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
J Antimicrob Chemother 2010; 65:2101- 7; PMID:20719764; http://dx.doi.org/10.1093/jac/dkq313,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Proc Natl Acad Sci U S A  2012; 109:11354-9; PMID:22733761; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Cell Microbiol 2010; 12:1634-47; PMID:20633027;  http://dx.doi.org/10.1111/j.1462-5822.2010.01496.x 37.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
J Leukoc Biol  2010; 88:445-62; PMID:20445014; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
"Lancet Infect  Dis 2013; 13:362-72; PMID:23531389; http://dx.doi.org/10.1016/S1473-3099(13)70034-3 39. den Hertog AL, Mayboroda OA, Klatser PR, Anthony  RM.",OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
PLoS Pathog 2011; 7:e1002207;  PMID:22072958; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Clin Infect Dis 2012; 55:572-81; PMID:22615332;  http://dx.doi.org/10.1093/cid/cis487 31.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
N Engl J Med 2012; 366:2151-60;  PMID:22670901; http://dx.doi.org/10.1056/ NEJMoa1112433 32.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
J Exp Med  2004; 199:1191-9; PMID:15117974; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Protein Cell 2010;  1:82-95; PMID:21204000; http://dx.doi.org/10.1007/ s13238-010-0006-1 34.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
PLoS One  2012; 7:e52790; PMID:23285185; http://dx.doi.org/10.1371/journal.pone.005279024.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Protein Cell  2010; 1:1011-22; PMID:21153518; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
T uberculosis (Edinb) 2010; 90:16- 24; PMID:19945347; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
J Antimicrob Chemother 2011; 66:1766- 72; PMID:21622974; http://dx.doi.org/10.1093/jac/ dkr203 27.,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
Int J Antimicrob Agents 2012; 39:124- 9; PMID:22079533; http://dx.doi.org/10.1016/j.ijan- timicag.2011.09.018 28.,OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
J Infect Dis 2013; 208:199-202;  PMID:23564636; http://dx.doi.org/10.1093/infdis/ jit152,Non-OADS,/arxiv_data1/oa_pdf/d3/31/kvir-04-06-10925397.PMC5359728.pdf
"www.landesbioscience.com Virulence 473Virulence 4:6, 473–482; August 15, 2013; © 2013 Landes Bioscience ReseAR ch p ApeR ReseAR ch p ApeR *Correspondence to: Junjie Yue; Email: yue_junjie@126.com; Zhixian Gao; Email: gaozhx@163.com; Long Liang; Email: ll@bmi.ac.cn Submitted: 03/22/13; Revised: 06/28/13; Accepted: 07/11/13http://dx.doi.org/10.4161/viru.25730Introduction Bacterial pathogens often cause various epidemic diseases, which  threaten human health and lives.1,2 A growing number of research - ers have conducted related research and made great achievements in the field of bacterial pathogens.",Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
"24 The phenotypes of the 278 non-pathogenic bacterial strains  and their habitats status were obtained from the GenBank (http://www.ncbi.nlm.nih.gov/Genbank/): prokaryotic attri-butes table (e.g., pathogenic in, disease and environment: habitat fields) and Genomes Online Database (GOLD) (http://www.genomesonline.org/): organism information (e.g., phenotype, disease, and habitat fields).",OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Science 1999; 284:1311-3; PMID:10334978;  http://dx.doi.org/10.1126/science.284.5418.1311 2.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Science 2000; 287:443-9;  PMID:10642539; http://dx.doi.org/10.1126/sci- ence.287.5452.443 3.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Postgrad Med J 2002; 78:216- 24; PMID:11930024; http://dx.doi.org/10.1136/ pmj.78.918.216 4.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nat Rev Microbiol 2004; 2:67-72; PMID:15035010;  http://dx.doi.org/10.1038/nrmicro799 5.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nature 2007; 449:835-42; PMID:17943120; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nat Rev  Microbiol 2004; 2:91; PMID:15040257; http://dx.doi.org/10.1038/nrmicro825 8.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
J Bacteriol 2003; 185:1831- 40; PMID:12618447; http://dx.doi.org/10.1128/ JB.185.6.1831-1840.2003 9.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
BMC Genomics 2006; 7:128;  PMID:16734888; http://dx.doi.org/10.1186/1471- 2164-7-128 10.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
FEMS Microbiol Lett  2001; 201:1-7; PMID:11445159; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
PLoS Pathog 2006; 2:e42; PMID:16733541;  http://dx.doi.org/10.1371/journal.ppat.0020042 12.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Naturwissenschaften 2000; 87:1-11; PMID:10663126;  http://dx.doi.org/10.1007/s001140050001 13.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Genome Biol 2008; 9:225;  PMID:18598378; http://dx.doi.org/10.1186/gb-2008- 9-6-225 14.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
PLoS  Pathog 2007; 3:e7; PMID:17257059; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
PLoS One 2009; 4:e8094;  PMID:19956607; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Science 2000; 287:2204- 15; PMID:10731134; http://dx.doi.org/10.1126/sci- ence.287.5461.2204 18.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nucleic Acids Res 2008;  36(Database issue):D539-42; PMID:17984080;  http://dx.doi.org/10.1093/nar/gkm951 19.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Bioinformatics 2008; 24:319-24;  PMID:18042555; http://dx.doi.org/10.1093/bioinfor- matics/btm585 20.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Annu Rev Microbiol 2000; 54:641- 79; PMID:11018140; http://dx.doi.org/10.1146/ annurev.micro.54.1.641 21.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Microbes Infect 2001; 3:545-8;  PMID:11418328; http://dx.doi.org/10.1016/S1286- 4579(01)01410-1 22.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Cell Microbiol  2006; 8:1707-19; PMID:16939533; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Clin Microbiol Rev 2004; 17:14- 56; PMID:14726454; http://dx.doi.org/10.1128/ CMR.17.1.14-56.2004 24.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Curr  Med Chem 2008; 15:1116-25; PMID:18473807;  http://dx.doi.org/10.2174/092986708784221430 25.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Emerg Infect Dis 1999; 5:224- 34; PMID:10221874; http://dx.doi.org/10.3201/ eid0502.990206 26.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
T rends Microbiol 2002; 10:39-45;  PMID:11755084; http://dx.doi.org/10.1016/S0966- 842X(01)02259-4 27.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Vet Microbiol  2005; 107:225-32; PMID:15863281; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Proc Natl Acad Sci U S A 2005; 102:3004-9; PMID:15703294; http://dx.doi.org/10.1073/ pnas.0409900102 29.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
J Biol Chem 2003; 278:19159-63; PMID:12582172;  http://dx.doi.org/10.1074/jbc.M208552200 30.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
J Biol Chem 2006; 281:5461-7; PMID:16377616;  http://dx.doi.org/10.1074/jbc.M51289720031.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
J Clin Microbiol  2005; 43:533-8; PMID:15695641; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Annu Rev Phytopathol 2004; 42:385- 414; PMID:15283671; http://dx.doi.org/10.1146/ annurev.phyto.42.040103.110731 34.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Proc Natl Acad Sci U S A  2002; 99:12397-402; PMID:12213957; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nat Rev Microbiol 2006; 4:811-25; PMID:17041629;  http://dx.doi.org/10.1038/nrmicro1526 36.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nat Rev Microbiol 2003; 1:137-49;  PMID:15035043; http://dx.doi.org/10.1038/nrmi- cro753 37.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Cell Microbiol 2008; 10:2377-86;  PMID:18549454; http://dx.doi.org/10.1111/j.1462- 5822.2008.01187.x 38.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Annu Rev Genet 2005; 39:309-38;  PMID:16285863; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
J Mol Biol 2003; 328:749-67;  PMID:12706730; http://dx.doi.org/10.1016/S0022- 2836(03)00269-9 40.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nat Med 2004; 10:842-8; PMID:15247912; http://dx.doi.org/10.1038/nm1079 41.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Appl Environ Microbiol 2000; 66:4396- 400; PMID:11010889; http://dx.doi.org/10.1128/AEM.66.10.4396-4400.2000 44.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nucleic Acids Res 2003; 31:400-2; PMID:12520033; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
OMICS 2008; 12:129- 36; PMID:18416669; http://dx.doi.org/10.1089/omi.2008.0016 48.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nucleic Acids Res 2010; 38(Database issue):D346-54;  PMID:19914934; http://dx.doi.org/10.1093/nar/ gkp848 49.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
PLoS Comput Biol 2009; 5:e1000262;  PMID:19148271; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nucleic Acids Res 2001;  29:22-8; PMID:11125040; http://dx.doi.org/10.1093/ nar/29.1.22 51.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Genome Res  2002; 12:493-502; PMID:11875039; http://dx.doi.org/10.1101/gr.21200252.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
J Mol Biol 2001; 314:1041- 52; PMID:11743721; http://dx.doi.org/10.1006/ jmbi.2000.5197 53.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nucleic Acids Res 2005; 33(Database issue):D476-80;  PMID:15608241; http://dx.doi.org/10.1093/nar/ gki107 54.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nucleic Acids Res 2008; 36(Database issue):D281-8;  PMID:18039703; http://dx.doi.org/10.1093/nar/ gkm960 55.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
PLoS One  2012; 7:e32423; PMID:22427835; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Mol Microbiol  2002; 46:1053-67; PMID:12421311; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Infect Immun  2004; 72:2057-66; PMID:15039327; http://dx.doi.org/10.1128/IAI.72.4.2057-2066.2004 58.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Nat Immunol 2004; 5:1166-74;  PMID:15489856; http://dx.doi.org/10.1038/ni1131 59.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Proc Natl Acad Sci U S  A 2004; 101:841-6; PMID:14715899; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Science 2004; 303:1358- 61; PMID:14988561; http://dx.doi.org/10.1126/sci- ence.1094226 61.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Infect Immun 2005; 73:3096- 103; PMID:15845517; http://dx.doi.org/10.1128/ IAI.73.5.3096-3103.2005 63.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Annu Rev Biochem 2002; 71:635-700;  PMID:12045108; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Cell 2004; 117:285-97; PMID:15109490;  http://dx.doi.org/10.1016/S0092-8674(04)00343-5 65.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
Curr Opin Microbiol 2008;  11:3-8; PMID:18289922; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
FEMS  Microbiol Lett 2006; 255:175-86; PMID:16448494;  http://dx.doi.org/10.1111/j.1574-6968.2006.00102.x,OADS,/arxiv_data1/oa_pdf/58/88/kvir-04-06-10925730.PMC5359729.pdf
" Special FocuS  Review virulence 4:6, 564–571; a ugust 15, 2013; © 2013 landes Bioscience 564 virulence volume 4 issue 6Introduction Since effective antiretroviral therapy (ART) became widely avail - able, the risks for morbidity and mortality due to opportunistic  infections have greatly decreased for persons living with HIV  *Correspondence to: Susan M Graham; Email: grahamsm@uw.edu Submitted: 04/09/13; Revised: 05/30/13; Accepted: 05/30/13http://dx.doi.org/10.4161/viru.25221Introduction : H iv infection is associated with vascular  dysfunction and adverse cardiovascular outcomes.",Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
J Infect  Dis 2006; 194:11-9; PMID:16741877; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
AIDS  2008; 22:2409-18; PMID:19005264; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
HIV Clin T rials 2008; 9:177-85;  PMID:18547904; http://dx.doi.org/10.1310/hct0903- 177 5.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Clin Infect Dis  2011; 53:1130-9; PMID:21998280; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Curr Opin HIV AIDS 2010; 5:498- 503; PMID:20978393; http://dx.doi.org/10.1097/COH.0b013e32833ed6f4 8.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
J Infect Dis 2010; 201:1783-5;  PMID:20446849; http://dx.doi.org/10.1086/652751 9.,OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
J Infect Dis 2002; 185:456-62;  PMID:11865397; http://dx.doi.org/10.1086/338572 10.,OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
PLoS Med 2008;  5:e203; PMID:18942885; http://dx.doi.org/10.1371/ journal.pmed.005020311.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
AIDS  2009; 23:1841-9; PMID:19455012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
HIV  Med 2006; 7:218-30; PMID:16630034; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Cardiovasc J  Afr 2011; 22:134-40; PMID:21713302; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Circulation  2006; 113:e72-5; PMID:16476853; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Circulation 2006; 113:e152-5; PMID:16490825; http://dx.doi.org/10.1161/ CIRCULATIONAHA.105.595538,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Thromb Res 2012; 129:301- 8; PMID:22192157; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
AIDS 2006; 20:59- 66; PMID:16327320; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
BMC INfect  Dis 2013; 13:263; PMID: 23734875; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Int J Infect Dis 2012; 16:e89- 93; PMID:22154082; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Clin Immunol Immunopathol 1994; 72:328-34; PMID:7914841; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Circulation 2004; 109:1603-8; PMID:15023877; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
N Engl J Med 2006; 355:2283-96; PMID:17135583;  http://dx.doi.org/10.1056/NEJMoa06236027.,OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
J Infect Dis 2009; 199:1186-94; PMID:19275490;  http://dx.doi.org/10.1086/597475 28.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
J Infect Dis 2009; 200:973-83; PMID:19678756; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
AIDS 2010; 24:1509- 17; PMID:20505494; http://dx.doi.org/10.1097/ QAD.0b013e32833ad914 30.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
AIDS  2011; 25:787-95; PMID:21412059; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
AIDS Patient Care STDS 2003; 17:147-53; PMID:12737638; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Thromb Haemost 2010; 104:1228-34;  PMID:20886182; http://dx.doi.org/10.1160/TH10- 04-0233 34.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Clin Infect  Dis 2012; 54:984-94; PMID:22337823; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Circulation 2006; 113:e289- 92; PMID:16505179; http://dx.doi.org/10.1161/ CIRCULATIONAHA.105.595546 17.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
J Acquir Immune Defic Syndr 2009; 50:430- 2; PMID:19322038; http://dx.doi.org/10.1097/QAI.0b013e31819a292c 18.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Cell Adhes Commun  1995; 3:179-85; PMID:8846020; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
Atherosclerosis  2009; 204:e1-3; PMID:19185298; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
AIDS Patient Care STDS 2011; 25:269-72; PMID:21466379; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
HIV Med 2011; 12:594-601;  PMID:21645196; http://dx.doi.org/10.1111/j.1468- 1293.2011.00935.x 23.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
AIDS  2010; 24:1958-61; PMID:20613460; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
AIDS 2010; 24:1377-80; PMID:20559042; http://dx.doi.org/10.1097/ QAD.0b013e3283396024 26.,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
AIDS Res Hum Retroviruses 2011; 27:295- 302; PMID:20969457; http://dx.doi.org/10.1089/ aid.2010.0187,Non-OADS,/arxiv_data1/oa_pdf/9f/c3/kvir-04-06-10925221.PMC5359730.pdf
"Specifically,  *Correspondence to: Warren L Lee; Email: warren.lee@utoronto.ca Submitted: 04/15/13; Revised: 07/15/13; Accepted: 07/16/13http://dx.doi.org/10.4161/viru.25779The development of severe influenza has been attributed,  in part, to a heightened innate immune response.",Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
JAMA  2009; 302:1872-9; PMID:19822627; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Clin Infect Dis 2007; 45:1568-75; PMID:18190317;  http://dx.doi.org/10.1086/523584 4.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Am J Respir  Crit Care Med 2008; 178:969-76; PMID:18689466;  http://dx.doi.org/10.1164/rccm.200803-455OC 7.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Proc Natl Acad Sci U S A 2000; 97:10282- 7; PMID:10920189; http://dx.doi.org/10.1073/ pnas.160041997 8.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Curr  Opin Crit Care 2008; 14:22-30; PMID:18195622;  http://dx.doi.org/10.1097/MCC.0b013e3282f269b9 9.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Am J Pathol 2000; 156:1951-9;  PMID:10854218; http://dx.doi.org/10.1016/S0002- 9440(10)65068-710.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Nature 2007; 445:319-23; PMID:17230189;  http://dx.doi.org/10.1038/nature05495 12.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
PLoS Pathog 2008; 4:e1000115; PMID:18670648;  http://dx.doi.org/10.1371/journal.ppat.1000115 13.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Infect Dis 2010; 202:1161-70; PMID:20815704; http://dx.doi.org/10.1086/656365 14.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
"Lancet 2004; 363:617-9; PMID:14987888; http://dx.doi.org/10.1016/ S0140-6736(04)15595-5 15. de Jong MD, Simmons CP , Thanh TT, Hien VM, Smith GJ, Chau TN, et al.",OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Nat Med 2006; 12:1203-7;  PMID:16964257; http://dx.doi.org/10.1038/nm1477 16.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Virol 2010; 84:12576-88; PMID:20926563; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Biochem Biophys Res Commun 2003; 306:244-9;  PMID:12788095; http://dx.doi.org/10.1016/S0006- 291X(03)00945-8 19.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Am J Respir Cell Mol Biol 2003; 28:574- 81; PMID:12707013; http://dx.doi.org/10.1165/ rcmb.2002-0075OC 20.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
FASEB J 2003; 17:407-16;  PMID:12631580; http://dx.doi.org/10.1096/fj.02- 0672com 21.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Infect Dis 2010; 202:991-1001;  PMID:20731583; http://dx.doi.org/10.1086/656044 22.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Respir Res 2009; 10:102; PMID:19874627; http://dx.doi.org/10.1186/1465- 9921-10-102 23.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Cell 2011; 146:980-91;  PMID:21925319; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Biol Chem 2005; 280:17320-8; PMID:15728185; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Proc Natl Acad Sci U S A 1986; 83:3460- 4; PMID:3486418; http://dx.doi.org/10.1073/ pnas.83.10.3460 56.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Clin Invest 1996; 97:493-500; PMID:8567972; http://dx.doi.org/10.1172/JCI118440 59.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Vascul Pharmacol  2008; 49:141-50; PMID:18625343; http://dx.doi.org/10.1016/j.vph.2008.06.004 61.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Chest 2012; 141:1490-5; PMID:22383669; http://dx.doi.org/10.1378/chest.11- 2860 64.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Clin Invest 2012; 122:2661- 71; PMID:22684106; http://dx.doi.org/10.1172/ JCI61303 65.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Clin Invest 2006; 116:3211- 9; PMID:17143330; http://dx.doi.org/10.1172/ JCI29499 66.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Am J Respir  Crit Care Med 2012; 185:628-36; PMID:22246174;  http://dx.doi.org/10.1164/rccm.201108-1533OC 67.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Exp Mol Pathol 2012; 92:287-95; PMID:22421441;  http://dx.doi.org/10.1016/j.yexmp.2012.03.003 68.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Am  J Physiol Lung Cell Mol Physiol 2010; 299:L652- 63; PMID:20729389; http://dx.doi.org/10.1152/ ajplung.00202.2009 69.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Immunol Res 2011; 51:15-25;  PMID:21901448; http://dx.doi.org/10.1007/s12026- 011-8240-z40.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Clin Infect Dis 2011; 52:e14- 7; PMID:21288835; http://dx.doi.org/10.1093/cid/ciq125 41.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Prev Med 1975; 4:115-25; PMID:1153392; http://dx.doi.org/10.1016/0091-7435(75)90077-8 44.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Stroke 1978; 9:549-58; PMID:741484; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Neuroepidemiology  2004; 23:228-35; PMID:15316249; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Intern Med  1989; 225:293-6; PMID:2732669; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Stroke  2002; 33:513-8; PMID:11823662; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Stroke 2005; 36:1501-6;  PMID:15947266; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
N Engl J Med 2003; 348:1322-32; PMID:12672859; http://dx.doi.org/10.1056/ NEJMoa025028 51.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Eur Heart J 2007; 28:1178- 9; PMID:17470675; http://dx.doi.org/10.1093/eur- heartj/ehm073 53.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Crit Care 2009; 13:R201;  PMID:20003352; http://dx.doi.org/10.1186/cc8208 54.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Am J Pathol 2011; 179:199- 210; PMID:21703402; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Am J T rop Med Hyg 2013; 88:461- 3; PMID:23382162; http://dx.doi.org/10.4269/ ajtmh.12-0132 28.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Science 2004; 303:1532-5;  PMID:15001782; http://dx.doi.org/10.1126/sci-ence.1092385 29.,OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
PLoS  One 2012; 7:e32366; PMID:22389696; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Virol 2012; 86:667-78; PMID:22072765;  http://dx.doi.org/10.1128/JVI.06348-11 31.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Immunol  2009; 183:5180-9; PMID:19786538; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
PLoS One 2012; 7:e47323; PMID:23115643; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Virol 2000; 74:8018-27; PMID:10933711;  http://dx.doi.org/10.1128/JVI.74.17.8018-8027.2000 34.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
J Immunol 2011; 186:164-73;  PMID:21106851; http://dx.doi.org/10.4049/jimmu- nol.0904170 35.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Nature 2012; 492:252-5; PMID:23143332; http://dx.doi.org/10.1038/nature11603 37.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Physiol Rev 2006; 86:279-367; PMID:16371600; http://dx.doi.org/10.1152/ physrev.00012.2005 39.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
Sci T ransl Med 2010; 2:23ra19;  PMID:20375003; http://dx.doi.org/10.1126/scitrans- lmed.3000678,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/kvir-04-06-10925779.PMC5359731.pdf
"3 Typica l HUS,  also known as diarrhea-associated HUS (D+HUS), accounts  *Correspondence to: Philip A Marsden; Email: p.marsden@utoronto.ca Submitted: 05/20/2013; Revised: 08/13/2013; Accepted: 08/13/2013http://dx.doi.org/10.4161/viru.26143Shiga toxin-producing E. coli  represents a significant global  health concern, especially as hypervirulent pathogens surface  amidst outbreaks of hemolytic uremic syndrome (H uS).",Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Immunobiology 2012; 217:235-43; PMID:21852019;  http://dx.doi.org/10.1016/j.imbio.2011.07.022 2.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
N Engl J Med 2009; 361:1676-87; PMID:19846853; http://dx.doi.org/10.1056/ NEJMra0902814 4.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Kidney Int Suppl  2009; (Suppl):S4-7; PMID:19180132; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Kidney Int Suppl 2009; (Suppl):S17-9;  PMID:19180125; http://dx.doi.org/10.1038/ ki.2008.612 6.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Curr Opin Nephrol  Hypertens 2012; 21:433-40; PMID:22660553; http://dx.doi.org/10.1097/MNH.0b013e328354a62e 7.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Lancet 1983; 1:619-20; PMID:6131302; http://dx.doi.org/10.1016/S0140-6736(83)91795-6 8.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J Infect Dis 1985; 151:775- 82; PMID:3886804; http://dx.doi.org/10.1093/ infdis/151.5.775 9.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Proc Natl Acad Sci U S A 1990; 87:7839- 43; PMID:2172966; http://dx.doi.org/10.1073/ pnas.87.20.7839 10.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Vet Microbiol  2010; 140:360-70; PMID:19410388; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Pediatr Nephrol 2008; 23:1749- 60; PMID:18704506; http://dx.doi.org/10.1007/ s00467-008-0935-614.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Toxins (Basel) 2010; 2:2769- 94; PMID:21297888; http://dx.doi.org/10.3390/tox- ins2122769 15.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J Clin Invest 2012; 122:759-76; PMID:22232208; http://dx.doi.org/10.1172/JCI57313 17.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Nat Rev Nephrol 2012; 8:658-69; PMID:22986362; http://dx.doi.org/10.1038/nrne- ph.2012.196 18.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J Pediatr 1994; 125:511-8; PMID:7931868; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Pediatr Nephrol 2010; 25:2231-40;  PMID:20424866; http://dx.doi.org/10.1007/s00467- 010-1522-1 20.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Pediatr Nephrol 2013; In press;  PMID:23288350; http://dx.doi.org/10.1007/s00467- 012-2383-6 21.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Clin Infect  Dis 2012; 54:1413-21; PMID:22412065; http://dx.doi.org/10.1093/cid/cis196 22.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Clin Infect Dis 2012; 55:33-41; PMID:22431799;  http://dx.doi.org/10.1093/cid/cis299 24.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Antimicrob Agents Chemother  2012; 56:3277-82; PMID:22391549; http://dx.doi.org/10.1128/AAC.06315-11 25.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Clin Infect Dis 2012; 55:760-3; PMID:22670035; http://dx.doi.org/10.1093/cid/ cis53326.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Lancet 2011; 378:1089-93;  PMID:21871657; http://dx.doi.org/10.1016/S0140- 6736(11)61145-8 27.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Pediatrics 2005; 115:e673-80; PMID:15930195; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
PLoS  One 2013; 8:e55278; PMID:23460784; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
N Engl J Med 2011; 365:1771- 80; PMID:21696328; http://dx.doi.org/10.1056/ NEJMoa1106483 31.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
N Engl J Med 2011; 365:1763-70; PMID:22029753;  http://dx.doi.org/10.1056/NEJMoa1106482 32.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
PLoS One 2011; 6:e22751;  PMID:21799941; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
N Engl J Med 2011; 365:718- 24; PMID:21793736; http://dx.doi.org/10.1056/ NEJMoa1107643 38.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Comparative genom- ics of recent Shiga toxin-producing Escherichia coli  O104:H4: short-term evolution of an emerging patho- gen. MBio 2013; 4:e00452-12; PMID:23341549;  http://dx.doi.org/10.1128/mBio.00452-12 39.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J Clin Microbiol 2012; 50:2951-63; PMID:22760050; http://dx.doi.org/10.1128/ JCM.00860-12 40.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Lancet 1983; 2:216; PMID:6135046; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Science  1984; 226:694-6; PMID:6387911; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J Clin Invest 1998; 101:372-82; PMID:9435309; http://dx.doi.org/10.1172/JCI522 44.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Eur J Biochem 1988; 171:45-50; PMID:3276522;  http://dx.doi.org/10.1111/j.1432-1033.1988.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Arch Biochem Biophys 1992; 293:140- 6; PMID:1731630; http://dx.doi.org/10.1016/0003-9861(92)90376-849.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Curr Top Microbiol Immunol 2012;  357:137-78; PMID:22130961; http://dx.doi.org/10.1007/82_2011_155 54.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Circ Res  2007; 100:158-73; PMID:17272818; http://dx.doi.org/10.1161/01.RES.0000255691.76142.4a 55.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Blood 2003; 102:1323-32; PMID:12702508; http://dx.doi.org/10.1182/blood- 2002-10-3301 57.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Microvasc  Res 1994; 47:377-87; PMID:8084301; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J Thromb Haemost 2005; 3:752-62;  PMID:15842359; http://dx.doi.org/10.1111/j.1538- 7836.2005.01205.x 59.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Science 1993; 261:600-3; PMID:8342023; http://dx.doi.org/10.1126/science.8342023 60.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Genomics 1995; 28:495- 500; PMID:7490086; http://dx.doi.org/10.1006/ geno.1995.1180 61.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J  Am Soc Nephrol 2009; 20:1714-23; PMID:19443644;  http://dx.doi.org/10.1681/ASN.2008060640 62.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J Clin Invest  2007; 117:3708-19; PMID:18037996; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Nat Med 2004; 10:858-64;  PMID:15235597; http://dx.doi.org/10.1038/nm1075 66.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Nat Med 2006; 12:557-67;  PMID:16648859; http://dx.doi.org/10.1038/nm1400 67.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Blood 2010; 115:5102-10;  PMID:20154215; http://dx.doi.org/10.1182/blood- 2009-07-230284 68.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Blood 2001; 97:937-45; PMID:11159520; http://dx.doi.org/10.1182/blood.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
N Engl J Med 2002; 346:23- 32; PMID:11777999; http://dx.doi.org/10.1056/ NEJMoa011033 71.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Blood  2005; 106:4199-209; PMID:16131569; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Blood 2001; 98:1828-35; PMID:11535517;  http://dx.doi.org/10.1182/blood.V98.6.1828 74.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Kidney Int  2002; 62:846-56; PMID:12164866; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Curr Opin Nephrol Hypertens 2010; 19:242- 7; PMID:20186056; http://dx.doi.org/10.1097/MNH.0b013e3283378f25,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J Immunol 2009; 182:6394- 400; PMID:19414792; http://dx.doi.org/10.4049/ jimmunol.0900151 78.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Clin J Am Soc Nephrol 2009; 4:1920-4; PMID:19820137; http://dx.doi.org/10.2215/ CJN.02730409 79.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Blood 2011; 117:5503-13; PMID:21447825; http://dx.doi.org/10.1182/blood- 2010-09-309161 80.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J Immunol  2011; 187:172-80; PMID:21642543; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
N Engl J Med  2011; 364:2561-3; PMID:21612462; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Nat Rev Nephrol 2012; 8:622-33; PMID:22986360;  http://dx.doi.org/10.1038/nrneph.2012.195 83.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
Nephrol Dial T ransplant 2012; 27:3807- 15; PMID:23114903; http://dx.doi.org/10.1093/ndt/ gfs394 85.,Non-OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
J Infect Dis 2013; 208:929-33;  PMID:23801605; http://dx.doi.org/10.1093/infdis/ jit268.,OADS,/arxiv_data1/oa_pdf/de/1d/kvir-04-06-10926143.PMC5359733.pdf
"7 –8, 348 –366, http://dx.doi.org/10.1080/13698575.2016.1269879 © 2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/a4/6d/chrs-18-348.PMC5359734.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduc- tion in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/a4/6d/chrs-18-348.PMC5359734.pdf
ORCID Jens O. Zinn http://orcid.org/0000-0002-4992-9123362 J.O.,Non-OADS,/arxiv_data1/oa_pdf/a4/6d/chrs-18-348.PMC5359734.pdf
"2, 274 –283 http://dx.doi.org/10.1080/03004430.2016.1237566",Non-OADS,/arxiv_data1/oa_pdf/1b/d0/gecd-187-274.PMC5359735.pdf
"Retrieved November, 2015, from http://www.engineeringuk.com/report Wassermann, S. ( 1990 ).Serious players in the primary classroom .",Non-OADS,/arxiv_data1/oa_pdf/1b/d0/gecd-187-274.PMC5359735.pdf
"8, 1128–1141 http://dx.doi.org/10.1080/09515089.2016.1224826 Qualitative tools and experimental philosophy James Andow  Department of Philosophy, University of Reading, Reading, UK ABSTRACT Experimental philosophy brings empirical methods to philosophy.",Non-OADS,/arxiv_data1/oa_pdf/97/89/cphp-29-1128.PMC5359736.pdf
"ORCID James Andow   http://orcid.org/0000-0002-5760-0475 References Ahlenius, H., & Tännsjö, T. (2012).",Non-OADS,/arxiv_data1/oa_pdf/97/89/cphp-29-1128.PMC5359736.pdf
"Retrieved from http://plato.stanford.edu/entries/introspection/ Skulmowski, A., Bunge, A., Cohen, B. R., Kreilkamp, B., & Troxler, N. (2015).",Non-OADS,/arxiv_data1/oa_pdf/97/89/cphp-29-1128.PMC5359736.pdf
"Retrieved August 19, 2016, from http://experimental-philosophy.yale.edu/ ExperimentalPhilosophy.html Van Someren, M. W ., Barnard, Y .",Non-OADS,/arxiv_data1/oa_pdf/97/89/cphp-29-1128.PMC5359736.pdf
"Yet, in the field of sepsis, the molecular pathogenesis of microvascular disruption has been relatively under-studied, with  Correspondence to: Samir M Parikh; Email: sparikh1@bidmc.harvard.edu Submitted: 04/11/13; Revised: 05/01/13; Accepted: 05/02/13http://dx.doi.org/10.4161/viru.24906Dynamic changes in microvascular endothelial structure and  function are pivotal in the acute inflammatory response, the body’s rapid, coordinated effort to localize, sequester, and  eliminate microbial invaders at their portal of entry.",Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
N Engl J Med  1983; 308:553-8; PMID:6402699; http://dx.doi.org/10.1056/NEJM198303103081002 2.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Science 1985; 229:869-71; PMID:3895437; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Nat Cell Biol 2008; 10:513-26;  PMID:18425120; http://dx.doi.org/10.1038/ncb1714 37.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
J Biol Chem  2011; 286:8055-66; PMID:21212269; http://dx.doi.org/10.1074/jbc.M110.192641 39.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
PLoS Med 2006; 3:e46;  PMID:16417407; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Nat Med 2006; 12:235-9;  PMID:16462802; http://dx.doi.org/10.1038/nm1351 41.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Proc Natl Acad Sci U S A 2006; 103:15491- 6; PMID:17030814; http://dx.doi.org/10.1073/ pnas.0607538103 45.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Mol Cell Biol  2009; 29:2011-22; PMID:19223473; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
J Pharmacol Exp Ther 2013; 345:2-6;  PMID:23378191; http://dx.doi.org/10.1124/ jpet.112.201061 47.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Am J Respir Crit Care Med  2007; 175:1014-26; PMID:17322110; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
J Clin Invest 1997; 100:2072- 8; PMID:9329972; http://dx.doi.org/10.1172/ JCI119740 24.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Blood 2006; 107:4754-62; PMID:16514057; http://dx.doi.org/10.1182/ blood-2006-01-0141 25.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
J Cell Biol 2005; 170:993- 1004; PMID:16157706; http://dx.doi.org/10.1083/ jcb.200507082 27.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
J  Clin Invest 2012; 122:1991-2005; PMID:22585576;  http://dx.doi.org/10.1172/JCI58832 28.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Nat Med 2000; 6:460-3;  PMID:10742156; http://dx.doi.org/10.1038/74725 30.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Science 1999; 286:2511-4; PMID:10617467; http://dx.doi.org/10.1126/science.286.5449.2511 31.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Circulation 2005; 111:97-105; PMID:15611372; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
J Biol Chem 2007; 282:23910- 8; PMID:17562701; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Am J Physiol Heart Circ Physiol 2006; 290:H107- 18; PMID:16126815; http://dx.doi.org/10.1152/ajp- heart.00542.2005 34.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Blood  2003; 102:4407-9; PMID:12933576; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Nat Cell Biol 2008; 10:527-37; PMID:18425119; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Proc Natl Acad Sci U S A 1993; 90:9355- 8; PMID:8415706; http://dx.doi.org/10.1073/ pnas.90.20.9355 11.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Genes Dev 1994; 8:1897- 909; PMID:7958865; http://dx.doi.org/10.1101/ gad.8.16.1897 13.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Science 1997; 277:55-60; PMID:9204896;  http://dx.doi.org/10.1126/science.277.5322.55 14.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Cell 1996; 87:1171-80; PMID:8980224;  http://dx.doi.org/10.1016/S0092-8674(00)81813-9 15.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Blood 2004; 103:4150-6; PMID:14976056; http://dx.doi.org/10.1182/blood-2003-10-3685 16.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Nat Struct Mol Biol  2006; 13:524-32; PMID:16732286; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
J Biol Chem 2005; 280:20126-31;  PMID:15769741; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
FEBS Lett  1999; 443:353-6; PMID:10025962; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Mol Cell 2010; 37:643-55; PMID:20227369; http://dx.doi.org/10.1016/j.mol- cel.2010.02.007,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Intensive Care Med 2009; 35:1024-30;  PMID:19271210; http://dx.doi.org/10.1007/s00134- 009-1413-8 76.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Am J Pathol  2010; 177:3233-43; PMID:20952594; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Crit Care Med 2007; 35:199- 206; PMID:17110873; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Shock 2009; 31:348- 53; PMID:18791490; http://dx.doi.org/10.1097/ SHK.0b013e318188bd06 80.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Ther Apher Dial  2009; 13:520-7; PMID:19954476; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Intensive Care Med 2010; 36:462-70;  PMID:19956923; http://dx.doi.org/10.1007/s00134- 009-1726-7 83.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Crit Care 2010; 14:R89;  PMID:20482750; http://dx.doi.org/10.1186/cc9020 84.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Crit  Care 2010; 14:R91; PMID:20492647; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
"BMC Infect Dis 2010; 10:143; PMID:20509945; http://dx.doi.org/10.1186/1471- 2334-10-14363. van der Heijden M, Pickkers P , van Nieuw Amerongen  GP , van Hinsbergh VW, Bouw MP , van der Hoeven  JG, et al.",OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Intensive Care Med  2009; 35:1567-74; PMID:19551369; http://dx.doi.org/10.1007/s00134-009-1560-y 64.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
PLoS One 2009; 4:e4912;  PMID:19300530; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Am J Gastroenterol 2010; 105:2287- 92; PMID:20461065; http://dx.doi.org/10.1038/ ajg.2010.183 68.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Ann Surg  2008; 247:320-6; PMID:18216540; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Cytokine 2008; 44:310-3; PMID:18952457; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Clin Infect Dis  2011; 52:e157-61; PMID:21460306; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Crit Care Med 2012; 40:3034-41; PMID:22890252;  http://dx.doi.org/10.1097/CCM.0b013e31825fdc31 73.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Crit Care 2008; 12:R147;  PMID:19025590; http://dx.doi.org/10.1186/cc7130 74.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Am J Respir  Crit Care Med 2011; 183:1344-53; PMID:21257790;  http://dx.doi.org/10.1164/rccm.201005-0701OC50.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Crit  Care 2011; 15:R261; PMID:22040774; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Shock 2005; 24(Suppl 1):1- 6; PMID:16374365; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
J Biol Chem 2013; 288:12469-77; PMID:23504320;  http://dx.doi.org/10.1074/jbc.M112.433979 54.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
J Clin Invest 2011; 121:2278- 89; PMID:21606590; http://dx.doi.org/10.1172/ JCI46322 55.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Crit Care Med 2011; 39:702-10; PMID:21242795;  http://dx.doi.org/10.1097/CCM.0b013e318206d285 57.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Crit  Care 2010; 14:180; PMID:20727223; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Thorax 2008; 63:903-9; PMID:18559364;  http://dx.doi.org/10.1136/thx.2007.087387 59.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Crit Care Med  2012; 40:1731-7; PMID:22610178; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
PLoS  One 2012; 7:e51932; PMID:23284823; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
Clin Cancer Res 2007; 13:2115-20; PMID:17404094; http://dx.doi.org/10.1158/1078- 0432.CCR-06-2509,Non-OADS,/arxiv_data1/oa_pdf/15/4a/kvir-04-06-10924906.PMC5359737.pdf
"www.landesbioscience.com Virulence 453Virulence 4:6, 453–466; August 15, 2013; © 2013 Landes BiosciencereseArch p Aper  reseArch p Aper *Correspondence to: Andrew C Doxey; Email: acdoxey@uwaterloo.ca Submitted: 02/11/13; Revised: 05/17/13; Accepted: 05/25/13http://dx.doi.org/10.4161/viru.25180Introduction Molecular mimicry can be broadly defined as sequence or struc - tural resemblance between microbial and host molecules.",Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
"For the detected collagen-like and LRR mimics, the detected  repeats were aligned, adjusted where necessary to a common length, and sequence logos were generated using seqlogo with default parameters (http://weblogo.berkeley.edu).",OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
A resource containing pre - dicted mimicry candidates discussed in this paper is available at http://doxey.uwaterloo.ca/mimicry/.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Protein sequence data sets for human as well as 163 bacterial genomes (see Table S1  for a complete list)  were retrieved from the NCBI (RefSeq human protein database build 36 [37742 proteins]) and the Comprehensive Microbial Resource 23 at TIGR/JVCI (http://cmr.jcvi.org).,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
T rends Biochem  Sci 2000; 25:223-4; PMID:10782090; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Mol Microbiol 1999; 31:1333-43;  PMID:10200955; http://dx.doi.org/10.1046/j.1365- 2958.1999.01240.x 36.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Infect  Immun 2000; 68:4930-7; PMID:10948107; http://dx.doi.org/10.1128/IAI.68.9.4930-4937.2000 37.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Sci Signal 2009;  2:pe6; PMID:19193605; http://dx.doi.org/10.1126/scisignal.256pe6 38.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Science 2004; 303:1358-61; PMID:14988561; http://dx.doi.org/10.1126/sci- ence.1094226 39.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nature 2007; 450:365- 9; PMID:17952054; http://dx.doi.org/10.1038/ nature06336 40.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
FEMS Microbiol Lett  1989; 48:179-84; PMID:2656380; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Mol Microbiol 1999; 31:1477- 88; PMID:10200966; http://dx.doi.org/10.1046/ j.1365-2958.1999.01291.x 42.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nat Med  2007; 13:284-5; PMID:17342139; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nucleic Acids Res 1996; 24:4420-49; PMID:8948633;  http://dx.doi.org/10.1093/nar/24.22.4420 45.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Microb Pathog 2009; 46:63-72; PMID:19059331; http://dx.doi.org/10.1016/j.mic- path.2008.10.014 46.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Biol Chem 2007; 282:22993- 3004; PMID:17535811; http://dx.doi.org/10.1074/ jbc.M61141220018.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Science 2002; 295:679- 82; PMID:11809974; http://dx.doi.org/10.1126/sci- ence.1067025 19.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Mol Cell 1999; 4:1063-72; PMID:10635330;  http://dx.doi.org/10.1016/S1097-2765(00)80234-8 20.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
BMC Evol  Biol 2008; 8:316; PMID:19014598; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nucleic Acids Res 2001; 29:123-5; PMID:11125067;  http://dx.doi.org/10.1093/nar/29.1.123 24.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nucleic Acids Res 1997; 25:3389-402; PMID:9254694; http://dx.doi.org/10.1093/ nar/25.17.3389 25.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Cell 2002; 108:583-6; PMID:11893328; http://dx.doi.org/10.1016/S0092- 8674(02)00665-7 26.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Cell Microbiol 2012; 14:10-8; PMID:21951829; http://dx.doi.org/10.1111/ j.1462-5822.2011.01703.x 27.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Biol Chem 2007; 282:9973- 82; PMID:17251184; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nat Protoc 2009; 4:44- 57; PMID:19131956; http://dx.doi.org/10.1038/ nprot.2008.211 30.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Annu Rev Microbiol  1999; 53:155-87; PMID:10547689; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Infect Immun  2000; 68:6542-53; PMID:11083763; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Cell 1991; 65:1127- 41; PMID:1905979; http://dx.doi.org/10.1016/0092- 8674(91)90009-NReferences 1.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
N Engl J Med 1999; 341:2068- 74; PMID:10615080; http://dx.doi.org/10.1056/ NEJM199912303412707 2.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Curr Top Microbiol Immunol 2005; 296:1-17;  PMID:16329189; http://dx.doi.org/10.1007/3-540- 30791-5_1 3.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Clin Rev  Allergy Immunol 2012; 42:102-11; PMID:22095454;  http://dx.doi.org/10.1007/s12016-011-8294-7 4.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Curr Opin Rheumatol 2012; 24:408-16;  PMID:22617826; http://dx.doi.org/10.1097/ BOR.0b013e32835461d3 5.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
BMC Immunol 2012; 13:13; PMID:22435930; http://dx.doi.org/10.1186/1471- 2172-13-13 6.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Science  1997; 276:718-25; PMID:9115192; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nature 2001; 412:701-5; PMID:11507631;  http://dx.doi.org/10.1038/35089000 8.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nat Rev Mol Cell  Biol 2001; 2:578-88; PMID:11483991; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nature  2007; 449:827-34; PMID:17943119; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nat Rev Microbiol 2009; 7:787-97;  PMID:19806153; http://dx.doi.org/10.1038/nrmi- cro2222 11.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Annu Rev Microbiol 2001; 55:709-42;  PMID:11544372; http://dx.doi.org/10.1146/annurev.micro.55.1.709 12.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Bacteriol  2010; 192:6154-9; PMID:20870767; http://dx.doi.org/10.1128/JB.00818-10 13.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Annu Rev  Microbiol 2011; 65:111-28; PMID:21639786; http://dx.doi.org/10.1146/annurev-micro-090110-102927 14.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nature 2008; 454:1005-8; PMID:18650806; http://dx.doi.org/10.1038/nature07170 16.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Science 1999; 286:291-5; PMID:10514372; http://dx.doi.org/10.1126/science.286.5438.291 17.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
PLoS Pathog  2008; 4:e1000128; PMID:18704168; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
BMC Microbiol 2010; 10:320; PMID:21159159;  http://dx.doi.org/10.1186/1471-2180-10-320 75.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nat Immunol 2006; 7:1250-7; PMID:17110941;  http://dx.doi.org/10.1038/ni1412 77.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Biol Chem 2005; 280:18375- 85; PMID:15705585; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
PLoS One 2012; 7:e52278; PMID:23300632;  http://dx.doi.org/10.1371/journal.pone.0052278 80.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Proteins  2000; 41:224-37; PMID:10966575; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Self Nonself 2010; 1:328- 34; PMID:21487508; http://dx.doi.org/10.4161/ self.1.4.13315 82.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Structure 2012; 20:161- 71; PMID:22178248; http://dx.doi.org/10.1016/j.str.2011.10.021 83.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
PLoS  Comput Biol 2012; 8:e1002364; PMID:22319434; http://dx.doi.org/10.1371/journal.pcbi.1002364 84.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Genomics 1991; 11:635-50; PMID:1774068; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
T rends Genet  2000; 16:276-7; PMID:10827456; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Biol Chem 2004; 279:51760- 8; PMID:15456768; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nature 1998; 396:133-40;  PMID:9823893; http://dx.doi.org/10.1038/24094 63.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Biol Chem 2011; 286:16555- 66; PMID:21385872; http://dx.doi.org/10.1074/jbc.M110.211078 64.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Bacteriol  2010; 192:3294-303; PMID:20435729; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Biol Chem 2003; 278:22183- 6; PMID:12724317; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Bacteriol 2001; 183:3345- 52; PMID:11344142; http://dx.doi.org/10.1128/ JB.183.11.3345-3352.2001 68.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Leukoc Biol  2003; 73:339-43; PMID:12629147; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
J Cell Biol 1991; 112:279- 88; PMID:1988462; http://dx.doi.org/10.1083/jcb.112.2.279 72.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Infect Immun 2000; 68:1125-33; PMID:10678916; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
FEMS Microbiol Lett  2008; 285:170-6; PMID:18557785; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
T rends Microbiol  2008; 16:173-80; PMID:18353648; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Prog Lipid Res  2003; 42:115-62; PMID:12547654; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Mol Microbiol 2004; 51:471- 81; PMID:14756787; http://dx.doi.org/10.1046/ j.1365-2958.2003.03839.x 51.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nature 2003; 423:87-91; PMID:12721630;  http://dx.doi.org/10.1038/nature01582 52.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
FEMS Microbiol  Rev 1998; 22:323-32; PMID:9862125; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
PLoS Pathog 2009; 5:e1000704; PMID:20041211; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
EMBO J  1997; 16:2730-44; PMID:9184219; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Nature 2003; 422:888-93;  PMID:12712204; http://dx.doi.org/10.1038/ nature01597 56.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Neuron 2001; 30:677-87; PMID:11430802; http://dx.doi.org/10.1016/S0896-6273(01)00327-0 58.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Science 1998; 282:2076-9; PMID:9851927;  http://dx.doi.org/10.1126/science.282.5396.2076 59.,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Curr Opin Microbiol 2006; 9:86-94;  PMID:16406773; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
Cell Microbiol 2007; 9:1922-35;  PMID:17388784; http://dx.doi.org/10.1111/j.1462- 5822.2007.00924.x,Non-OADS,/arxiv_data1/oa_pdf/2b/cd/kvir-04-06-10925180.PMC5359739.pdf
"2, 145–156 http://dx.doi.org/10.1080/01443410.2016.1143087 Group discussions and test-enhanced learning: individual  learning outcomes and personality characteristics Tova Stenlunda, Fredrik U. Jönssonb and Bert Jonssona adepartment of Psychology, umeå university, umeå, s weden; bdepartment of Psychology, s tockholm university,  stockholm, s weden Collaborative or cooperative learning is widely applied in educational settings and it is often seen  as a valuable learning condition by educators.",Non-OADS,/arxiv_data1/oa_pdf/83/a2/cedp-37-145.PMC5359742.pdf
"2, 96 –110 http://dx.doi.org/10.1080/01459740.2016.1231676",Non-OADS,/arxiv_data1/oa_pdf/c2/45/gmea-36-096.PMC5359743.pdf
"ORCID Matthew Little http://orcid.org/0000-0001-6644-2336 References Airhihenbuwa, C. O.",Non-OADS,/arxiv_data1/oa_pdf/c2/45/gmea-36-096.PMC5359743.pdf
http://www.isec.ac.in/Monograph%202.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c2/45/gmea-36-096.PMC5359743.pdf
Government of India 2011 SRS Statistical Report 2011. http://www.censusindia.gov.in/2011-common/vitalstatistics.html .,OADS,/arxiv_data1/oa_pdf/c2/45/gmea-36-096.PMC5359743.pdf
http://mospi.nic.in/Mospi_New/site/home.aspx .,Non-OADS,/arxiv_data1/oa_pdf/c2/45/gmea-36-096.PMC5359743.pdf
http://www.mofpi.nic.in .,Non-OADS,/arxiv_data1/oa_pdf/c2/45/gmea-36-096.PMC5359743.pdf
https://www.idf.org/sites/default/files/Atlas-poster-2014_EN.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c2/45/gmea-36-096.PMC5359743.pdf
http://www.eldis.org/vfile/upload/1/ document/0708/doc15357.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c2/45/gmea-36-096.PMC5359743.pdf
"The Hindu, May 18. http://www.thehindu.com/ news/states/tamil-nadu/article2027215.ece .",Non-OADS,/arxiv_data1/oa_pdf/c2/45/gmea-36-096.PMC5359743.pdf
"*Correspondence to: Andrea V Page; Email: APage@mtsinai.on.ca Submitted: 03/21/13; Accepted: 04/02/13http://dx.doi.org/10.4161/viru.24530endothelial dysfunction contributes to the pathogenesis  of a variety of potentially serious infectious diseases and  syndromes, including sepsis and septic shock, hemolytic- uremic syndrome, severe malaria, and dengue hemorrhagic  fever.",Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Blood  2005; 106:4199-209; PMID:16131569; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Curr Opin Hematol  2011; 18:177-85; PMID:21423010; http://dx.doi.org/10.1097/MOH.0b013e328345a4cf 4.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Semin Diagn Pathol 2007; 24:227-36; PMID:18085063; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Circulation 2006; 113:2335-62; PMID:16702488; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care 2009; 13:207;  PMID:19435476; http://dx.doi.org/10.1186/cc7153 7.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit  Care 2008; 12:R94; PMID:18664247; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care 2010; 14:R89;  PMID:20482750; http://dx.doi.org/10.1186/cc9020 9.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
PLoS Med 2006; 3:e46;  PMID:16417407; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Shock 2009; 31:348- 53; PMID:18791490; http://dx.doi.org/10.1097/ SHK.0b013e318188bd06 11.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Cytokine 2008; 44:310- 3; PMID:18952457; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care 2008; 12:R147;  PMID:19025590; http://dx.doi.org/10.1186/cc7130 13.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Immunol Lett 2009; 125:65-71; PMID:19539650; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care Med 2007; 35:199- 206; PMID:17110873; http://dx.doi.org/10.1097/01.CCM.0000251640.77679.D7 15.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Intensive Care  Med 2009; 35:1567-74; PMID:19551369; http://dx.doi.org/10.1007/s00134-009-1560-y 17.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Intensive Care Med 2010; 36:462-70;  PMID:19956923; http://dx.doi.org/10.1007/s00134- 009-1726-7 19.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care Med 2012; 40:3034-41; PMID:22890252;  http://dx.doi.org/10.1097/CCM.0b013e31825fdc31 21.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care Med  2012; 40:1731-7; PMID:22610178; http://dx.doi.org/10.1097/CCM.0b013e3182451c87 22.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care Med 2011; 39:702-10; PMID:21242795;  http://dx.doi.org/10.1097/CCM.0b013e318206d285 23.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit  Care 2010; 14:R91; PMID:20492647; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
BMC Infect Dis 2010; 10:143;  PMID:20509945; http://dx.doi.org/10.1186/1471-2334-10-143 25.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Clin Infect Dis 2011; 52:e157-61; PMID:21460306; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care 2004; 8:R82-90;  PMID:15025782; http://dx.doi.org/10.1186/cc2459 54.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care  Med 1998; 26:933-8; PMID:9590325; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
PLoS One 2013; 8:e54481; PMID:23349902; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Pediatr Infect Dis  J 2006; 25:894-7; PMID:17006283; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Clin Infect Dis 2002; 35:277-85; PMID:12115093; http://dx.doi.org/10.1086/341410 60.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Circ Res  2007; 100:158-73; PMID:17272818; http://dx.doi.org/10.1161/01.RES.0000255691.76142.4a 61.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
BMC  Pediatr 2010; 10:22; PMID:20398379; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Intensive  Care Med 2012; 38:863-71; PMID:22398755; http://dx.doi.org/10.1007/s00134-012-2476-5 64.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care Med  2000; 28:2600-7; PMID:10921602; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
J Crit Care 2013; In press; PMID:23414982;  http://dx.doi.org/10.1016/j.jcrc.2012.11.00239.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
J Thromb Haemost  2007; 5:2284-90; PMID:17764538; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
PLoS One 2011; 6:e25626;  PMID:22125593; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Blood 2009;  114:5102-11; PMID:19822897; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
PLoS  One 2011; 6:e21587; PMID:21720563; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
J  Thromb Haemost 2009; 7:843-50; PMID:19187073; http://dx.doi.org/10.1111/j.1538-7836.2009.03313.x 46.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Thromb Haemost  2010; 103:1181-7; PMID:20390223; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care Med  2007; 35:2375-82; PMID:17944029; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
"PLoS Pathog  2009; 5:e1000349; PMID:19300493; http://dx.doi.org/10.1371/journal.ppat.1000349 49. de Mast Q, Groot E, Asih PB, Syafruddin D, Oosting  M, Sebastian S, et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
N Engl J Med 2001; 345:408-16; PMID:11496851; http://dx.doi.org/10.1056/NEJM200108093450603 52.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
"J T rauma  1998; 44:789-94, discussion 794-5; PMID:9603079;  http://dx.doi.org/10.1097/00005373-199805000- 0000826.",Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
J  Infect Dis 2013; 208:929-33; PMID:23801605;  http://dx.doi.org/10.1093/infdis/jit268 27.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
PLoS One 2009; 4:e4912;  PMID:19300530; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Malar J 2009; 8:295; PMID:20003529; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
PLoS One  2010; 5:e15291; PMID:21209923; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
PLoS One  2010; 5:e9481; PMID:20208992; http://dx.doi.org/10.1371/journal.pone.0009481 32.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care Med 2012; 40:952- 9; PMID:22343839; http://dx.doi.org/10.1097/ CCM.0b013e3182373157 33.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Malar J 2011; 10:383; PMID:22192385; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Am J T rop Med  Hyg 2012; 87:943-6; PMID:22949515; http://dx.doi.org/10.4269/ajtmh.2012.12-0020 35. van Hinsbergh VWM.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Semin  Immunopathol 2012; 34:93-106; PMID:21845431; http://dx.doi.org/10.1007/s00281-011-0285-5 36.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
T rends Cardiovasc  Med 2005; 15:302-8; PMID:16297768; http://dx.doi.org/10.1016/j.tcm.2005.09.005 37.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Shock  2005; 24:508-12; PMID:16317379; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Shock 2008; 29:452-7; PMID:18598002;  http://dx.doi.org/10.1097/SHK.0b013e31815072c1 91.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
"J T ransl Med 2011; 9:23; PMID:21371321; http://dx.doi.org/10.1186/1479-5876-9-23 92. van der Flier M, van Leeuwen HJ, van Kessel KP ,  Kimpen JL, Hoepelman AI, Geelen SP .",OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Shock 2005; 23:35-8; PMID:15614129; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Anesth Analg 2008; 106:1820-6; PMID:18499616;  http://dx.doi.org/10.1213/ane.0b013e31816a643f 94.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care 2011; 15:R11;  PMID:21219633; http://dx.doi.org/10.1186/cc9412 95.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Pediatr Nephrol 2004; 19:754-60;  PMID:15141341; http://dx.doi.org/10.1007/s00467- 004-1475-3 96.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
PLoS One 2011; 6:e28540; PMID:22174834; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Ann T rop Paediatr  2007; 27:179-84; PMID:17716445; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
J Virol 2007; 81:1592-600; PMID:17151115; http://dx.doi.org/10.1128/ JVI.01642-06 100.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Eur J Intern Med 2013; 24:132- 8; PMID:23352000; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care 2009; 13:R93;  PMID:19538738; http://dx.doi.org/10.1186/cc7923 80.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Pediatr Infect Dis J 1998; 17:899-904; PMID:9802632; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Acta  T rop 2007; 102:20-8; PMID:17397790; http://dx.doi.org/10.1016/j.actatropica.2007.02.011 86.,OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
J Med Virol  2004; 72:445-50; PMID:14748068; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Nat Med 2003; 9:669- 76; PMID:12778165; http://dx.doi.org/10.1038/ nm0603-66966.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Blood Coagul Fibrinolysis 2007; 18:179- 86; PMID:17287636; http://dx.doi.org/10.1097/ MBC.0b013e328040bf9a 71.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Clin Immunol Immunopathol 1998; 87:139-44; PMID:9614928; http://dx.doi.org/10.1006/clin.1998.4523 72.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care 2010; 14:R182; PMID:20942957;  http://dx.doi.org/10.1186/cc9290 75.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Intensive Care Med 2004; 30:867-74;  PMID:15067502; http://dx.doi.org/10.1007/s00134- 004-2253-1 77.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
Crit Care Med  1999; 27:2656-61; PMID:10628605; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/fc/kvir-04-06-10924530.PMC5359744.pdf
"1, 100 –106 http://dx.doi.org/10.1080/00071668.2016.1237768 © 2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/fb/ee/cbps-58-100.PMC5359745.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, tran sformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/fb/ee/cbps-58-100.PMC5359745.pdf
"Tight junctions, also referred to as zonula occludens, are pre - dominantly composed of occludins and claudins, and are com - monly located at the apical surface of the inter-endothelial cell  *Correspondence to: W Conrad Liles;   Email: wcliles@medicine.washington.eduSubmitted: 04/01/13; Revised: 07/11/13; Accepted: 07/12/13http://dx.doi.org/10.4161/viru.25740Recent evidence suggests that loss of endothelial barrier  function and resulting microvascular leak play important mechanistic roles in the pathogenesis of infection-related  end-organ dysfunction and failure.",Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
PLoS Med 2007; 4:e269;  PMID:17803352; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Virol 2012; 86:6408-15; PMID:22496214;  http://dx.doi.org/10.1128/JVI.00213-12 4.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit Care Med 2002;  30(Suppl):S268-73; PMID:12004247; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Virol 2010;  84:11227-34; PMID:20810734; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Curr Opin Hematol  2010; 17:230-6; PMID:20393283; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Ann  N Y Acad Sci 2008; 1123:134-45; PMID:18375586;  http://dx.doi.org/10.1196/annals.1420.01610.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nat Rev Mol Cell Biol 2006; 7:359-71; PMID:16633338; http://dx.doi.org/10.1038/ nrm1911 11.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nat Cell Biol  2006; 8:1223-34; PMID:17060906; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Dev Cell 2008; 14:25-36;  PMID:18194650; http://dx.doi.org/10.1016/j.dev- cel.2007.10.019 13.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit Care 2011; 15:R11; PMID:21219633; http://dx.doi.org/10.1186/cc9412 14.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit  Care 2010; 14:R91; PMID:20492647; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Shock  2005; 24:508-12; PMID:16317379; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Shock  2005; 23:35-8; PMID:15614129; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit Care 2011; 15:135; PMID:21457513;  http://dx.doi.org/10.1186/cc10044 18.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
"Available at: http://clinicaltrials.gov/ct2/ show/NCT01063010 Accessed March 10, 2013.19.",Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Virol  2011; 85:2296-303; PMID:21177802; http://dx.doi.org/10.1128/JVI.02319-10 21.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Biochem J 2000; 349:385-402;  PMID:10880336; http://dx.doi.org/10.1042/0264-6021:3490385 24.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Cell 1999; 99:301-12;  PMID:10555146; http://dx.doi.org/10.1016/S0092- 8674(00)81661-X 26.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Sci T ransl Med 2010; 2:23ra19;  PMID:20375003; http://dx.doi.org/10.1126/scitrans- lmed.3000678 56.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Retrovirology  2013; 10:2; PMID:23294842; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nature 2012; 492:252-5; PMID:23143332; http://dx.doi.org/10.1038/nature11603 58.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nature 2000; 407:242-8; PMID:11001067; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Cell 1996; 87:1161-9; PMID:8980223;  http://dx.doi.org/10.1016/S0092-8674(00)81812-7 60.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nat Med 2000; 6:460-3;  PMID:10742156; http://dx.doi.org/10.1038/74725 62.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Circ Res 2000; 87:603- 7; PMID:11009566; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nat Med 2000; 6:131-2; PMID:10655092; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Kidney Int  2009; 76:1180-91; PMID:19812542; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Circulation 2005; 111:97- 105; PMID:15611372; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Am J Respir Crit Care Med  2007; 175:1014-26; PMID:17322110; http://dx.doi.org/10.1164/rccm.200609-1370OC 67.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit Care Med 2008; 36:262- 7; PMID:18007265; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit  Care 2011; 15:R261; PMID:22040774; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Biol Chem  2002; 277:21453-7; PMID:11967257; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nat Rev Drug Discov 2010; 9:883-97;  PMID:21031003; http://dx.doi.org/10.1038/nrd3248 43.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
T rends Mol Med 2011; 17:463- 72; PMID:21514226; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Biol Chem 2003; 278:47281-90; PMID:12954648; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Immunol Res 2011; 51:15-25;  PMID:21901448; http://dx.doi.org/10.1007/s12026- 011-8240-z 46.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Cell 2011; 146:980-91;  PMID:21925319; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Science 2010; 328:1290-4; PMID:20522778;  http://dx.doi.org/10.1126/science.1188635 48.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Biol Chem 2007; 282:7254-64; PMID:17218309; http://dx.doi.org/10.1074/jbc.M610581200 49.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Biol Chem 1998; 273:30719-28; PMID:9804847; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nat Med  2005; 11:298-304; PMID:15723073; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
PLoS  One 2009; 4:e5391; PMID:19401765; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Shock 2012; 38:275-80; PMID:22777114;  http://dx.doi.org/10.1097/SHK.0b013e318264b95d 53.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nat Med 2008; 14:448- 53; PMID:18345009; http://dx.doi.org/10.1038/nm174227.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Am J Respir Crit Care Med 2012; 185:58- 66; PMID:21980034; http://dx.doi.org/10.1164/ rccm.201108-1381OC 29.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Mol Med 2011; 17:717-25; PMID:21556483;  http://dx.doi.org/10.2119/molmed.2010.00214 30.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Blood 2005; 105:3178-84; PMID:15626732; http://dx.doi.org/10.1182/blood-2004-10-3985 31.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Thorax 2009; 64:114-20; PMID:19008297; http://dx.doi.org/10.1136/ thx.2008.099135 32.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
N  Engl J Med 2005; 353:1332-41; PMID:16192478;  http://dx.doi.org/10.1056/NEJMoa050935 33.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
N  Engl J Med 2001; 344:699-709; PMID:11236773; http://dx.doi.org/10.1056/NEJM200103083441001 34.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Lancet 2007; 369:836-43;  PMID:17350452; http://dx.doi.org/10.1016/S0140- 6736(07)60411-5 35.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
N Engl J Med 2012; 366:2055- 64; PMID:22616830; http://dx.doi.org/10.1056/NEJMoa1202290 37.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Endotoxemia and sepsis mortal- ity reduction by non-anticoagulant activated protein C. J Exp Med 2007; 204:2439-48; PMID:17893198;  http://dx.doi.org/10.1084/jem.20070404 38.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Am J Respir Crit Care Med 2004; 170:987- 93; PMID:15282202; http://dx.doi.org/10.1164/ rccm.200405-684OC 39.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nat Chem  Biol 2006; 2:434-41; PMID:16829954; http://dx.doi.org/10.1038/nchembio804,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit Care 2001;  5:151-7; PMID:11353932; http://dx.doi.org/10.1186/ cc1015 97.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Clin Invest 2000; 105:1663-8; PMID:10862779;  http://dx.doi.org/10.1172/JCI10413 98.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Am J Physiol Lung Cell Mol Physiol  2007; 293:L131-41; PMID:17416739; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Expert Opin Biol Ther 2009;  9:1259-70; PMID:19691441; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nat Med 2009; 15:42-9;  PMID:19098906; http://dx.doi.org/10.1038/nm.1905 106.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
"PLoS One 2011; 6:e25171; PMID:21980392;  http://dx.doi.org/10.1371/journal.pone.0025171 107. dos Santos CC, Murthy S, Hu P , Shan Y, Haitsma JJ, Mei SH, et al.",OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Am J Pathol 2012; 181:1681- 92; PMID:23083833; http://dx.doi.org/10.1016/j.ajpath.2012.08.009 108.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Biol Chem  2010; 285:26211-22; PMID:20554518; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Microvasc Res 2003; 65:118-24;  PMID:12686169; http://dx.doi.org/10.1016/S0026- 2862(02)00033-X 83.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Biochem Biophys  Res Commun 2000; 269:97-102; PMID:10694484;  http://dx.doi.org/10.1006/bbrc.2000.2238 84.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Arterioscler Thromb Vasc Biol 2003; 23:58-63; PMID:12524225; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
BMC Microbiol 2012; 12:73; PMID:22587610;  http://dx.doi.org/10.1186/1471-2180-12-73 86.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Clin Invest  2005; 115:1666-74; PMID:15931395; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Am  J Physiol Lung Cell Mol Physiol 2010; 299:L652- 63; PMID:20729389; http://dx.doi.org/10.1152/ ajplung.00202.2009 88.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Microvasc  Res 2010; 79:56-62; PMID:19931545; http://dx.doi.org/10.1016/j.mvr.2009.11.006 89.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Biochem J 2000; 348:241-55; PMID:10816416;  http://dx.doi.org/10.1042/0264-6021:3480241 90.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Biochem Biophys Res Commun 1994; 198:1177- 82; PMID:8117275; http://dx.doi.org/10.1006/ bbrc.1994.1166 91.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Proc Natl Acad Sci U S A 1989; 86:3394- 8; PMID:2524068; http://dx.doi.org/10.1073/ pnas.86.9.3394 92.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Biol Chem 2002;  277:44385-98; PMID:12213803; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Appl Physiol 2013; 114:307-15;  PMID:23195629; http://dx.doi.org/10.1152/jap- plphysiol.01249.2011 94.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit Care 2012; 16:R182; PMID:23036162;  http://dx.doi.org/10.1186/cc11666 71.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
PLoS Med 2006; 3:e46;  PMID:16417407; http://dx.doi.org/10.1371/journal.pmed.0030046 72.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Nat Med 2006; 12:235-9;  PMID:16462802; http://dx.doi.org/10.1038/nm1351 73.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit Care 2008; 12:R147;  PMID:19025590; http://dx.doi.org/10.1186/cc7130 74.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Intensive Care Med 2010; 36:462-70;  PMID:19956923; http://dx.doi.org/10.1007/s00134- 009-1726-7 75.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit Care Med 2012; 40:3034-41; PMID:22890252;  http://dx.doi.org/10.1097/CCM.0b013e31825fdc31 76.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Proc Natl Acad Sci U S A 2006; 103:15491- 6; PMID:17030814; http://dx.doi.org/10.1073/ pnas.0607538103 78.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
T rends Immunol  2007; 28:88-98; PMID:17197237; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Am J Cardiol 2002; 89:901-8; PMID:11950425; http://dx.doi.org/10.1016/S0002- 9149(02)02236-1 80.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Antiviral Res 2013; 98:332-43;  PMID:23523944; http://dx.doi.org/10.1016/j.antivi- ral.2013.03.015 81.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Expert Rev Anti Infect  Ther 2011; 9:807-22; PMID:21810053; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
Crit Care Med 2009; 37(Suppl):S30-7;  PMID:19104223; http://dx.doi.org/10.1097/ CCM.0b013e3181922bd3109.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Biol Chem 2003; 278:48848- 60; PMID:14514674; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Exp Med  2009; 206:691-705; PMID:19255147; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
J Cell Sci 2010; 123:3796- 807; PMID:20971705; http://dx.doi.org/10.1242/jcs.067645,OADS,/arxiv_data1/oa_pdf/58/93/kvir-04-06-10925740.PMC5359747.pdf
"1, 1 –12 http://dx.doi.org/10.1080/00071668.2016.1245849 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/56/c5/cbps-24-001.PMC5359748.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, tran sformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/56/c5/cbps-24-001.PMC5359748.pdf
"3-5 Of the two envelope glycoproteins HA and NA 16 HA  (H1–H16) and 9 NA (N1–N9) subtypes have been distinguished  *Correspondence to: Thomas C Mettenleiter;   Email: thomas.mettenleiter@fli.bund.deSubmitted: 05/02/13; Revised: 07/09/13; Accepted: 07/10/13http://dx.doi.org/10.4161/viru.25710Avian influenza viruses (AIV) of H5 and H7 subtypes exhibit two  different pathotypes in poultry: infection with low pathogenic (LP) strains results in minimal, if any, health disturbances,  whereas highly pathogenic (HP) strains cause severe morbidity  and mortality.",Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Vet J 2002; 164:202-15; PMID:12505393;  http://dx.doi.org/10.1053/tvjl.2002.0716 3.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Ann N Y Acad Sci 2007; 1102:1-25; PMID:17470908;  http://dx.doi.org/10.1196/annals.1408.001 4.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Biomed Pharmacother 2000; 54:196-209; PMID:10872718;  http://dx.doi.org/10.1016/S0753-3322(00)89026-5 6.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2005; 79:2814-22; PMID:15709000; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Lancet 2004; 363:1099-103;  PMID:15064027; http://dx.doi.org/10.1016/S0140- 6736(04)15892-3 9.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 2005; 49:317-27;  PMID:16252482; http://dx.doi.org/10.1637/7390- 060305R.1 11.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Vet Microbiol 1992; 33:303-10; PMID:1481363;  http://dx.doi.org/10.1016/0378-1135(92)90058-2,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Clin Microbiol Rev 2007; 20:243-67; PMID:17428885; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Comp Immunol Microbiol Infect Dis 2009; 32:351-63; PMID:18442853; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Vet Microbiol 2000; 74:3-13; PMID:10799774; http://dx.doi.org/10.1016/S0378- 1135(00)00160-7 17.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
"World Organisation for Animal Health,  Paris, France 2009:http://www.oie.int/eng/normes/ mmanual/2008/pdf/2.03.04 AI.pdf.",Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Gen Virol 1983; 64:2127- 37; PMID:6619800; http://dx.doi.org/10.1099/0022- 1317-64-10-2127 20.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology  1981; 113:725-35; PMID:7023022; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology 1987; 158:218-27; PMID:3576972; http://dx.doi.org/10.1016/0042-6822(87)90256-X 22.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Adv Virus Res 1988; 34:247-81;  PMID:3046255; http://dx.doi.org/10.1016/S0065-3527(08)60520-5 23.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Arch Virol  1994; 134:185-94; PMID:7506519; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology 1981; 115:361- 74; PMID:7032055; http://dx.doi.org/10.1016/0042- 6822(81)90117-3 26.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology 1999; 258:1- 20; PMID:10329563; http://dx.doi.org/10.1006/ viro.1999.9716 27.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Arch Virol 2001; 146:87-97; PMID:11266220;  http://dx.doi.org/10.1007/s00705017019328.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Rev Med Virol 2010; 20:298- 310; PMID:20629046; http://dx.doi.org/10.1002/ rmv.657 30.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Arch Virol  1991; 116:261-5; PMID:1848066; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology 1995; 206:755-9; PMID:7831837; http://dx.doi.org/10.1016/S0042-6822(95)80004-2 32.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Acta T rop 2002; 83:7-11;  PMID:12062787; http://dx.doi.org/10.1016/S0001- 706X(02)00057-8 33.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology 1995; 209:664-70; PMID:7778300;  http://dx.doi.org/10.1006/viro.1995.1301 34.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian  Dis 1997; 41:335-46; PMID:9201397; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Proc Natl Acad Sci U S A 1998; 95:10224- 8; PMID:9707628; http://dx.doi.org/10.1073/ pnas.95.17.10224 36.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2010; 84:940-52; PMID:19889765; http://dx.doi.org/10.1128/JVI.01581-09 37.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virus  Res 2011; 162:8-11; PMID:21968297; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Nucleic Acids Res 2008; 36:e139;  PMID:18832366; http://dx.doi.org/10.1093/nar/ gkn646 40.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Gen Virol 2011;  92:51-9; PMID:20881092; http://dx.doi.org/10.1099/ vir.0.023887-0 41.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2011; 85:10354- 63; PMID:21795332; http://dx.doi.org/10.1128/JVI.00605-1142.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology  1984; 139:303-16; PMID:6516214; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology  1985; 146:130-7; PMID:4036005; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Microb Pathog 1988; 5:311-8; PMID:3070264;  http://dx.doi.org/10.1016/0882-4010(88)90032-0 48.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology  1989; 168:274-80; PMID:2916326; http://dx.doi.org/10.1016/0042-6822(89)90267-5 49.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 1991; 35:824-33;  PMID:1838476; http://dx.doi.org/10.2307/1591616 50.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology 1985; 147:49-60;  PMID:2414922; http://dx.doi.org/10.1016/0042- 6822(85)90226-0 54.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology 1995; 213:223-30; PMID:7483266; http://dx.doi.org/10.1006/ viro.1995.1562 55.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian  Dis 1996; 40:425-37; PMID:8790895; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Gen Virol 1996; 77:1493-504;  PMID:8757992; http://dx.doi.org/10.1099/0022-1317-77-7-1493,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Vet Res 2010;  41:66; PMID:20546698; http://dx.doi.org/10.1051/ vetres/2010038 86.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Influenza Other Respi Viruses 2007; 1:157-66; PMID:19432631; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Influenza Other Respi Viruses  2009; 3:107-17; PMID:19453487; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Influenza Other Respi Viruses 2009; 3:21-8;  PMID:19453438; http://dx.doi.org/10.1111/j.1750- 2659.2009.00075.x 89.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology  2009; 390:212-20; PMID:19535120; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 2007; 51(Suppl):189-93; PMID:17494552; http://dx.doi.org/10.1637/7617- 042506R.1 91.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virol  J 2010; 7:137; PMID:20576101; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Vet Rec 1995; 137:439;  PMID:8560706; http://dx.doi.org/10.1136/ vr.137.17.439 93.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Arch Virol 2000; 145:1047- 58; PMID:10881690; http://dx.doi.org/10.1007/ s007050050695 94.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Vaccine 2011; 29:7424- 9; PMID:21803098; http://dx.doi.org/10.1016/j.vac- cine.2011.07.064 96.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 2007;  51(Suppl):363-5; PMID:17494584; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Emerg Infect  Dis 2004; 10:693-9; PMID:15200862; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Pathol 2001; 30:179-83; PMID:19184894;  http://dx.doi.org/10.1080/03079450120044597 73.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian  Dis 2001; 45:257-61; PMID:11332492; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Vet Res 2011; 42:24; PMID:21314907; http://dx.doi.org/10.1186/1297- 9716-42-24 76.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 2003;  47(Suppl):1145-9; PMID:14575131; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J  Virol 2012; 86:584-8; PMID:22013034; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2010; 84:11858- 65; PMID:20844052; http://dx.doi.org/10.1128/ JVI.01011-10 79.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Gen Virol 2013;  94:50-8; PMID:23052391; http://dx.doi.org/10.1099/ vir.0.045153-0 80.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 2010; 54(Suppl):527-31;  PMID:20521689; http://dx.doi.org/10.1637/8707- 031709-Reg.1 81.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2010; 84:6733- 47; PMID:20410267; http://dx.doi.org/10.1128/ JVI.02427-09 82.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Zoonoses Public Health 2008; 55:1; PMID:18201320; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Infect Dis  2005; 192:1318-22; PMID:16170747; http://dx.doi.org/10.1086/444390 84.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virus  Res 1997; 49:173-86; PMID:9213392; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2004; 78:8372-81; PMID:15254209;  http://dx.doi.org/10.1128/JVI.78.15.8372-8381.2004 59.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Pathol 2004; 33:288-97; PMID:15223555;  http://dx.doi.org/10.1080/0307945042000203407 60.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 2007; 51(Suppl):167-73;  PMID:17494549; http://dx.doi.org/10.1637/7621- 042606R1.1 61.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Arch Virol 2010; 155:1439-51; PMID:20577770; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Arch Virol  2011; 156:565-76; PMID:21197555; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2005; 79:11412- 21; PMID:16103192; http://dx.doi.org/10.1128/ JVI.79.17.11412-11421.2005 64.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Am Vet Med Assoc 2006; 228:1869- 75; PMID:16784375; http://dx.doi.org/10.2460/ javma.228.12.1869 65.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Vet Microbiol 2004; 98:197-208;  PMID:15036528; http://dx.doi.org/10.1016/j.vet - mic.2003.10.018 67.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Pathol  2000; 29:289-94; PMID:19184817; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Pathol  2000; 29:537-43; PMID:19184849; http://dx.doi.org/10.1080/03079450020016779 70.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Arch Virol 2002; 147:1611-21; PMID:12181679; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2006; 80:11115- 23; PMID:16971424; http://dx.doi.org/10.1128/ JVI.00993-06 129.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology 1999; 261:15- 9; PMID:10484749; http://dx.doi.org/10.1006/viro.1999.9820 132.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avilable online at: http://www.who.int/influenza/human_animal_interface/EN_GIP_2013 0604CumulativeNumberH5N1cases.pdf (Accessed  03.July.2013).,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
PLoS One 2012; 7:e30960;  PMID:22363523; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2011; 85:1834- 46; PMID:21123376; http://dx.doi.org/10.1128/JVI.01648-10 136.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Arch Virol  2009; 154:969-79; PMID:19475480; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Am J Pathol 2008; 172:1155-70;  PMID:18403604; http://dx.doi.org/10.2353/ ajpath.2008.070791 138.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2009; 83:9901-10; PMID:19625397;  http://dx.doi.org/10.1128/JVI.00608-09 140.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2008; 82:4544-53; PMID:18305037; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 1970; 14:66-74;  PMID:4314007; http://dx.doi.org/10.2307/1588557114.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Proc Natl Acad Sci U S A 2004; 101:1356- 61; PMID:14745020; http://dx.doi.org/10.1073/ pnas.0308352100 116.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 2010; 54(Suppl):453-6; PMID:20521678; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Lancet 2004; 363:587-93;  PMID:14987882; http://dx.doi.org/10.1016/S0140- 6736(04)15589-X 120.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Infect Dis 2007; 196:258-65; PMID:17570113; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
"J Virol 2010; 84:1597-606; PMID:19939933;  http://dx.doi.org/10.1128/JVI.01783-09 123. de Wit E, Fouchier RA.",OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Clin Virol 2008; 41:1-6; PMID:18340670; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Am J Pathol 2010; 177:2185- 90; PMID:20847292; http://dx.doi.org/10.2353/ ajpath.2010.100401 125.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Vet  Rec 1993; 132:535-6; PMID:8322444; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 2007; 51(Suppl):396-400; PMID:17494593; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 2004; 48:119-28;  PMID:15077805; http://dx.doi.org/10.1637/7080 100.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 2004; 48:928-34; PMID:15666877;  http://dx.doi.org/10.1637/7218-060304R 101.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Emerg Infect  Dis 2004; 10:2196-9; PMID:15663860; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Virol 2009; 83:7075-84; PMID:19458003;  http://dx.doi.org/10.1128/JVI.00535-09 104.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
J Gen Virol  2005; 86:727-31; PMID:15722533; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Emerg Infect Dis  2004; 10:2192-5; PMID:15663859; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian  Dis 2010; 54(Suppl):213-9; PMID:20521634; http://dx.doi.org/10.1637/8822-040209-Reg.1 107.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Emerg Infect Dis 2009; 15:1492- 5; PMID:19788823; http://dx.doi.org/10.3201/ eid1509.080231 108.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avaialbel online at: http://web.oie.int/wahis/reports/ en_imm_0000012067_20120622_132313.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Pathol  2004; 33:565-70; PMID:15763723; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virology  1994; 204:462-5; PMID:8091680; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Nature 1989; 340:156-7; PMID:2544809;  http://dx.doi.org/10.1038/340156a0149.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Aust Vet J  1992; 69:140-2; PMID:1642597; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Pathol 1981; 10:481-7; PMID:18770163;  http://dx.doi.org/10.1080/03079458108418498 151.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Vet Microbiol 1979; 4:223-34;  http://dx.doi.org/10.1016/0378-1135(79)90058-0 153.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
PLoS  One 2011; 6:e14722; PMID:21373190; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian  Dis 1969; 13:606-10; PMID:5818061; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 1969; 13:603-6;  PMID:5818060; http://dx.doi.org/10.2307/1588534 144.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Avian Dis 1989; 33:695-706;  PMID:2619663; http://dx.doi.org/10.2307/1591147 145.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virus Res 1992; 23:223- 40; PMID:1320795; http://dx.doi.org/10.1016/0168- 1702(92)90110-U 146.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Virus  Res 1997; 51:115-24; PMID:9498610; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
Aust Vet J 1976; 52:384; PMID:985260; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/kvir-04-06-10925710.PMC5359749.pdf
The malfunction of the  *Correspondence to: Christina F Spiropoulou; Email: ccs8@cdc.gov Submitted: 04/15/13; Revised: 06/25/13; Accepted: 06/27/13http://dx.doi.org/10.4161/viru.25569The loss of the endothelium barrier and vascular leakage  play a central role in the pathogenesis of hemorrhagic fever viruses.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Expert Rev Anti Infect Ther 2011;  9:49-59; PMID:21171877; http://dx.doi.org/10.1586/ eri.10.142 2.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2005; 79:10442-50;  PMID:16051836; http://dx.doi.org/10.1128/ JVI.79.16.10442-10450.20053.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Nat Med 2000; 6:886-9;  PMID:10932225; http://dx.doi.org/10.1038/78645 4.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Nat  Med 2003; 9:921-7; PMID:12808447; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
T rans  R Soc T rop Med Hyg 2012; 106:1-2; PMID:22137535; http://dx.doi.org/10.1016/j.trstmh.2011.08.014 6.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Infect Dis 2004; 189:1411-8;  PMID:15073678; http://dx.doi.org/10.1086/383043 40.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Clin Diagn Virol 1995; 3:165-72;  PMID:15566798; http://dx.doi.org/10.1016/0928- 0197(94)00032-P 43.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Infect Dis 2002; 186:1165-8;  PMID:12355369; http://dx.doi.org/10.1086/343813 47.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Infect Dis 2000; 181:2-9; PMID:10608744; http://dx.doi.org/10.1086/315215 48.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Infect Dis 2010; 201:923-35; PMID:20158392;  http://dx.doi.org/10.1086/651018 51.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
PLoS Negl T rop Dis 2010; 4:e924;  PMID:21200427; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Infect Dis 1979; 140:527-33; PMID:117061;  http://dx.doi.org/10.1093/infdis/140.4.527 25.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Rev Infect Dis 1989; 11(Suppl 4):S830- 9; PMID:2665015; http://dx.doi.org/10.1093/cli- nids/11.Supplement_4.S830 26.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Curr Top Microbiol Immunol  2010; 338:99-114; PMID:19802581; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Hum Immunol  2010; 71:1135-40; PMID:20732366; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Sci T ransl Med 2011; 3:ra128; PMID:22190239; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol  2011; 85:7775-87; PMID:21632767; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Nat Med  2000; 6:816-20; PMID:10888933; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Exp Med 2003; 197:823- 9; PMID:12682107; http://dx.doi.org/10.1084/ jem.20021840 36.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Nature 2008; 453:672- 6; PMID:18496526; http://dx.doi.org/10.1038/ nature07013 37.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2005; 79:8004- 13; PMID:15956546; http://dx.doi.org/10.1128/ JVI.79.13.8004-8013.2005 13.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Am J Epidemiol 2002; 156:40-51; PMID:12076887; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Curr Top Microbiol Immunol 2010; 338:67- 82; PMID:19802579; http://dx.doi.org/10.1007/978- 3-642-02215-9_6 15. WHO.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Infection 2013; 41:709- 14; PMID:23277366; http://dx.doi.org/10.1007/ s15010-012-0392-9 18.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
T rop Med Int Health  2011; 16:936-48; PMID:21624014; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Clin  Infect Dis 2012; 55:1216-24; PMID:22865871;  http://dx.doi.org/10.1093/cid/cis655 21.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
T rans R Soc T rop Med Hyg  1987; 81:816-20; PMID:3450004; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Crit Care Med 2011; 39:702-10; PMID:21242795;  http://dx.doi.org/10.1097/CCM.0b013e318206d285 80.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Virology 2012; 422:326-37; PMID:22129847;  http://dx.doi.org/10.1016/j.virol.2011.10.030 82.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Gen Virol 2006; 87:3623-30; PMID:17098977;  http://dx.doi.org/10.1099/vir.0.82093-0 83.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
EMBO Rep 2006; 7:1176- 81; PMID:17028575; http://dx.doi.org/10.1038/ sj.embor.7400814 84.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Clin Infect Dis 2002; 35:277-85;  PMID:12115093; http://dx.doi.org/10.1086/341410 86.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
PLoS Negl T rop  Dis 2012; 6:e1628; PMID:22563509; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Infect 2007; 55:e23-8; PMID:17573116; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Immunol  2011; 187:6483-90; PMID:22079981; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Med  Virol 2003; 69:82-90; PMID:12436482; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Mem Inst Oswaldo Cruz 2001; 96:229-32;  PMID:11285501; http://dx.doi.org/10.1590/S0074- 02762001000200015 67.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
BMC Infect Dis 2008; 8:86;  PMID:18578883; http://dx.doi.org/10.1186/1471- 2334-8-86 69.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Pediatr Infect Dis J 2012; 31:e232- 8; PMID:22926216; http://dx.doi.org/10.1097/ INF .0b013e31826fd456 70.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2009; 83:8638-45; PMID:19535452;  http://dx.doi.org/10.1128/JVI.00581-09 71.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol  2006; 80:10208-17; PMID:17005698; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Ann N Y Acad Sci 2009;  1171(Suppl 1):E42-7; PMID:19751401; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2007; 81:1592- 600; PMID:17151115; http://dx.doi.org/10.1128/ JVI.01642-06 74.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Biochem Biophys Res Commun 2007; 356:763- 8; PMID:17382900; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Endothelium 2006; 13:335-40; PMID:17090406;  http://dx.doi.org/10.1080/10623320600972135 76.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Med Virol 2004; 72:445- 50; PMID:14748068; http://dx.doi.org/10.1002/ jmv.20007 77.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Am J T rop Med  Hyg 2012; 87:943-6; PMID:22949515; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
PLoS Med 2006; 3:e46;  PMID:16417407; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Med Virol 1999; 59:329- 34; PMID:10502265; http://dx.doi.org/10.1002/ (SICI)1096-9071(199911)59:3<329::AID- JMV12>3.0.CO;2-G 53.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Immunol Cell Biol 2011; 89:122- 9; PMID:20421879; http://dx.doi.org/10.1038/icb.2010.61 55.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
PLoS Negl T rop Dis 2011; 5:e926;  PMID:21245912; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol  2005; 79:5414-20; PMID:15827155; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
PLoS Pathog  2012; 8:e1002780; PMID:22761576; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Cell Host Microbe 2010; 8:410-21; PMID:21075352;  http://dx.doi.org/10.1016/j.chom.2010.10.007 60.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2010; 84:9760- 74; PMID:20660196; http://dx.doi.org/10.1128/ JVI.01051-10 61.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Mem Inst Oswaldo Cruz  2006; 101:437-49; PMID:16951817; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Microbes Infect 2006; 8:2324-30; PMID:16793309;  http://dx.doi.org/10.1016/j.micinf.2006.04.019 126.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Am J Clin Pathol 2001; 116:665-72;  PMID:11710682; http://dx.doi.org/10.1309/CNWF-DC72-QYMR-M8DA 128.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Gen  Virol 1993; 74:515-8; PMID:8445370; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Emerg Infect  Dis 2006; 12:166-8; PMID:16494739; http://dx.doi.org/10.3201/eid1201.050930 133.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Infect Dis 2000; 182:43-8; PMID:10882580; http://dx.doi.org/10.1086/315657 134.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Infect Dis 2010; 202:242-6;  PMID:20521946; http://dx.doi.org/10.1086/653482 135.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Infect Dis  1999; 179:295-302; PMID:9878011; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2001; 75:6070- 85; PMID:11390609; http://dx.doi.org/10.1128/JVI.75.13.6070-6085.2001 137.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Viral Immunol 2002; 15:609-25; PMID:12513931;  http://dx.doi.org/10.1089/088282402320914548 138.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Med Virol  2005; 75:267-75; PMID:15602733; http://dx.doi.org/10.1002/jmv.20266 139.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Proc Natl Acad Sci U S A  2002; 99:13837-42; PMID:12368479; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Infect Dis  1996; 173:1297-303; PMID:8648200; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
AJR Am  J Roentgenol 2002; 178:159-63; PMID:11756112; http://dx.doi.org/10.2214/ajr.178.1.1780159 114.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Emerg Infect Dis 2003; 9:1438-43; PMID:14718088; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Emerg Infect Dis 1998;  4:687-94; PMID:9866751; http://dx.doi.org/10.3201/ eid0404.980425 116.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2009; 83:5046-55; PMID:19279096;  http://dx.doi.org/10.1128/JVI.02409-08 118.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Crit Care Med 2002;  30(Suppl):S268-73; PMID:12004247; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
"Pediatr Infect Dis J 2007; 26:283-90, discussion 291- 2; PMID:17414388; http://dx.doi.org/10.1097/01.inf.0000258612.26743.10 120.",OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
FEMS Immunol Med  Microbiol 2005; 43:99-102; PMID:15607642; http://dx.doi.org/10.1016/j.femsim.2004.10.004 122.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2012; 86:6408-15; PMID:22496214; http://dx.doi.org/10.1128/JVI.00213-12 123.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Immunol Lett 2007; 113:117- 20; PMID:17897725; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Exp Biol Med (Maywood) 2011; 236:515- 23; PMID:21502191; http://dx.doi.org/10.1258/ ebm.2011.010339 94.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Science 1993; 262:914- 7; PMID:8235615; http://dx.doi.org/10.1126/sci-ence.8235615 96.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Viruses  2010; 2:2559-86; PMID:21994631; http://dx.doi.org/10.3390/v2122559 97.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Antiviral Res 2008; 78:162- 9; PMID:18093668; http://dx.doi.org/10.1016/j.anti-viral.2007.10.012 98.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Emerg Infect Dis 2005; 11:1848-53; PMID:16485469; http://dx.doi.org/10.3201/ eid1112.050501 99.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Emerg Infect Dis 1997; 3:95-104; PMID:9204290; http://dx.doi.org/10.3201/ eid0302.970202 100.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Nat Med 2012; 18:1448;  PMID:23042337; http://dx.doi.org/10.1038/ nm1012-1448a 102.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Virus Res 2011; 162:138- 47; PMID:21945215; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Virology 1994; 200:715-23; PMID:8178455;  http://dx.doi.org/10.1006/viro.1994.1235 106.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Curr Top Microbiol Immunol 2001; 256:33-46;  PMID:11217405; http://dx.doi.org/10.1007/978-3- 642-56753-7_3 107.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Virology 2003; 308:48-63; PMID:12706089;  http://dx.doi.org/10.1016/S0042-6822(02)00092-2 108.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Thorac  Cardiovasc Surg 2008; 135:579-84; PMID:18329474; http://dx.doi.org/10.1016/j.jtcvs.2007.11.020,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2007; 81:2769- 76; PMID:17202220; http://dx.doi.org/10.1128/ JVI.02402-06 160.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2010; 84:11790- 801; PMID:20844031; http://dx.doi.org/10.1128/ JVI.00916-10 161.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Virology 1995; 206:8-15;  PMID:7831843; http://dx.doi.org/10.1016/S0042-6822(95)80014-X 162.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Clin Immunol  Immunopathol 1996; 78:47-55; PMID:8599883;  http://dx.doi.org/10.1006/clin.1996.0007 163.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Viral Immunol 2007; 20:206-13; PMID:17425435;  http://dx.doi.org/10.1089/vim.2006.0039 165.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Platelets  2010; 21:85-93; PMID:20063989; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Microbes Infect 2004; 6:238-45; PMID:15049335;  http://dx.doi.org/10.1016/j.micinf.2003.10.017 167.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Immunol 2010; 184:1031- 40; PMID:20008293; http://dx.doi.org/10.4049/jim-munol.0902773149.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
"Novartis Found Symp 2007; 283:4-13, discussion  13-7, 238-41; PMID:18300410; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Nat Cell Biol 2008; 10:923-34;  PMID:18604199; http://dx.doi.org/10.1038/ncb1752 151.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
FEBS Lett 2009; 583:1-6; PMID:19059243; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Nat Cell Biol  2006; 8:1223-34; PMID:17060906; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Cell Sci 2008; 121:2115- 22; PMID:18565824; http://dx.doi.org/10.1242/jcs.017897 155.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2010; 84:7405- 11; PMID:20463083; http://dx.doi.org/10.1128/ JVI.00576-10 156.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol  2011; 85:2296-303; PMID:21177802; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Dev Cell 2008; 14:25-36;  PMID:18194650; http://dx.doi.org/10.1016/j.dev- cel.2007.10.019 158.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol  2006; 80:1087-97; PMID:16414986; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Virol J 2011; 8:223; PMID:21569520; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
PLoS Pathog 2010; 6:e1000779;  PMID:20174562; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Virology 1997; 238:380- 90; PMID:9400611; http://dx.doi.org/10.1006/ viro.1997.8827 143.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Arch Virol 2010; 155:971-5;  PMID:20372945; http://dx.doi.org/10.1007/s00705-010-0655-7 145.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol 2010;  84:11227-34; PMID:20810734; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
J Virol  2010; 84:4832-9; PMID:20181715; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
Adv Virol 2012; 2012:674360; PMID:22956954; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/48/kvir-04-06-10925569.PMC5359750.pdf
"The majority of malaria  deaths are caused by infections with Plasmodium falciparum , but  the presenting symptoms and pattern of illness vary according to transmission intensity, patient age, and host and parasite genetic  *Correspondence to: Kevin C Kain; Email: kevin.kain@uhn.ca Submitted: 05/19/2013; Revised: 07/27/2013; Accepted: 07/29/2013http://dx.doi.org/10.4161/viru.25949Malaria affects millions of people around the world and a small  subset of those infected develop cerebral malaria.",Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Neuron  2008; 57:178-201; PMID:18215617; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Glia 1998; 23:1-10; PMID:9562180; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Semin Immunopathol 2009; 31:497-511;  PMID:19779720; http://dx.doi.org/10.1007/s00281- 009-0177-0 6.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Brain Res  2007; 1171:18-29; PMID:17764664; http://dx.doi.org/10.1016/j.brainres.2007.07.034 7.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Neuropathol Exp Neurol 2008; 67:1113- 21; PMID:19018243; http://dx.doi.org/10.1097/ NEN.0b013e31818f9ca8 8.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
PLoS  Pathog 2012; 8:e1002982; PMID:23133375; http://dx.doi.org/10.1371/journal.ppat.100298210.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Cereb Blood Flow Metab 2013; 33:13- 21; PMID:23072749; http://dx.doi.org/10.1038/ jcbfm.2012.153 11.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Anat 2002;  200:629-38; PMID:12162730; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
FASEB J 2008; 22:146-58; PMID:17761522;  http://dx.doi.org/10.1096/fj.07-8319com 14.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Cell Biol  2003; 161:653-60; PMID:12743111; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Nature 2010; 468:562- 6; PMID:20944625; http://dx.doi.org/10.1038/ nature09513 16.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Dev Cell 2008; 14:25-36;  PMID:18194650; http://dx.doi.org/10.1016/j.dev-cel.2007.10.019 18.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Mol Med 2011; 17:717-25; PMID:21556483;  http://dx.doi.org/10.2119/molmed.2010.0021419.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Sci T ransl Med 2010; 2:23ra19;  PMID:20375003; http://dx.doi.org/10.1126/scitrans- lmed.3000678 20.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
PLoS One 2011; 6:e17440; PMID:21364762; http://dx.doi.org/10.1371/journal.pone.0017440 22.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
PLoS One  2010; 5:e15291; PMID:21209923; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Malar J 2009; 8:295; PMID:20003529; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Malar J 2011; 10:383; PMID:22192385; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
PLoS One 2009; 4:e4912; PMID:19300530; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Crit Care Med 2012; 40:952- 9; PMID:22343839; http://dx.doi.org/10.1097/ CCM.0b013e3182373157 27.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Nat Med 2006; 12:235-9; PMID:16462802; http://dx.doi.org/10.1038/nm1351 29.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Cell Host Microbe 2013; 13:215-26; PMID:23414761;  http://dx.doi.org/10.1016/j.chom.2013.01.010 31.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Malar J 2013; 12:50; PMID:23383853;  http://dx.doi.org/10.1186/1475-2875-12-50 32.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Br J Ophthalmol 2008; 92:689-93; PMID:18408080;  http://dx.doi.org/10.1136/bjo.2007.128371 33.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Gerontol A Biol Sci Med Sci 2008; 63:135-40;  PMID:18314447; http://dx.doi.org/10.1093/gero- na/63.2.135 34.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Cell 2003; 115:139-50; PMID:14567912;  http://dx.doi.org/10.1016/S0092-8674(03)00803-1 35.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Infect Dis  2009; 200:1522-9; PMID:19803726; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Nat Med 2006; 12:1417-22;  PMID:17099710; http://dx.doi.org/10.1038/nm1499 37.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Am J Pathol 2003; 162:1651-60; PMID:12707049; http://dx.doi.org/10.1016/S0002-9440(10)64299-X39.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Biol Chem 2006; 281:29190-200; PMID:16891661;  http://dx.doi.org/10.1074/jbc.M604310200 41.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Prostaglandins Other Lipid Mediat 2010; 91:139-44;  PMID:19808013; http://dx.doi.org/10.1016/j.prosta-glandins.2009.04.002 42.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Cell 1999; 96:795-806;  PMID:10102268; http://dx.doi.org/10.1016/S0092- 8674(00)80590-5 43.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Neuropsychol Rev 2010; 20:327-48; PMID:21042938;  http://dx.doi.org/10.1007/s11065-010-9148-4 44.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Brain 1996; 119:1763- 74; PMID:8931596; http://dx.doi.org/10.1093/ brain/119.5.1763 46.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Age (Dordr)  2013; 35:59-67; PMID:22057895; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Neuroscientist 2005;  11:400-7; PMID:16151042; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
T rop Med Int Health 2011; 16:263-71; PMID:21143354; http://dx.doi.org/10.1111/j.1365- 3156.2010.02704.x 51.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Brain Res Dev Brain  Res 1989; 50:11-32; PMID:2582602; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Nat Rev Neurosci  2005; 6:955-65; PMID:16288299; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J  Comp Neurol 1997; 387:167-78; PMID:9336221;  http://dx.doi.org/10.1002/(SICI)1096- 9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z54.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Pediatr Neurol  2003; 29:34-41; PMID:13679119; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Neurosurgery  1998; 42:300-10; PMID:9482180; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Neurosci 2012; 32:9588- 600; PMID:22787045; http://dx.doi.org/10.1523/ JNEUROSCI.5977-11.2012 58.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Eur J Neurosci 1995; 7:1584-95; PMID:7551185; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Brain 1997; 120:435- 44; PMID:9126055; http://dx.doi.org/10.1093/ brain/120.3.435 62.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Curr Biol 1998;  8:923-6; PMID:9707404; http://dx.doi.org/10.1016/ S0960-9822(07)00373-9 63.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
"Cell Tissue Res 2005; 320:369-78; PMID:15846513; http://dx.doi.org/10.1007/s00441-005-1088-6 64. van der Heyde HC, Nolan J, Combes V, Gramaglia  I, Grau GE.",OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
T rends Parasitol 2006; 22:503-8; PMID:16979941;  http://dx.doi.org/10.1016/j.pt.2006.09.002 65.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
PLoS  One 2013; 8:e54481; PMID:23349902; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Am J Pathol 2012; 180:1028- 39; PMID:22260922; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Am J Pathol 2012; 180:246-55; PMID:22079430; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Malar Res T reat 2012; 2012:679090; PMID:23097741; http://dx.doi.org/10.1155/2012/679090 70.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Mol Biochem Parasitol  2003; 128:187-93; PMID:12742585; http://dx.doi.org/10.1016/S0166-6851(03)00075-6 71.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Nat Med 2004; 10:143-5; PMID:14745442; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Am J Pathol  2011; 178:2146-58; PMID:21514429; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Neurosci Lett 2010; 476:89- 93; PMID:20385203; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Brain Behav Immun 2010; 24:138- 52; PMID:19765643; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
PLoS Pathog 2012; 8:e1003099; PMID:23300448;  http://dx.doi.org/10.1371/journal.ppat.1003099 77.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
PLoS One 2012; 7:e44004;  PMID:22952850; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
PLoS Pathog  2010; 6:e1000916; PMID:20502682; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Parasitol Int 2006; 55:107- 12; PMID:16388977; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Infect Dis 2007; 195:942-50; PMID:17330783; http://dx.doi.org/10.1086/512083 83.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Infect Dis  1999; 180:1742-6; PMID:10515846; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Mech Ageing Dev 2003; 124:143-6;  PMID:12633933; http://dx.doi.org/10.1016/S0047- 6374(02)00041-6 86.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Asian Pac J T rop Med 2013; 6:195-9;  PMID:23375032; http://dx.doi.org/10.1016/S1995- 7645(13)60022-X 87.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Hepatology 2009; 50:1914-23;  PMID:19821483; http://dx.doi.org/10.1002/hep.23203 88.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
BMC Musculoskelet Disord 2013; 14:2; PMID:23281803;  http://dx.doi.org/10.1186/1471-2474-14-2 89.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Nat Med 2007; 13:703-10;  PMID:17496899; http://dx.doi.org/10.1038/nm1586 90.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Infect Dis 2010; 202:624-32; PMID:20617898;  http://dx.doi.org/10.1086/654929 92.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Blood 2002; 100:879-87; PMID:12130498; http://dx.doi.org/10.1182/blood.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Biogerontology  2005; 6:27-37; PMID:15834661; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Blood 2009; 114:4243-52; PMID:19713460; http://dx.doi.org/10.1182/ blood-2009-06-226415 98.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Infect Dis 2003; 187:1283-90; PMID:12696008;  http://dx.doi.org/10.1086/373992 99.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Malar J 2011; 10:52; PMID:21356073; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Malar  J 2012; 11:13; PMID:22233563; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
T rop Med Int Health 2011; 16:906-13; PMID:21615630; http://dx.doi.org/10.1111/j.1365- 3156.2011.02788.x 102.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Lancet 2005; 366:717-25; PMID:16125588;  http://dx.doi.org/10.1016/S0140-6736(05)67176-0 103.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Lancet 2010; 376:1647- 57; PMID:21062666; http://dx.doi.org/10.1016/ S0140-6736(10)61924-1 104.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Clin Infect Dis 2008; 47:151-7; PMID:18533842; http://dx.doi.org/10.1086/589287 105.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Lancet 2012; 379:413-31; PMID:22305225; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Am  J T rop Med Hyg 2013; 88:542-6; PMID:23339204;  http://dx.doi.org/10.4269/ajtmh.12-0538 107.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Dev Behav Pediatr  2002; 23:353-64; PMID:12394524; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Brain Res  Brain Res Rev 2003; 43:57-69; PMID:14499462;  http://dx.doi.org/10.1016/S0165-0173(03)00192-9 109.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
T rop  Med Int Health 2005; 10:3-10; PMID:15655008;  http://dx.doi.org/10.1111/j.1365-3156.2004.01345.x 110.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Neurol Neurosurg Psychiatry  2005; 76:476-81; PMID:15774431; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Pediatrics  2007; 119:e360-6; PMID:17224457; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Br J Ophthalmol  2004; 88:321-4; PMID:14977760; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J T rop Pediatr 1991;  37:86-7; PMID:2027172; http://dx.doi.org/10.1093/ tropej/37.2.86 114.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Arch Ophthalmol 1997; 115:997- 1003; PMID:9258221; http://dx.doi.org/10.1001/ archopht.1997.01100160167005 117.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Malar J 2010; 9:232; PMID:20704742; http://dx.doi.org/10.1186/1475-2875-9-232 118.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Ocul Immunol Inflamm 2008; 16:239-41; PMID:19065421; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
QJM 1998; 91:845- 52; PMID:10024950; http://dx.doi.org/10.1093/ qjmed/91.12.845 122.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Am J T rop Med Hyg  2011; 84:141-7; PMID:21212217; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
T rans R Soc T rop Med Hyg 2009; 103:665-71; PMID:19344925; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Arch  Ophthalmol 2004; 122:1141-7; PMID:15302654;  http://dx.doi.org/10.1001/archopht.122.8.1141125.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
T rans R Soc T rop Med Hyg  2001; 95:618-21; PMID:11816433; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Future Microbiol 2011; 6:349-55;  PMID:21449844; http://dx.doi.org/10.2217/fmb.11.3 130.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Int J Parasitol 2006; 36:555- 68; PMID:16616145; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Neuropathol Exp Neurol 1987; 46:223-31; PMID:3546601; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Neurobiol Dis 2004; 16:1-13;  PMID:15207256; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Malar J 2007; 6:138; PMID:17958887; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
N Engl J Med  1982; 306:313-9; PMID:7033788; http://dx.doi.org/10.1056/NEJM198202113060601138.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
J Infect Dis  1988; 158:325-31; PMID:3042874; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Clin Infect  Dis 2011; 53:349-55; PMID:21810747; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Lancet  1991; 337:573-6; PMID:1671941; http://dx.doi.org/10.1016/0140-6736(91)91638-B 141.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
T rans R Soc T rop Med Hyg 1991; 85:362-4; PMID:1949139; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
AJNR  Am J Neuroradiol 2012; 33:1740-6; PMID:22517285;  http://dx.doi.org/10.3174/ajnr.A3035 144.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Clin Infect Dis 1995; 21:300-9; PMID:8562735;  http://dx.doi.org/10.1093/clinids/21.2.300 145.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Malar J 2011; 10:267; PMID:21923924; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
T rials 2011; 12:176;  PMID:21752262; http://dx.doi.org/10.1186/1745-6215-12-176 148.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
Med Hypotheses 2011; 77:437-44; PMID:21745716;  http://dx.doi.org/10.1016/j.mehy.2011.06.003 149.,Non-OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
N Engl J Med  2005; 353:23-32; PMID:16000353; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/55/kvir-04-06-10925949.PMC5359751.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Nikolaos K Paschos, MD, PhD, Depart - ment of Orthopaedic Surgery, Penn Sports Medicine, University of  Pennsylvania Health System, 235 S 33rd St, Philadelphia, PA 19104,  United States.",Non-OADS,/arxiv_data1/oa_pdf/78/d8/WJO-8-212.PMC5359756.pdf
World J Orthop  2017; 8(3): 212-217  Available  from: URL:  http://www.wjgnet.com/ 2218-5836 /full/v8/i3/212.,Non-OADS,/arxiv_data1/oa_pdf/78/d8/WJO-8-212.PMC5359756.pdf
htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i3.212 Anterior cruciate ligament (ACL) tear is a devastating  injury with both short and long term consequences.,Non-OADS,/arxiv_data1/oa_pdf/78/d8/WJO-8-212.PMC5359756.pdf
Short-term knee functional impairment is successfully Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.5312/wjo.v8.i3.212World J Orthop  2017 March 18; 8(3): 212-217 ISSN 2218-5836 (online),Non-OADS,/arxiv_data1/oa_pdf/78/d8/WJO-8-212.PMC5359756.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/78/d8/WJO-8-212.PMC5359756.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Elizabeth K Tissingh, MBBS, MSc,  MRCS,  Cambridge University Hospitals NHS Foundation  Trust, Addenbrooke’s and Rosie Hospitals, Box 37, Cambridge  Biomedical Campus, Cambridge CB2 0QQ,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/b9/24/WJO-8-218.PMC5359757.pdf
World J Orthop  2017; 8(3): 218-220  Available  from: URL:  http://www.wjgnet.com/ 2218-5836 /full/v8/i3/218.,Non-OADS,/arxiv_data1/oa_pdf/b9/24/WJO-8-218.PMC5359757.pdf
htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i3.218 Acetabular fractures in older patients pose a challenge  for both patients and clinicians providing care.,Non-OADS,/arxiv_data1/oa_pdf/b9/24/WJO-8-218.PMC5359757.pdf
For patients managed with open  Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.5312/wjo.v8.i3.218World J Orthop  2017 March 18; 8(3): 218-220 ISSN 2218-5836 (online),Non-OADS,/arxiv_data1/oa_pdf/b9/24/WJO-8-218.PMC5359757.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b9/24/WJO-8-218.PMC5359757.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Markus Regauer, MD,  Klinik für  Allgemeine, Unfall und Wiederherstellungschirurgie, Klinikum  der Ludwig-Maximilians-Universität München, Standort  Großhadern, Marchioninistraße 15, 81377 Munich,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/97/36/WJO-8-221.PMC5359758.pdf
"Maximum range  of motion of the ankle was measured and ligamentous  stability was evaluated by use of standard X-rays after  application of varus, valgus or sagittal stress with 150  Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.5312/wjo.v8.i3.221World J Orthop  2017 March 18; 8(3): 221-228 ISSN 2218-5836 (online)",Non-OADS,/arxiv_data1/oa_pdf/97/36/WJO-8-221.PMC5359758.pdf
"World J Orthop  2017; 8(3): 221-228   Available from: URL:  http://www.wjgnet.com/ 2218-5836 /full/ v8/i3/221.htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i3.221 INTRODUCTION T otal loss of talus due to trauma[1-5] or avascular necrosis[6-9],  for example, still remains to be a major challenge in  foot and ankle surgery with severely limited treatment  options[2,4,5,8,9].",Non-OADS,/arxiv_data1/oa_pdf/97/36/WJO-8-221.PMC5359758.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/97/36/WJO-8-221.PMC5359758.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Brian R Waterman, MD, MAJ, MC,   Department of Orthopaedic Surgery and Rehabilitation, William  Beaumont Army Medical Center, 5005 North Piedras St, El Paso,  TX 79920, United States.",Non-OADS,/arxiv_data1/oa_pdf/9e/eb/WJO-8-229.PMC5359759.pdf
Core tip:  Non-anatomic stabilization procedures may result  in overconstraint or incongruence of the glenohumeral Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.5312/wjo.v8.i3.229World J Orthop  2017 March 18; 8(3): 229-241 ISSN 2218-5836 (online),Non-OADS,/arxiv_data1/oa_pdf/9e/eb/WJO-8-229.PMC5359759.pdf
"World J Orthop  2017; 8(3): 229-241  Available from: URL:   http://www.wjgnet.com/ 2218-5836 /full/v8/i3/229.htm  DOI:  http://dx.doi.org/10.5312/wjo.v8.i3.229 INTRODUCTION Glenohumeral instability is a frequent problem en­ countered within high ­risk patient populations[1,2], and  it poses important short ­ and long ­term implications for  shoulder function.",Non-OADS,/arxiv_data1/oa_pdf/9e/eb/WJO-8-229.PMC5359759.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9e/eb/WJO-8-229.PMC5359759.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Greg A J Robertson, MBChB, BMedSci  (Hons), MSc, MRCSEd,  Edinburgh Orthopaedic Trauma  Unit, Royal Infirmary of Edinburgh, 51 Little France Crescent,  Edinburgh, Scotland EH16 4SA,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/5e/42/WJO-8-242.PMC5359760.pdf
Core tip:  This editorial article offers a current perspective  on the treatment of lower limb stress fractures in the  Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.5312/wjo.v8.i3.242World J Orthop  2017 March 18; 8(3): 242-255 ISSN 2218-5836 (online),Non-OADS,/arxiv_data1/oa_pdf/5e/42/WJO-8-242.PMC5359760.pdf
World J Orthop   2017; 8(3): 242-255  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/5e/42/WJO-8-242.PMC5359760.pdf
com/ 2218-5836 /full/v8/i3/242.htm  DOI: http://dx.doi.org/10.5312/ wjo.v8.i3.242 INTRODUCTION Stress fractures represent one of the more serious  injuries in sport[1].,Non-OADS,/arxiv_data1/oa_pdf/5e/42/WJO-8-242.PMC5359760.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5e/42/WJO-8-242.PMC5359760.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Invited manuscript Correspondence to:  Benjamin Blondel, MD, PhD,  Spine Unit,  Hôpital de la Timone, 264 rue Saint Pierre, 13005 Marseille,  France.",Non-OADS,/arxiv_data1/oa_pdf/45/c2/WJO-8-256.PMC5359761.pdf
"Moments in sagittal  plane at the lumbosacral junction were statistically  correlated to the age ( P = 0.003), underlining the fact  that sagittal mechanical constraints at the lumbosacral Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.5312/wjo.v8.i3.256World J Orthop  2017 March 18; 8(3): 256-263 ISSN 2218-5836 (online)",Non-OADS,/arxiv_data1/oa_pdf/45/c2/WJO-8-256.PMC5359761.pdf
World J Orthop  2017; 8(3): 256-263   Available from: URL:  http://www.wjgnet.com/ 2218-5836 /full/v8/ i3/256.htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i3.,OADS,/arxiv_data1/oa_pdf/45/c2/WJO-8-256.PMC5359761.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/45/c2/WJO-8-256.PMC5359761.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Wael A Rahman, MBBCh, MSc,  MD(Ortho), Assistant Professor,  Orthopaedic Department,  Mansoura University, 60 El-Gomhoria street, Mansoura, Dakahlia  35516, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/03/d7/WJO-8-264.PMC5359762.pdf
"The organisms were identified preoperatively in  14 patients (93.3%), coagulase negative Staphylococcus  was the infecting organism in 8 patients (53.3%).Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.5312/wjo.v8.i3.264World J Orthop  2017 March 18; 8(3): 264-270 ISSN 2218-5836 (online)",Non-OADS,/arxiv_data1/oa_pdf/03/d7/WJO-8-264.PMC5359762.pdf
World J Orthop  2017; 8(3): 264-270  Available  from: URL:  http://www.wjgnet.com/ 2218-5836 /full/v8/i3/ 264. htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i3.,OADS,/arxiv_data1/oa_pdf/03/d7/WJO-8-264.PMC5359762.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/03/d7/WJO-8-264.PMC5359762.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Andrei Fernandes Joaquim, MD,  Department of Neurology, Division of Neurosurgical, State Univer - sity of Campinas, Tessália Vieira de Camargo Street, Campinas  13083-887, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/91/3a/WJO-8-271.PMC5359763.pdf
Four  patients (40%) had facetary subluxation demonstrated Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.5312/wjo.v8.i3.271World J Orthop  2017 March 18; 8(3): 271-277 ISSN 2218-5836 (online),Non-OADS,/arxiv_data1/oa_pdf/91/3a/WJO-8-271.PMC5359763.pdf
World J Orthop  2017;  8(3): 271-277  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/91/3a/WJO-8-271.PMC5359763.pdf
com/ 2218-5836 /full/v8/i3/ 271.htm  DOI: http://dx.doi.org/10.5312/ wjo.v8.i3.,OADS,/arxiv_data1/oa_pdf/91/3a/WJO-8-271.PMC5359763.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/91/3a/WJO-8-271.PMC5359763.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Tatsunori Ikemoto, MD, PhD,  Institute  of Physical Fitness, Sports Medicine and Rehabilitation, Aichi  Medical University, 1-1 yazako karimata, Nagakute, Aichi  480-1195, Japan.",Non-OADS,/arxiv_data1/oa_pdf/fe/90/WJO-8-278.PMC5359764.pdf
"Subsequently, a multiple linear regression was conducted Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.5312/wjo.v8.i3.278World J Orthop  2017 March 18; 8(3): 278-285 ISSN 2218-5836 (online)",Non-OADS,/arxiv_data1/oa_pdf/fe/90/WJO-8-278.PMC5359764.pdf
World J Orthop  2017; 8(3): 278-285   Available from: URL:  http://www.wjgnet.com/ 2218-5836 /full/ v8/i3/ 278.htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i3.,OADS,/arxiv_data1/oa_pdf/fe/90/WJO-8-278.PMC5359764.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/fe/90/WJO-8-278.PMC5359764.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Alessandro Calistri, MD,  Department of  Orthopedic and Traumatology, ANCA Clinic, Via de Notaris 2b, 00197 Rome, Italy.",Non-OADS,/arxiv_data1/oa_pdf/36/b6/WJO-8-286.PMC5359765.pdf
"Such mistakes,  Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.5312/wjo.v8.i3.286World J Orthop  2017 March 18; 8(3): 286-289 ISSN 2218-5836 (online)",Non-OADS,/arxiv_data1/oa_pdf/36/b6/WJO-8-286.PMC5359765.pdf
World J Orthop  2017; 8(3): 286-289  Available  from: URL:  http://www.wjgnet.com/ 2218-5836 /full/v8/i3/286.,Non-OADS,/arxiv_data1/oa_pdf/36/b6/WJO-8-286.PMC5359765.pdf
htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i3.286 INTRODUCTION Metal-on-metal hip resurfacing has gained popularity as  a feasible treatment option for young and active patients  with hip osteoarthritis and high functional expectations.,Non-OADS,/arxiv_data1/oa_pdf/36/b6/WJO-8-286.PMC5359765.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/36/b6/WJO-8-286.PMC5359765.pdf
"http://informahealthcare.com/amy ISSN: 1350-6129 (print), 1744-2818 (electronic) Amyloid, 2016; 23(3): 178–183 !2016 Pfizer Inc.",Non-OADS,/arxiv_data1/oa_pdf/96/fd/iamy-23-178.PMC5359776.pdf
"Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-com-mercial re-use, distribution, and reproduction in any medium, providedthe original work is properly cited, and is not altered, transformed, orbuilt upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/96/fd/iamy-23-178.PMC5359776.pdf
"This is an Open Access article distributed under the terms of th e Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.BIOMARKERS, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/2b/ba/ibmk-21-607.PMC5359777.pdf
"7, 607–613http://dx.doi.org/10.3109/1354750X.2016.1171900",Non-OADS,/arxiv_data1/oa_pdf/2b/ba/ibmk-21-607.PMC5359777.pdf
"4, 431–441 http://dx.doi.org/10.1080/08912963.2016.1178740 Yuhania: a unique angiosperm from the Middle Jurassic of Inner Mongolia, China Zhong-Jian Liua  and Xin Wangb  ashenzhen Key laboratory for orchid conservation and Utilization, National orchid conservation center of china and orchid conservation & research  center of shenzhen, shenzhen 518114, china; bstate Key laboratory of Palaeobiology and s tratigraphy, Nanjing i nstitute of g eology and Palaeontology,  cas, Nanjing 210008, china ABSTRACT Despite increasing claims of pre-Cretaceous angiosperms, whether there really are angiosperms in the  Jurassic is apparently still an open question for many people before further evidence is available.",Non-OADS,/arxiv_data1/oa_pdf/56/f0/ghbi-29-431.PMC5359780.pdf
"this is an open a ccess article distributed under the terms of the creative c ommons a ttribution-Nonc ommercial-NoDerivatives license (http://creativecommons.org/licenses/by-nc-nd/4.0/),  which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.KEYWORDS angiosperm; fossil; origin;  evolution; Jurassic; china; YuhaniaARTICLE HISTORY received 22 January 2016 accepted 12 april 2016 CONTACT Xin Wang  xinwang@nigpas.ac.cn  supplemental data for this article can be seen at http://dx.doi.org/10.1080/08912963.2016.1178740 OPEN AC CESS",Non-OADS,/arxiv_data1/oa_pdf/56/f0/ghbi-29-431.PMC5359780.pdf
HIsT orIC aL BIoL ogy   439 ORCID Zhong­Jian Liu   http://orcid.org/0000-0003-4390-3878 Xin Wang   http://orcid.org/0000-0002-4053-5515 References APG.,Non-OADS,/arxiv_data1/oa_pdf/56/f0/ghbi-29-431.PMC5359780.pdf
doi:http://dx.doi.org/10.1111/nph.13871.,Non-OADS,/arxiv_data1/oa_pdf/56/f0/ghbi-29-431.PMC5359780.pdf
282. doi:http://dx.doi.org/10.1098/rspb.2015.1045.,Non-OADS,/arxiv_data1/oa_pdf/56/f0/ghbi-29-431.PMC5359780.pdf
Available  from: http://www.mobot.org/MOBOT/research/APweb/.,Non-OADS,/arxiv_data1/oa_pdf/56/f0/ghbi-29-431.PMC5359780.pdf
"This further indicates that active monitoring of formalin diffusion would be needed to ensurecomplete formalin diffusion to an entire specimen in thequickest time possible (Supplemental movie, Supplemental Digital Content 1, http://links.lww.com/AIMM/A148 shows the relationship between the T OF curve and diffusion across t h ee n t i r et i s s u es p e c i m e n ) .F inally, we collected apparent fixative diffusion data from 11 d ifferent tissue-specific car- cinomas matched with normal t issue, white and gray brain matter, and lung tissue with emphysema (Fig.",Non-OADS,/arxiv_data1/oa_pdf/49/92/pai-25-160.PMC5359782.pdf
http://dx.doi.org/10.1097/j.pain.0000000000000814 April 2017·Volume 158·Number 4 www.painjournalonline.com 669,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/jop-158-669.PMC5359787.pdf
http://dx.doi.org/10.1097/j.pain.0000000000000810 660 C.I.,Non-OADS,/arxiv_data1/oa_pdf/fe/36/jop-158-660.PMC5359788.pdf
http://dx.doi.org/10.1097/j.pain.0000000000000785 560 H.L.,Non-OADS,/arxiv_data1/oa_pdf/72/73/jop-158-560.PMC5359789.pdf
"Allthese limitations will be addressed in the DOLORisk study (http://dolorisk.eu/), a European consortium which aims to identify risk factors for NP.",Non-OADS,/arxiv_data1/oa_pdf/72/73/jop-158-560.PMC5359789.pdf
http://dx.doi.org/10.1097/j.pain.0000000000000831 April 2017·Volume 158·Number 4 www.painjournalonline.com 543,Non-OADS,/arxiv_data1/oa_pdf/fc/ad/jop-158-543.PMC5359791.pdf
"https://doi.org/10.1177/2055116917691069 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons   Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial  use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and  Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Journal of Feline Medicine and Surgery Open  Reports  1 –8 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2055116917691069 journals.sagepub.com/home/jfmsopenreports This paper was handled and processed  by the European Editorial Office (ISFM) for  publication in JFMS Open Reports Introduction Feline lung–digit syndrome (FLDS) refers to a clinical  entity where primary lung tumours (often bronchogenic adenocarcinoma), which may be clinically silent in them- selves, present because of metastatic lesions in one or  more digits.",Non-OADS,/arxiv_data1/oa_pdf/43/3e/10.1177_2055116917691069.PMC5359792.pdf
"E-mail: wangbw@pku.edu.cn; gaosong@pku.edu.cn; Web: http://www.chem.pku.edu.cn/mmm/; Fax: +8610-6275-1708 bJiangsu Key Laboratory for NSLSCS, School of Physical Science and Technology, Nanjing Normal University, Nanjing 210023, P. R. China cDepartment of Chemistry, Key Laboratory of Advanced Energy Materials Chemistry (MOE), State Key Laboratory of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin 300071, China †Electronic supplementary information (ESI) available: Synthetic procedures, structure, magnetism, ab initio calculation, magnetic interaction analysis, Fig.",Non-OADS,/arxiv_data1/oa_pdf/a0/cf/SC-008-C6SC03621J.PMC5359878.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 2 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/2is clear that undergraduate mentorship increases persistence in  STEM fields, we believe that introducing mentors at an earlier  age will improve students’ confidence – especially those from  underrepresented or disadvantaged backgrounds – in their  ability to perform research and will encourage students to  choose and maintain a STEM major as undergraduates.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
CoSBBI is a part of the University of Pittsburgh  Cancer Institute (UPCI) Academy (http://www.upci.upmc.,Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"A direct goal of the UPCI Academy and CoSBBI is to  increase the number of students prepared for STEM fields as  undergraduates from underrepresented populations, as defined  by the National Institutes of Health (NIH) (http://www.ninds.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 3 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/2awareness, leadership, scientific communication, and more.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
The program culminates  with presentations at the Duquesne University Summer  Undergraduate Research Symposium (http://www.duq.edu/ academics/schools/natural‑and‑environmental‑sciences/ undergraduate‑research/summer‑research‑symposium).,Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 4 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/2their undergraduate studies and beyond.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Most of our scholars are enrolled at regional  schools (n = 12) such as the University of Pittsburgh, CMU, and  Pennsylvania State University, or at the US News ranked top 25  universities (http://www.colleges.usnews.rankingsandreviews.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
One scholar independently published her research  on the discovery of an overexpressed gene in an aggressive  breast cancer subtype in the International High School Journal of  Science (http://www.ihsjs.com/magazines/IHSJS‑Dec‑2015/).,Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
Another scholar attended the next-generation high school  summit at the White House to present his analysis of  the effect of fusion genes on the development of breast  cancer (http://www.triblive.com/news/allegheny/9413966‑74/ cancer -kurukulasuriya -allderdice?sf42404517 =  1#axzz3r5QbbSZB).,Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 5 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/2was an alumnus of the program who later became a CoSBBI  intern in a pathology informatics laboratory.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 6 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/2scientists” significantly increased from the pre‑ to post‑test.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 7 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/2the UPCI Academy, Victoria Khersonsky for her technical  support for CoSBBI scholars, and DBMI graduate students  and faculty/staff mentors for their unwavering support  and enthusiasm, and all mentors who donated their time  throughout the University of Pittsburgh.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
Available from: https://www.nlm.nih.gov/ep/ GrantTrainInstitute.html.,Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
Available  from: https://www.healthit.gov/sites/default/files/rtc_adoption_and_ exchange9302014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
Available from: http://www.usnews.com/news/ stem‑solutions/articles/2014/04/24/the‑crucial ‑role‑of‑mentors‑in‑stem.,Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 8 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/2Abstracts The Logic of Cancer Ishan Levy1, Roger Day2 1Department of Biomedical Informatics, University of Pittsburgh Cancer Institute,  Computer Science, Biology and Biomedical Informatics, Summer Academy,  2Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 9 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/2liquids of relatively low viscosity (e.g., water).",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 10 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/22Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 11 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/2the inherently uns table  breast cancer genome, we hypothesize  that fusion genes may mediate breast cancer metastasis.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
"Journal of Pathology Informatics 12 J Pathol Inform 2017, 1:2  http://www.jpathinformatics.org/content/8/1/2of 130 million emergency room visits.",Non-OADS,/arxiv_data1/oa_pdf/e7/c2/JPI-8-2.PMC5359992.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"Journal of Pathology Informatics 2 J Pathol Inform 2017, 1:7  http://www.jpathinformatics.org/content/8/1/7comply with the model assumptions, then the model under  investigation can be used to detect future values of the data.",Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"Journal of Pathology Informatics 3 J Pathol Inform 2017, 1:7  http://www.jpathinformatics.org/content/8/1/7exponential smoothing model for a noisy time-series requires  more historical data to cancel out the noise to accurately  estimate the future values.",Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"Journal of Pathology Informatics 4 J Pathol Inform 2017, 1:7  http://www.jpathinformatics.org/content/8/1/7models for forecasting, it is required to select the optimal  model, the initial values, and the values of the parameters α,  β, and γ. Akaike information criterion (AIC)[16,17] is a method used to  calculate the likelihood/probability of the model to predict the  future values.",OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"Journal of Pathology Informatics 5 J Pathol Inform 2017, 1:7  http://www.jpathinformatics.org/content/8/1/7Shiny R package.",Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"The software can be accessed online through the  following link: https://github.com/ClinicalLaboratory/ Clinical-Laboratory results  and dIscussIon Figure  2 shows a linear regression model fitted to the  monthly clinical laboratory test volumes for the period of  April 2011–March 2015 from all medical facilities located  in the Province of Alberta, Canada.",Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"Journal of Pathology Informatics 6 J Pathol Inform 2017, 1:7  http://www.jpathinformatics.org/content/8/1/7in the trend and seasonal patterns cannot be captured correctly  by Holt-Winters models and the linear regression model is the  best model to fit the data in this case with minimum RMSE.",Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"Journal of Pathology Informatics 7 J Pathol Inform 2017, 1:7  http://www.jpathinformatics.org/content/8/1/7“Help and Citation” tab and click “Download Sample  Text data” or “Download Sample CSV data”.",Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"However, it requires trained files from the following GitHub repository: https://github.com/ ClinicalLaboratory/Clinical-Laboratory.",Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"Journal of Pathology Informatics 8 J Pathol Inform 2017, 1:7  http://www.jpathinformatics.org/content/8/1/7personnel to design, implement, validate, select the best model,  and interpret the model parameters.",Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"Journal of Pathology Informatics 9 J Pathol Inform 2017, 1:7  http://www.jpathinformatics.org/content/8/1/7as soon as 1 month after the start of a utilization management  intervention.",Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
Available from: https://www.datamarket.com/data/set/22y6/ precipitation-in-mm-eastport-usa-1887-1950#!ds = 22y6 and  display = line.,OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
Available from: https://www.rpubs.com/ nohaelprince/47545.,Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
"Journal of Pathology Informatics 10 J Pathol Inform 2017, 1:7  http://www.jpathinformatics.org/content/8/1/736.",Non-OADS,/arxiv_data1/oa_pdf/27/e0/JPI-8-7.PMC5359993.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
"J Pathol Inform 2017, 1:3  http://www.jpathinformatics.org/content/8/1/3Journal of Pathology Informatics 2Before the work described herein, aspects of the case review  process were carried out in an idiosyncratic and manual fashion.",Non-OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
"J Pathol Inform 2017, 1:3  http://www.jpathinformatics.org/content/8/1/3Journal of Pathology Informatics 3was 4 hours per person per day (with single fellow and/or  resident participating).",Non-OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
"J Pathol Inform 2017, 1:3  http://www.jpathinformatics.org/content/8/1/3Journal of Pathology Informatics 4be added.",Non-OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
"It was developed using the CSLA.NET  (http://cslanet.com/) and Model‑View‑ViewModel (MVVM)  light (https://mvvmlight.codeplex.com/) frameworks,  using a MVVM (https://msdn.microsoft.com/en‑us/library/ hh848246.aspx) design pattern to separate application logic  from the presentation layer.",OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
Portions of the user interface  were implemented using the MahApps.Metro user interface  toolkit for Windows Presentation Foundation applications  (http://mahapps.com/).,OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
"J Pathol Inform 2017, 1:3  http://www.jpathinformatics.org/content/8/1/3Journal of Pathology Informatics 5 Figure 2: Surgical pathology listing viewer application.",Non-OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
"J Pathol Inform 2017, 1:3  http://www.jpathinformatics.org/content/8/1/3Journal of Pathology Informatics 6may be enabled with a toggle button.",Non-OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
"J Pathol Inform 2017, 1:3  http://www.jpathinformatics.org/content/8/1/3Journal of Pathology Informatics 7One immediate benefit of moving the surgical list review  process to an electronic platform was the transferability of  completed case annotations when a surgical date would change.",Non-OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
"J Pathol Inform 2017, 1:3  http://www.jpathinformatics.org/content/8/1/3Journal of Pathology Informatics 8caseload for review on the evening before the surgical day.",Non-OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
Available from: http://www.ihi.org/resources/pages/ihiwhitepapers/ goingleaninhealthcare.aspx.,Non-OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
Available  from: http://www.agilemanifesto.org/.,Non-OADS,/arxiv_data1/oa_pdf/71/a0/JPI-8-3.PMC5359996.pdf
Available FREE in open access from:  http://www.clinicalimagingscience.,Non-OADS,/arxiv_data1/oa_pdf/71/c7/JCIS-7-11.PMC5359997.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/c3/18/JPI-8-5.PMC5359998.pdf
"J Pathol Inform 2017, 1:5  http://www.jpathinformatics.org/content/8/1/5Journal of Pathology Informatics 2Methods Tissue Samples A total of 2005 tissues for training or validation of the system  were previously diagnosed by two independent pathologists  [Table s 1 and 2].",OADS,/arxiv_data1/oa_pdf/c3/18/JPI-8-5.PMC5359998.pdf
"J Pathol Inform 2017, 1:5  http://www.jpathinformatics.org/content/8/1/5Journal of Pathology Informatics 3conditions are integrated into ROIs which are examined at  × 40  for confirmation.",OADS,/arxiv_data1/oa_pdf/c3/18/JPI-8-5.PMC5359998.pdf
"J Pathol Inform 2017, 1:5  http://www.jpathinformatics.org/content/8/1/5Journal of Pathology Informatics 4techniques (methods), several candidate contours are extracted  for as many nuclei as possible on that ROI.",OADS,/arxiv_data1/oa_pdf/c3/18/JPI-8-5.PMC5359998.pdf
"J Pathol Inform 2017, 1:5  http://www.jpathinformatics.org/content/8/1/5Journal of Pathology Informatics 5distances between the extracted glands and the candidate areas,  the SIG detector decides whether a candidate ROI is suspicious  for SIG carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/c3/18/JPI-8-5.PMC5359998.pdf
"J Pathol Inform 2017, 1:5  http://www.jpathinformatics.org/content/8/1/5Journal of Pathology Informatics 6other 1905 gastric tissues [ Table  2].",Non-OADS,/arxiv_data1/oa_pdf/c3/18/JPI-8-5.PMC5359998.pdf
"J Pathol Inform 2017, 1:5  http://www.jpathinformatics.org/content/8/1/5Journal of Pathology Informatics 7Yamaguchi Endocrine Research Association, and the grant  of “University-Industry Joint Research Project” for private  universities as well as a matching fund subsidy from the  MEXT, 2007–2009.",Non-OADS,/arxiv_data1/oa_pdf/c3/18/JPI-8-5.PMC5359998.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/12/44/JPI-8-6.PMC5359999.pdf
"J Pathol Inform 2017, 1:6  http://www.jpathinformatics.org/content/8/1/6Journal of Pathology Informatics 2used to discuss interesting cases, quiz questions, and other  pathology-related academic issues.",Non-OADS,/arxiv_data1/oa_pdf/12/44/JPI-8-6.PMC5359999.pdf
"J Pathol Inform 2017, 1:6  http://www.jpathinformatics.org/content/8/1/6Journal of Pathology Informatics 3Web-based communities and hosted services, such as social  networking sites (i.e., Facebook, WhatsApp), video sharing  sites (i.e., YouTube), wikis, and blogs, are all tools of Web 2.0.",OADS,/arxiv_data1/oa_pdf/12/44/JPI-8-6.PMC5359999.pdf
"J Pathol Inform 2017, 1:6  http://www.jpathinformatics.org/content/8/1/6Journal of Pathology Informatics 4Acknowledgments The authors acknowledge the support of all the resident doctors  of Pathology Department of University College of Medical  Sciences, Dilshad Garden, Delhi, for their honest and unbiased  feedback and active participation in this study.",Non-OADS,/arxiv_data1/oa_pdf/12/44/JPI-8-6.PMC5359999.pdf
"miRNA targeting single‑nucleotide polymorphisms  selection miRNASNP (http://www.bioguo.org/miRNASNP/),  PolymiRTS Database (http://compbio.uthsc.edu/ miRSNP/),[27] and MirSNP (http://202.38.126.151/hmdd/ mirsnp/search/) were used to identify miRNAs targeting  variations within APOA5 target gene.",OADS,/arxiv_data1/oa_pdf/ec/4d/ABR-6-24.PMC5360002.pdf
"Furthermore, we  obtained insertion and deletion polymorphisms located on  APOA5 3'UTRs with SNP IDs from the National Center for Biotechnology Information (NCBI) dbSNP database  (http://www.ncbi.nlm.nih.gov/) and predicted miRNA  target sites from TargetScan[28] (http://www.targetscan.",OADS,/arxiv_data1/oa_pdf/ec/4d/ABR-6-24.PMC5360002.pdf
org/) and the miRanda (http://www.microrna.org/microrna/ getMirnaForm.do).,OADS,/arxiv_data1/oa_pdf/ec/4d/ABR-6-24.PMC5360002.pdf
"This variation  has been previously reported as insertion GA, which  was based on the data obtained from the NCBI dbSNP  database (http://www.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/ec/4d/ABR-6-24.PMC5360002.pdf
"The APOA5 rs72525532 variant  has been previously reported as insertion GA at 3' UTR  positions 285–286, which was based on the data obtained  from the NCBI dbSNP database (http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/ec/4d/ABR-6-24.PMC5360002.pdf
Available FREE in open access from:  http://www.clinicalimagingscience.,Non-OADS,/arxiv_data1/oa_pdf/e3/4f/JCIS-7-12.PMC5360005.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/eb/f8/JPI-8-4.PMC5360015.pdf
"Journal of Pathology Informatics 2 J Pathol Inform 2017, 1:4  http://www.jpathinformatics.org/content/8/1/4Arguments exist against the implementation of the algorithm  for the diagnostic evaluation of patients suspected of a HSV  CNS infection.",Non-OADS,/arxiv_data1/oa_pdf/eb/f8/JPI-8-4.PMC5360015.pdf
"Journal of Pathology Informatics 3 J Pathol Inform 2017, 1:4  http://www.jpathinformatics.org/content/8/1/4This study was approved by the Institutional  Review Board  of the V A Connecticut Healthcare System.",Non-OADS,/arxiv_data1/oa_pdf/eb/f8/JPI-8-4.PMC5360015.pdf
"Journal of Pathology Informatics 4 J Pathol Inform 2017, 1:4  http://www.jpathinformatics.org/content/8/1/4normal CSF protein and often a negative magnetic resonance  image (MRI),  a compelling  alternative  diagnosis,  and/or  clinical recovery [ Table  1].",Non-OADS,/arxiv_data1/oa_pdf/eb/f8/JPI-8-4.PMC5360015.pdf
"Journal of Pathology Informatics 5 J Pathol Inform 2017, 1:4  http://www.jpathinformatics.org/content/8/1/4The algorithm, a combination of clinical and laboratory  information, may outperform the current gold standard of  HSV PCR alone for the diagnosis of HSV CNS infection.",Non-OADS,/arxiv_data1/oa_pdf/eb/f8/JPI-8-4.PMC5360015.pdf
"Journal of Pathology Informatics 6 J Pathol Inform 2017, 1:4  http://www.jpathinformatics.org/content/8/1/4Financial support and sponsorship Nil.",Non-OADS,/arxiv_data1/oa_pdf/eb/f8/JPI-8-4.PMC5360015.pdf
Available  from: http://www.cms.gov/Medicare/ Medicare‑Fee‑for‑Service‑Payment/ClinicalLabFeeSched/clinlab.,Non-OADS,/arxiv_data1/oa_pdf/eb/f8/JPI-8-4.PMC5360015.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/0a/54/JPI-8-1.PMC5360018.pdf
"Journal of Pathology Informatics 2 J Pathol Inform 2017, 1:1  http://www.jpathinformatics.org/content/8/1/1features based on the white run length and percentage cluster  area were also shown to be useful for the classification of  biopsy images.",OADS,/arxiv_data1/oa_pdf/0a/54/JPI-8-1.PMC5360018.pdf
"Journal of Pathology Informatics 3 J Pathol Inform 2017, 1:1  http://www.jpathinformatics.org/content/8/1/1Where p’ (s) and p’’ (s) represent the first and second derivatives  of P (s), respectively, and α and β are constants weighting the  relative importance of the derivatives.",Non-OADS,/arxiv_data1/oa_pdf/0a/54/JPI-8-1.PMC5360018.pdf
"Journal of Pathology Informatics 4 J Pathol Inform 2017, 1:1  http://www.jpathinformatics.org/content/8/1/1process, which is based on the stochastic gradient descent  algorithm.",Non-OADS,/arxiv_data1/oa_pdf/0a/54/JPI-8-1.PMC5360018.pdf
"Journal of Pathology Informatics 5 J Pathol Inform 2017, 1:1  http://www.jpathinformatics.org/content/8/1/1 Figure 5:  Variation of mean squared error across training epochs  Figure 4: Examples of results obtained by the segmentation methods for  the benign hyperplasia, intraepithelial neoplasia, and carcinoma tissue  types.",Non-OADS,/arxiv_data1/oa_pdf/0a/54/JPI-8-1.PMC5360018.pdf
"Journal of Pathology Informatics 6 J Pathol Inform 2017, 1:1  http://www.jpathinformatics.org/content/8/1/1features derived from GLCMs, discrete wavelet transforms,  and Laplacian of Gaussian filters, computed on presegmented  regions, to classify the same images with an accuracy of  98.92%.",Non-OADS,/arxiv_data1/oa_pdf/0a/54/JPI-8-1.PMC5360018.pdf
"Journal of Pathology Informatics 7 J Pathol Inform 2017, 1:1  http://www.jpathinformatics.org/content/8/1/1Trends Eng  2009;1:250-4.",Non-OADS,/arxiv_data1/oa_pdf/0a/54/JPI-8-1.PMC5360018.pdf
"3, 645 –648 http://dx.doi.org/10.1080/21645515.2016.1241358",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"Lancet 1983; 2:355-7; PMID:6135869; http://dx.doi.org/10.1016/S0140-6736(83)90340-9 [2] Rappuoli R. Reverse vaccinology, a genome-based approach to vaccine development.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"Vaccine 2001; 19:2688-91; PMID:11257410; http://dx.doi.org/10.1016/S0264-410X(00)00554-5 [3] Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"Vaccine 2012; 30(Suppl 2):B87-97; PMID:22607904;http://dx.doi.org/10.1016/j.vaccine.2012.01.033 [4] Sejvar JJ, Johnson D, Popovic T, Miller JM, Downes F, Somsel P, Weyant R, Stephens DS, Perkins BA, Rosenstein NE.",OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"J Clin Microbiol2005; 43:4811-4; PMID:16145146; http://dx.doi.org/10.1128/JCM.43.9.4811-4814.2005 [5] Boutet R, Stuart JM, Kaczmarski EB, Gray SJ, Jones DM, Andrews N. Risk of laboratory-acquired meningococcal disease.",OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"J Hosp Infect2001; 49:282-4; PMID:11740877; http://dx.doi.org/10.1053/ jhin.2001.1084 [6] Borrow R, Findlow J, Gray S, Taylor S, Kaczmarski E. Safe laboratory handling of Neisseria meningitidis.",OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"J Infect 2014; 68:305-12;PMID:24440738; http://dx.doi.org/10.1016/j.jinf.2014.01.003 [7] Toneatto D, Ismaili S, Ypma E, Vienken K, Oster P, Dull P. The ﬁrst use of an investigational multicomponent meningo- coccal serogroup B vaccine (4CMenB) in humans.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"Hum Vaccin2011; 7:646-53; PMID:21904120; http://dx.doi.org/10.4161/ hv.7.6.15482 [8] Kimura A, Toneatto D, Kleinschmidt A, Wang H, Dull P. Immuno- genicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are atincreased risk for occupational exposure to meningococcal isolates.Clin Vaccine Immunol 2011; 18:483-6; PMID:21177912; http://dx.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"Vaccine 2015; 33:3322-30; PMID:26025807; http://dx.doi.org/10.1016/j.vaccine.2015.05.027 [10] McQuaid F, Snape MD, John TM, Kelly S, Robinson H, Houlden J, Voysey M, Toneatto D, Kitte C, Dull PM, et al.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"PediatrInfect Dis J 2014; 33:760-6; PMID:24722351; http://dx.doi.org/ 10.1097/INF.0000000000000327 [11] Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Cau- gant DA, Kriz P, Abad R, Bambini S, et al.",OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
Lancet Infect Dis 2013; 13:416- 25; PMID:23414709; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"Vaccine 2016; 34:2579-84; PMID:27083425;http://dx.doi.org/10.1016/j.vaccine.2016.04.009 [14] Frosi G, Biolchi A, Lo Sapio M, Rigat F, Gilchrist S, Lucidarme J, Fin- dlow J, Borrow R, Pizza M, Giuliani MM, et al.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
Vaccine 2013; 31:4968-74; PMID:23954380; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
Vaccine 2005; 23:2222-7; PMID:15755600; http://dx.doi.org/10.1016/j.vaccine.2005.01.051648 E. HONG ET AL.,OADS,/arxiv_data1/oa_pdf/0d/dd/khvi-13-03-1241358.PMC5360120.pdf
"3, 613 –620 http://dx.doi.org/10.1080/21645515.2016.1238535",Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
BMC Evol Biol 2010; 10:193;PMID:20569424; http://dx.doi.org/10.1186/1471-2148-10-193 [3] Geisbert TW.,Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
Geneva (Switzerland): World Health Organization; 2015 Oct 21. http://apps.who.int/ebola/current-s ituation/ebola-situation-report- 21-october-2015#main-content [5] Sridhar S. Clinical development of Ebola vaccines.,Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"Ther Adv Vaccines 2015; 3(5 –6): 125-38; PMID:26668751; http://dx.doi.org/ 10.1177/2051013615611017 [6] Stanley DA, Honko AN, Asiedu C, Trefry JC, Lau-Kilby AW, Johnson JC, Hensley L, Ammendola V, Abbate A, Grazioli F, et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"Geneva,Switzerland; 2014. http://www.who.int/immunization/research/ meetings_workshops/ebola_primeboost_21nov14/en/ [8] Lupton HW, Lambert RD, Bumgardner DL, Moe JB, Eddy GA. Inac- tivated vaccine for Ebola virus ef ﬁcacious in guineapig model.",Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"Lancet 1980; 2(8207):1294-5; PMID:6108462; http://dx.doi.org/10.1016/ S0140-6736(80)92352-1 [9] Zhu FC, Hou LH, Li JX, Wu SP, Liu P, Zhang GR, Hu YM, Meng FY, Xu JJ, Tang R, et al.",OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"Lancet 2015; 385(9984):2272-9;PMID:25817373; http://dx.doi.org/10.1016/S0140-6736(15)60553-0 [10] Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S,et al.",OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"Lancet 2015; 386(9996):857-66; PMID:26248676; http://dx.doi.org/10.1016/S0140-6736(15)61117-5 [11] Huttner A, Dayer JA, Yerly S, Combescure C, Auderset F, Desmeules J, Eickmann M, Finckh A, Goncalves AR, Hooper JW, et al.",OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"Lancet Infect Dis 2015; 15(10):1156-66; PMID:26248510; http://dx.doi.org/10.1016/S1473-3099(15)00154-1 [12] Tapia MD, Sow SO, Lyke KE, Haidara FC, Diallo F, Doumbia M, Traore A, Coulibaly F, Kodio M, Onwuchekwa U, et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"Lancet Infect Dis 2016; 16(1):31-42; PMID:26546548; http://dx.doi.org/10.1016/S1473-3099(15)00362-X [13] De Santis O, Audran R, Pothin E, Warpelin-Decrausaz L, Vallotton L, Wuerzner G, Cochet C, Estoppey D, Steiner-Monard V,Lonchampt S, et al.",OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
Lancet Infect Dis 2016; 16(3):311-20; PMID:26725450; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"N Engl J Med 2014; PMID:25426834; http://dx.doi.org/10.1056/NEJMoa1410863 [15] Ledgerwood JE, Sullivan NJ, Graham BS.",OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
N Engl J Med 2015; PMID:25830322; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"N Engl J Med 2016; 374(17):1647-60; PMID:25830326; http://dx.doi.org/10.1056/ NEJMoa1502924 [18] Bengtsson KL, Song H, Stertman L, Liu Y, Flyer DC, Massare MJ, Xu RH, Zhou B, Lu H, Kwilas SA, Hahn TJ, Kpamegan E, Hooper J, Carrion R Jr, Glenn G, Smith G. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zair e Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mi ce.",Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"Vaccine 2016 Apr 7; 34(16):1927-35; http://dx.doi.org/10.1016/j.vaccine.2016.02.033 [19] Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
Vaccine 2010; 29(2):304-13; PMID:21034824; http://dx.doi.org/10.1016/j.vaccine.2010.10.037 [20] Good Safety Information Practices.,Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"Atlanta (GA): Centers for Disease Control and Prevention; 20 Jul 2016. http://www.cdc.gov/vaccines/vac-gen/side-effects.htm [22] Quah BJ, Warren HS, Parish CR.",Non-OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"Nat Protoc 2007; 2 (9):2049-56; PMID:17853860; http://dx.doi.org/10.1038/nprot.2007.296 [23] Tukhvatulin AI, Dzharullaeva AS, Tukhvatulina NM, Shcheblyakov DV, Shmarov MM, Dolzhikova IV, Stanhope-Baker P, Naroditsky BS, Gudkov AV, Logunov DY, et al.",OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
PLoS One 2016 11(5):e0155650; PMID:27187797; http://dx.doi.org/10.1371/journal.pone.0155650620 I. V. DOLZHIKOVA ET AL.,OADS,/arxiv_data1/oa_pdf/e1/94/khvi-13-03-1238535.PMC5360131.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"3, 507 –513 http://dx.doi.org/10.1080/21645515.2016.1244592",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"ORCID Jefferson Russo Victor http://orcid.org/0000-0001-6092-8394 References [1] Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Placental transport of immunoglobulin G. Vaccine 2003; 21(24):3365-9; PMID:12850341; http://dx.doi.org/10.1016/ S0264-410X(03)00334-7 [4] Malek A, Sager R, Schneider H. Maternal-fetal transport of immuno- globulin G and its subclasses during the third trimester of human pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Am J Reprod Immunol 1994; 32(1):8-14; PMID:7945815; http://dx.doi.org/10.1111/j.1600-0897.1994.tb00873.x [5] Junghans RP, Anderson CL.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Clin Exp Allergy 2000; 30(1):34-40; PMID:10606928;http://dx.doi.org/10.1046/j.1365-2222.2000.00771.x [7] Vance GH, Grimshaw KE, Briggs R, Lewis SA, Mullee MA, Thornton CA, Warner JO.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Clin Exp Allergy 2004; 34(12):1855-61; PMID:15663559; http://dx.doi.org/10.1111/j.1365-2222.2004.02111.x [8] Fusaro A, Maciel M, Victor J, Oliveira C, Duarte A, Sato M. In ﬂuence of maternal murine immunization with Dermatophagoides pteronyssinus extract on the type I hypersensitivity response in off-spring.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Int Arch Allergy Immunol 2002; 127(3):208-16;PMID:11979046; http://dx.doi.org/10.1159/000053865 [9] Fusaro AE, Brito CA, Victor JR, Rigato PO, Goldoni AL, Duarte AJS, Sato MN.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Immunology 2007; 122(1):107- 15; PMID:17608811; http://dx.doi.org/10.1111/j.1365-2567.2007.02618.x [10] Fusaro AE, de Brito CA, Taniguchi EF, Muniz BP, Victor JR, Orii NM, da Silva Duarte AJ, Sato MN.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Balance between early life tolerance and sensitization in allergy: dependence on the timing andintensity of prenatal and postnatal allergen exposure of the mother.Immunology 2009; 128(1):e541-50; PMID:19740315; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"BMC Immunol 2010; 11:11; PMID:20222978; http://dx.doi.org/10.1186/1471-2172-11-11 [12] Lira AADL, Oliveira MGD, Oliveira LMD, Duarte AJDS, Sato MN, Victor JR.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Immunobiology 2014; 219(5):377-84; PMID:24582301; http://dx.doi.org/10.1016/j.imbio.2014.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"J Allergy Clin Immunol 2003; 111(2):269-77; PMID:12589344; http://dx.doi.org/10.1067/mai.2003.39 [15] Jarrett EE, Hall E. IgE suppression by maternal IgG.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Vaccine 2001; 19 (25–26):3331-46; PMID:11348697; http://dx.doi.org/10.1016/S0264- 410X(01)00028-7 [17] Kwon YM, Hwang HS, Lee JS, Ko EJ, Yoo SE, Kim MC, Lee YN, Kim KH, Song JM, Lee S, et al.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Antiviral Res2014; 104:1-6; PMID:24462695; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Vaccine 1998; 16(14 –15):1473-8; PMID:9711791; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Int Arch Allergy Immunol 2004; 133(3):285-94; PMID:14976398; http://dx.doi.org/ 10.1159/000076836 [20] Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"J Immunol2008; 180(2):793-9; PMID:18178817; http://dx.doi.org/10.4049/jimmunol.180.2.793 [22] Heyman B, Dahlstr €om J, Diaz De Sta /C14hl T, Getahun A, Wernersson S, Karlsson MC.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Scand J Immunol 2001; 53(4):331-4; discussion 339 –345; PMID:11285111; http://dx.doi.org/10.1046/j.1365-3083.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Eur J Immunol 1998; 28(7):2124-30; PMID:9692881;http://dx.doi.org/10.1002/(SICI)1521-4141(199807)28:07%3c2124::AID-IMMU2124%3e3.0.CO;2-A [26] Jerne NK.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Immu- nol Rev 1984; 79:5-24; PMID:6378763; http://dx.doi.org/10.1111/j.1600-065X.1984.tb00484.x [27] Borghesi C, Nicoletti C. Autologous anti-idiotypic antibody response is regulated by the level of circulating complementary idiotype.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Immunology 1996; 89(2):172-7; PMID:8943710; http://dx.doi.org/10.1046/j.1365-2567.1996.d01-724.x[28] Vakil M, Sauter H, Paige C, Kearney JF.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Eur J Immunol 1986; 16(9):1159-65; PMID:2428628;http://dx.doi.org/10.1002/eji.1830160921 [29] Bogen B, Dembic Z, Weiss S. Clonal deletion of speci ﬁc thymocytes by an immunoglobulin idiotype.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Eur J Immunol 2008; 38(1):90-101; PMID:18081043;http://dx.doi.org/10.1002/eji.200737872 [32] Polte T, Hennig C, Hansen G. Allergy prevention starts before conception: maternofetal transfer of tolerance protects against thedevelopment of asthma.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"J Allergy Clin Immunol 2008; 122(5):1022-30.e1025; http://dx.doi.org/10.1016/j.jaci.2008.09.014 [33] Lemieux R, Bazin R, N /C19eron S. Therapeutic intravenous immunoglo- bulins.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Mol Immunol 2005; 42(7):839-48; PMID:15829272; http://dx.doi.org/10.1016/j.molimm.2004.07.046 [34] Seite JF, Shoenfeld Y, Youinou P, Hillion S. What is the contents of the magic draft IVIg?",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Autoimmun Rev 2008; 7(6):435-9;PMID:18558358; http://dx.doi.org/10.1016/j.autrev.2008.04.012 [35] Sticherling M, Trawinski H. Effects of intravenous immunoglobulins on peripheral blood mononuclear cell activation in vitro.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Ann N Y Acad Sci 2007; 1110:694-708; PMID:17911484; http://dx.doi.org/10.1196/annals.1423.072 [36] Taw ﬁk DS, Cowan KR, Walsh AM, Hamilton WS, Goldman FD.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Pediatr Allergy Immunol 2012; 23(1):88-95; PMID:21265884; http://dx.doi.org/10.1111/j.1399-3038.2010.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Clin Exp Immunol 1998; 114(2):311-9; PMID:9822292; http://dx.doi.org/10.1046/j.1365-2249.1998.00712.x [38] Wu KH, Wu WM, Lu MY, Chiang BL.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Pediatr Allergy Immunol 2006; 17(1):60-8; PMID:16426257; http://dx.doi.org/10.1111/j.1399-3038.2005.00344.x [39] Siedlar M, Strach M, Bukowska-Strakova K, Lenart M, Sza ﬂarska A, W˛eglarczyk K, Rutkowska M, Baj-Krzyworzeka M, Pituch-Noworol- ska A, Kowalczyk D, et al.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Clin Immunol 2011; 139(2):122-32;PMID:21300572; http://dx.doi.org/10.1016/j.clim.2011.01.002 [40] Gille C, Dreschers S, Spring B, T /C19arnok A, Bocsi J, Poets CF, Orlikowsky TW.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Transplantation 2010; 89(12):1446-55; PMID:20463648; http://dx.doi.org/10.1097/TP.0b013e3181dd6bf1 [42] Stricker RB, Winger EE.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Am J Reprod Immunol 2005; 54(6):390-6; PMID:16305665; http://dx.doi.org/10.1111/j.1600-0897.2005.00335.x [43] Xu L, Chang V, Murphy A, Rock JA, Damewood M, Schlaff W, Zacur HA.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Am J Obstet Gynecol 1990; 163(5 Pt 1):1493-7;PMID:2240094; http://dx.doi.org/10.1016/0002-9378(90)90612-B512 J. R. VICTOR,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"JAMA1990; 264(11):1422-5; PMID:2118190; http://dx.doi.org/10.1001/ jama.1990.03450110068029 [45] Hill JA, Polgar K, Anderson DJ.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"JAMA 1995; 273(24):1933-6; PMID:7783303; http://dx.doi.org/10.1001/ jama.1995.03520480053039 [46] Mazer BD, Gelfand EW.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"J Allergy Clin Immunol 1991; 87(5):976-83; PMID:2026848; http://dx.doi.org/ 10.1016/0091-6749(91)90420-S [47] Jakobsson T, Croner S, Kjellman NI, Pettersson A, Vassella C, Bj€orkst /C19en B.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Allergy 1994; 49(6):413-20; PMID:8074263;http://dx.doi.org/10.1111/j.1398-9995.1994.tb00833.x [48] Jolles S, Hughes J, Rustin M. The treatment of atopic dermatitis with adjunctive high-dose i ntravenous immunoglobulin: a report of three patients and review of the literatu re.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Br J Dermatol 2000; 142(3):551-4; PMID:10735971; http://dx.doi.org/10.1046/j.1365-2133.2000.03377.x [49] Bemanian MH, Movahedi M, Farhoudi A, Gharagozlou M, Seraj MH, Pourpak Z, Nabavi M, Aghamohammadi A, Shirkhoda Z. Highdoses intravenous immunoglobulin versus oral cyclosporine in thetreatment of severe atopic dermatitis.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Allergy Asthma Immunol Res 2011; 3 (2):89-95; PMID:21461247; http://dx.doi.org/10.4168/aair.2011.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"J Allergy Clin Immu- nol 2001; 108(2):229-34; PMID:11496239; http://dx.doi.org/10.1067/mai.2001.116291 [52] Kabuto M, Fujimoto N, Tanaka T. Increase of interleukin-10-pro- ducing B cells associated with long-term remission after i.v.immunoglobulin treatment for pemphigus.",OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"J Dermatol 2016; 43 (7):815-8; PMID:26871259; http://dx.doi.org/10.1111/1346-8138.13295 [53] Sali AD, Karakasiliotis I, Evangelidou M, Avrameas S, Lymberi P. Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Clin Transl Immunology2015; 4(10):e42; PMID:26682050; http://dx.doi.org/10.1038/cti.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"Arthritis Rheumatol 2014; 66(7):1768-78; PMID:24644005; http://dx.doi.org/10.1002/art.38627 [55] Lin CH, Cheng SL.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Drug Des Devel Ther 2016; 10:2369-78; PMID:27528798; http://dx.doi.org/10.2147/DDDT.S112208 [56] Victor JR.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
J Immunol Res 2014; 2014:780386; PMID:25009823; http://dx.doi.org/10.1155/2014/780386 [57] Chen ST. Cellular sites of immunoglobulins.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
Arch Pediatr Adolesc Med 2011; 165(5):473-5; PMID:21536964; http://dx.doi.org/10.1001/archpediatrics.2011.46HUMAN VACCINES & IMMUNOTHERAPEUTICS 513,Non-OADS,/arxiv_data1/oa_pdf/95/e2/khvi-13-03-1244592.PMC5360138.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"3, 528 –532 http://dx.doi.org/10.1080/21645515.2016.1244149",Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
N Engl J Med 2008; 359:821-32; PMID:18716299; http://dx.doi.org/10.1056/NEJMsa0707052530 R. O. DILLMAN,Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"World JGastroenterol 2013; 19(47):8887-94; PMID:24379612; http://dx.doi.org/10.3748/wjg.v19.i47.8887 [3] Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"N Engl J Med 2010; 363(5):411-22; PMID:20818862; http://dx.doi.org/ 10.1056/NEJMoa1001294 [4] Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
J Clin Oncol 2015; 33(25)2780-8;PMID:26014293; http://dx.doi.org/10.1200/JCO.2014.58.3377 [5] Dillman RO.,OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"Vaccine Dev Ther 2013; 3:57-78; http://dx.doi.org/10.2147/VDT.S32396 [6] Levy R, Ganjoo KN, Leonard JP, Vose JM, Flinn IW, Ambinder RF, Connors JM, Berinstein NL, Belch AR, Bartlett NL, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"J Clin Oncol 2015; 33(34)4066-76; PMID:26351350; http://dx.doi.org/10.1200/JCO.2015.62.0500 [8] Vansteenkiste JF, Cho BC, Vanakesa T, De Pas T, Zielinski M, Kim MS, Jassem J, Yoshimura M, Dahabreh J, Nakayama H, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"J ClinOncol 2007; 25:474s; http://dx.doi.org/10.1016/j.clon.2013.04.009 [10] Giaccone G, Bazhenova LA, Nemunaitis J, Tan M, Juh /C19asz E, Ramlau R, van den Heuvel MM, Lal R, Kloecker GH, Eaton KD, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"Eur J Cancer 2015; 51(16):2321-9; PMID:26283035; http://dx.doi.org/ 10.1016/j.ejca.2015.07.035 [11] Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, et al.",Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"Lancet 1999; 353(9150):345-50;PMID:9950438; http://dx.doi.org/10.1016/S0140-6736(98)07186-4 [12] Testori A, Richards J, Whitman E, Mann GB, Lutzky J, Camacho L, Parmiani G, Tosti G, Kirkwood JM, Hoos A, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"J Clin Oncol 2008; 26(6):955-62; PMID:18281670; http://dx.doi.org/10.1200/JCO.2007.11.9941 [13] Dillman RO, DeLeon C, Beutel LD, Barth NM, Schwartzberg LS, Spi- tler LE, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"Cancer Biother Radiopharm 2002; 17(1):51-66; PMID:11915174; http://dx.doi.org/10.1089/ 10849780252824073[14] Schumacher TN, Schreiber RD.",Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"Science 2015; 348(6230):69-74; PMID:25838375; http://dx.doi.org/10.1126/science.aaa4971 [15] Hodi FS, O ’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"NEngl J Med 2010; 363(8):711-23; PMID:20525992; http://dx.doi.org/ 10.1056/NEJMoa1003466 [16] Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"N Engl J Med 2015; 372(26):2521- 32; PMID:25891173; http://dx.doi.org/10.1056/NEJMoa1503093 [17] Topalian SL, Sznol M, McDermott DF, Kluger HM, Carvajal RD, Sharfman WH, Brahmer JR, Lawrence DP, Atkins MB, Powderly JD,et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"J Clin Oncol 2014; 32(10):1020-30; PMID:24590637; http://dx.doi.org/10.1200/JCO.2013.53.0105 [18] Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Sri- nivas S, Tykodi SS, Sosman JA, Procopio G, Plimack ER, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"N Engl JMed 2015; 373(19):1803-13; PMID:26406148; http://dx.doi.org/ 10.1056/NEJMoa1510665 [19] Brahmer J, Reckamp KL, Baas P, CrinR L, Eberhardt WE, Poddub- skaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"N Engl J Med 2015; 373(17):1627-39; PMID:26412456; http://dx.doi.org/10.1056/NEJMoa1507643 [21] Herbst RS, Baas P, Kim DW, Felip E, P /C19erez-Gracia JL, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"N Engl J Med 2015; 372(4):311-9; PMID:25482239; http://dx.doi.org/10.1056/NEJMoa1411087 [24] Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Mur- ayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"J Clin Oncol 2015; 33(34):4015-22; PMID:26351349; http://dx.doi.org/10.1200/ JCO.2015.62.3397 [25] Seiwert TY, Burtness B, Mehra R, Weiss J, Berger R, Eder JP, Heath K, McClanahan T, Lunceford J, Gause C, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"Lancet Oncol 2016; 17(7):956-65; PMID:27247226;http://dx.doi.org/10.1016/S1470-2045(16)30066-3 [26] Nghiem PT, Bhatia S, Lipson EJ, Kudchadkar RR, Miller NJ, Anna- malai L, Berry S, Chartash EK, Daud A, Fling SP, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"NEngl J Med 2016; 374(26):2542; PMID:27093365; http://dx.doi.org/ 10.1056/NEJMoa1603702 [27] Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, Schadendorf D, Dummer R, Smylie M, Rutkowski P, et al.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
N Engl J Med 2015; 373(1):23034; http://dx.doi.org/10.1056/ NEJMoa1504030HUMAN VACCINES & IMMUNOTHERAPEUTICS 531,Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"Cancer Res 2012; 72(13)3125-30;PMID:22721837; http://dx.doi.org/10.1158/0008-5472.CAN-11-4094 [29] Carreno BM, Magrini V, Becker-Hapak M, Kaabinejadian S, Jundal J, Petti AA, Ly A, Lie WR, Hildebrand WH, Mardis ER, et al.",Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
Science 2015; 348 (6236):803-8; PMID:25837513; http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"J Immunother 2012; 3(8):641-9; http://dx.doi.org/10.1097/CJI.0b013e31826f79c8[33] Dillman RO, McClay EF, Amatruda TT, Depriest C, Carbonell DJ, Cornforth AN.",OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
Cancer Biot her Radiopharm 2015; 30(5):187-94; PMID:26083950; http://dx.doi.org/10.1089/cbr.2015.1843 [35] Oldham RK.,Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
J Cell Physiol Suppl 1986; 4:91-9; PMID:2427531; http://dx.doi.org/10.1002/jcp.1041290416 [36] Dillman RO.,OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"Cancer Biother Radiopharm 2011; 26(1):1-64; PMID:21355777; http://dx.doi.org/10.1089/cbr.2010.0902 [37] Dillman RO, Cornforth AN, Nistor GI.",Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
Expert Opin Biol Ther 2013; 13(5):643-56; PMID:23451922; http://dx.doi.org/10.1517/14712598.2013.759556532 R. O. DILLMAN,Non-OADS,/arxiv_data1/oa_pdf/c5/8a/khvi-13-03-1244149.PMC5360141.pdf
"3, 703 –710 http://dx.doi.org/10.1080/21645515.2016.1240846",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Jurisdiction ProgramStart DateRV jurisdictionTotal IS Cases 2003 –2013Total Infants <1 2013Total person-years for infants<1 2003-2013 British Columbia (BC) Yes Jan. 1, 2012 Yes 118 43,565 453,030 Alberta (AB) Yes June 1 2015 No 122 52,018 494,828Saskatchewan (SK) Yes Nov 1 2012 Yes 30 14,832 141,106Manitoba (MB) Yes Apr 1, 2014 No 39 15,748 158,158 Ontario (ON) Yes Aug 11, 2011 Yes 405 136,400 1,468,427 New Brunswick (NB) No — No 15 7,321 76,609 Nova Scotia (NS) No /C3— No 31 8,689 93,099 Newfoundland and Labrador (NL) Yes Sept 1, 2015 No 38 4,819 50,187Prince Edward Island (PEI) Yes Dec 1, 2010 Yes 3 1,405 14,404Yukon Territory (YT) Yes Oct 1 2012 Yes 1 416 3,921Northwest Territories (NT) Yes Fall 2013 No 2 636 7,231 Nunavut (NU) No — No 6 747 7,594 /C3Although NS does not have a publicly funded RV program, the Halifax metro area (which accounts for half the population of NS) did have a universal rotavi rus program for approximately 2 y during the study period, although the vaccine coverage achieved was low, never exceeding 40% (32) As per: http://www.phac-aspc.gc.ca/im/ptimprog-progimpt/table-1-eng.php (accessed March 16, 2016 and current as of February 3, 2016) Sask: http://www.gov.sk.ca/news?newsId Df4ec0c5b-401d-4d59-be4d-3eee346e5e9c YT:http://archive-ca.com/page/4365002/2014-07-29 /http://www.hss.gov.yk.ca/12-183.php ;http://www.hss.gov.yk.ca/pdf/im_manual_section1.pdfHUMAN VACCINES & IMMUNOTHERAPEUTICS 707",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"ORCID Steven Hawken http://orcid.org/0000-0002-3341-9022 Joanne M. Langley http://orcid.org/0000-0003-3270-7345 References [1] Buettcher M, Baer G, Bonhoeffer J, Schaad UB, Heininger U. Three- year surveillance of intussusception in children in Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
Pedi- atrics 2007; 120(3):473-80; PMID:17766518; http://dx.doi.org/10.1542/peds.2007-0035 [2] Cera S. Intestinal Intussusception.,Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Clin Colon Rectal Surg 2008; 21 (2):106-13; PMID:20011406; http://dx.doi.org/10.1055/s-2008- 1075859 [3] Jiang J, Jiang B, Parashar U, Nguyen T, Bines J, Patel MM.",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"N Engl J Med 2001; 344(8):564-72; PMID:11207352; http://dx.doi.org/10.1056/ NEJM200102223440804 [5] Patel MM, L /C19opez-Collada VR, Bulh ~oes MM, De Oliveira LH, M/C19arquez AB, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, et al.",OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"N Engl J Med 2011; 364(24):2283-92; PMID:21675888; http://dx.doi.org/10.1056/ NEJMoa1012952 [6] Vel /C19azquez FR, Colindres RE, Grajales C, Hern /C19andez MT, Mercadillo MG, Torres FJ, Cervantes-Apolinar M, DeAntonio-Suarez R,Ortega-Barria E, Blum M, et al.",OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Pediatr Infect Dis J 2012; 31(7):736-44;http://dx.doi.org/10.1097/INF.0b013e318253add3 [7] Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott E J ,B o o yR ,B i n e sJ E .I n t u s s u s c e p tion following ro tavirus vaccine administration: post-marketin g surveillance in the National Immunization Program in Australia.",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Vaccine 2011; 29(16):3061-6;PMID:21316503; http://dx.doi.org/10.1016/j.vaccine.2011.01.088 [8] Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, Bines J, McIntyre PB.",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
Clin Infect Dis 2013; 57(10):1427-34; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"N Engl J Med 2014; 370(6):513-9; PMID:24422678; http://dx.doi.org/10.1056/NEJMoa1311738 [10] Yen C, Tate JE, Steiner CA, Cortese MM, Patel MM, Parashar UD.",OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
N Engl J Med 2014; 370(6):503-12; PMID:24422676; http://dx.doi.org/10.1056/ NEJMoa1303164 [12] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
Rotavirus vaccine and intussusception 2010 [Available from: http://www.who.int/vaccinesafety/committee/ topics/rotavirus/rotarixandrotateq/Dec2010/en/[13] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Vaccine Safety Monitoring 2015 [Available from: http://www.phac-aspc.gc.ca/im/vs-sv/mon-surv- eng.php [16] Ducharme R, Benchimol EI, Deeks SL, Hawken S, Fergusson D A ,W i l s o nK .V a l i d a t i o no fd i a g n ostic codes for intussuscep- tion and quanti ﬁcation of childhood intussusception incidence in Ontario, Canada: a populatio n-based study.",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
J Pediatr 2013; 163(4):1073-9.e3; PMID:23809052; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Vaccine 2013; 31(38):4098-102; PMID:23871447; http://dx.doi.org/10.1016/j.vaccine.2013.06.084 [18] Justice F, Carlin J, Bines J.",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
J Paediatr Child Health 2005; 41(9-10):475-8; PMID:16150062; http://dx.doi.org/10.1111/j.1440-1754.2005.00686.x [19] Kolsen Fischer T. Intussusception in Early Childhood: a cohort study of 1.7 million children.,Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
Pediatrics 2004; 114(3):782-5; PMID:15342854; http://dx.doi.org/10.1542/peds.2004-0390 [20] Bines J. Intussusception and rotavirus vaccines.,Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Vaccine 2006; 24(18):3772-6; PMID:16099078; http://dx.doi.org/10.1016/j.vaccine.2005.07.031 [21] Tate JE, Simonsen L, Viboud C, Steiner C, Patel MM, Curns AT, Parashar UD.",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Pediatrics 2008; 121(5): e1125-32; PMID:18450856; http://dx.doi.org/10.1542/peds.2007- 1590 [22] Parashar UD, Holman RC, Cummings KC, Staggs NW, Curns AT, Zimmerman CM, Kaufman SF, Lewis JE, Vugia DJ, Powell KE, et al.",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Pediatrics 2000; 106(6):1413-21; PMID:11099597;http://dx.doi.org/10.1542/peds.106.6.1413 [23] Nakagomi T, Takahashi Y, Arisawa K, Nakagomi O.",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Epidemiol Infect 2006; 134(1):57-61; PMID:16409651; http://dx.doi.org/10.1017/ S0950268805004644 [24] Noguchi A, Nakagomi T, Kimura S, Takahashi Y, Matsuno K, Koizumi H, Watanabe A, Noguchi H, Ito T, Ohtsuka M, et al.",OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Japanese J Infect Dis 2012; 65(4):301-5; PMID:22814151;http://dx.doi.org/10.7883/yoken.65.301 [25] Tran LAT, Yoshida LM, Nakagomi T, Gauchan P, Ariyoshi K, Anh DD, Nakagomi O, Thiem VD.",OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Trop Med Health 2013; 41(3):121-7; PMID:24155653; http://dx.doi.org/10.2149/tmh.2013-09 [26] Jo DS, Nyambat B, Kim JS, Jang YT, Ng TL, Bock HL, Kilgore PE.",Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Int J Infect Dis 2009; 13(6): e383-8; PMID:19362503; http://dx.doi.org/10.1016/j.ijid.2009.01.011 [27] Kohl LJ, Streng A, Grote V, Koletzko S, Liese JG.",OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Euro J Pediatr 2010; 169(12):1487-93; PMID:20640443; http://dx.doi.org/10.1007/ s00431-010-1248-x [28] Jenke AC, Klaassen-Mielke R, Zilbauer M, Heininger U, Trampisch H, Wirth S. Intussusception: incidence and treatment-insights from the nationwide German surveillance.",OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
J Pediatr Gastroenterol Nutr 2011; 52(4):446-51; PMID:21415671; http://dx.doi.org/10.1097/MPG.0b013e31820e1becHUMAN VACCINES & IMMUNOTHERAPEUTICS 709,Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
Population-level impact of ontario ’s infant rota- virus immunization program: evidence of direct and indirect effects.PLoS One 2016; 11(5):e0154340; PMID:27168335; http://dx.doi.org/ 10.1371/journal.pone.0154340 [30] Canadian Institute for Health Information.,Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
Available from: https://www.cihi.ca/en/dad_multi-year_en.pdf[31] Statistics Canada.,Non-OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"Available from: http://www.statcan.gc.ca/ tables-tableaux/sum-som/l01/cst01/demo02a-eng.htm [32] Sanford C, Langley JM, Halperin SA, Zelman M, Program MMURV.",OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
Hum Vac-cin Immunother 2015; 11(4):870-4; PMID:25746110; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/52/khvi-13-03-1240846.PMC5360150.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium, provided the original work is prop- erly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
ORCID Kevin C. Gough http://orcid.org/0000- 0001-5211-208862 M. J. O’Connor et al.,Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"Nature 1997; 389(6650):498-501; PMID:9333239; http://dx.doi.org/10.1038/39057 [4] Casalone C, Zanusso G, Acutis P, Ferrari S, Capucci L, Tagliavini F, Monaco S, Caramelli M. Identiﬁca- tion of a second bovine amyloidotic spongiformencephalopathy: Molecular similarities with spo-radic creutzfeldt-jakob disease.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
J Clin Microbiol2007; 45(6):1821-9; PMID:17442800; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
Vet Microbiol 2006; 117(2-4):103-16;PMID:16916588; http://dx.doi.org/10.1016/j.vetmic.,OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"EMBO Rep 2004; 5(1):110-4; PMID:14710195; http://dx.doi.org/10.1038/sj.embor.7400054 [8] Seuberlich T, Heim D, Zurbriggen A. Atypical transmissible spongiform encephalopathies in ruminants: a challenge for disease surveillance and control.",OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"J Vet Diagn Invest 2010; 22(6):823-42; PMID:21088166; http://dx.doi.org/10.1177/ 104063871002200601 [9] Beringue V, Herzog L, Reine F, Le Dur A, Csalone C, Vilotte J-L, Laude H. Transmission of atypical bovine prions to mice transgenic for human prion protein.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"Emerg Infect Dis 2008; 14(12):1898e1901;http://dx.doi.org/10.3201/eid1412.080941 [10] Kong Q, Zheng M, Casalone C, Qing L, Huang S, Chakraborty B, Wang P, Chen F, Cali I, Corona C,et al.",OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
J Virol 2008; 82(7):3697e3701; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"PLoS One 2008; 3(8):e3017; PMID:18714385;http://dx.doi.org/10.1371/journal.pone.0003017 [12] Castilla J, Sa /C19a P, Soto C. Detection of prions in blood.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"Nat Med 2005; 11(9):982-5; PMID: 16127436; http://dx.doi.org/10.1038/nm1286 [13] Sa /C19a P, Castilla J, Soto C. Ultra-efﬁcient replication of infectious prions by automated protein misfolding cyclic ampliﬁcation.",OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"J Biol Chem 2006; 281(46):35245-52; PMID:16982620; http://dx.doi.org/ 10.1074/jbc.M603964200 [14] Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, Onwubiko HA, Priola SA,Caughey B. Simpliﬁed ultra-sensitive prion detection by recombinant PrP conversion with shaking.",OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"Nat Methods 2008; 5(3):211-2; PMID:18309304; http://dx.doi.org/10.1038/nmeth0308-211 [15] Masujin K, Orr /C19u CD, Miyazawa K, Groveman BR, Raymond LD, Hughson AG, Caughey B. Detectionof atypical H-type bovine spongiform encephalopa- thy and discrimination of bovine prion strains by real-time quaking-induced conversion.",OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"J Clin Micro-biol 2015; 54:676-86; http://dx.doi.org/10.1128/ JCM.02731-15 [16] Murayama Y, Ono F, Shimozaki N, Shibata H. L- Arginine ethylester enhances in vitro ampliﬁcation of PrP Scin macaques with atypical L-type bovine spongiform encephalopathy and enables presymp- tomatic detection of PrPScin the bodily ﬂuids.",OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
Biochem Biophys Res Commun 2016; 470:563-8; PMID:26802462; http://dx.doi.org/10.1016/j.bbrc.,OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"Em Inf Dis 2006; 12(12):1816-21; http://dx.doi.org/10.3201/eid1212.060965 [19] Wilesmith JW, Wells GAH, Cranwell MP, Ryan JBM.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"Vet Rec 1988; 123:638-44; PMID:3218047; http://dx.doi.org /10.1136/vr.123.25.638 [20] Arnold M., Wilesmith JW.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
PMID:15579333; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"Bank vole prion protein as an appar- ently universal substrate for RT-QuIC-based detection and discrimination of prion strains.PLoS Pathog 2015; 11(6):e1004983;PMID:26086786; http://dx.doi.org/10.1371/jour- nal.ppat.1004983 [22] Orr /C19u CD, Favole A, Corona C, Mazza M, Manca M, Groveman BR, Hughson AG, Acutis PL, Caramelli M, Zanusso G, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"J Clin Microbiol 2015; 53(4):1115-20; PMID:25609728; http://dx.doi.org/10 .1128/JCM.02906-14 [23] Taema MM, Maddison BC, Thorne L, Bishop K, Owen J, Hunter N, Baker CA, Terry LA, Gough KC.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"Mol Biotechnol 2012; 51(3):233-9; PMID: 21987099; http://dx.doi.org/10.1007/ s12033-011-9460-0 [24] Gough KC, Bishop K, Maddison BC.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"J Clin Micro 2014; 52(11):3863-68; http://dx.doi.org/10.1128/JCM.0169 3-14 [25] Gonzalez-Montalban N, Makarava N, Savtchenko R, Baskakov IV.",OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"Biochem 2011; 50(37):7933-40; http://dx.doi.org/10.1021/bi200950v [26] Masujin K, Okada H, Miyazawa K, Matsuura Y, Imamura M, Iwamaru Y, Mrayama Y, Yokoyama T.Emergence of a novel bovine spongiform encepha-lopathy (BSE) prion from an atypical H-type BSE.",OADS,/arxiv_data1/oa_pdf/d6/51/kprn-11-01-1259051.PMC5360153.pdf
"3, 236 –242 http://dx.doi.org/10.1080/16066359.2016.1247812",Non-OADS,/arxiv_data1/oa_pdf/98/ef/iart-25-236.PMC5360166.pdf
"Boca Raton: Chapman & Hall/CRC, Available from: https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/ .",Non-OADS,/arxiv_data1/oa_pdf/98/ef/iart-25-236.PMC5360166.pdf
"3, 711 –716 http://dx.doi.org/10.1080/21645515.2016.1238994",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"Emerg Infect Dis 2006; 12:304-6;PMID:16494759; http://dx.doi.org/10.3201/eid1202.050006 [2] Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD.",OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
Lancet Infect Dis 2012; 12:136-41; PMID:22030330; http://dx.doi.org/10.1016/S1473-3099(11)70253-5 [3] O ’Ryan M. The ever-changing landscape of rotavirus serotypes.,Non-OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
Pediatr Infect Dis J 2009; 28:S60-2; PMID:19252426; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"Pediatr Inf ect Dis J 2006; 25:S30-41; PMID:16397427; http://dx.doi.org/10.1097/01.inf.0000197707.70835.f3 [6] Maes P, Matthijnssens J, Rahman M, Van Ranst M. RotaC: a web- based tool for the complete genome classi ﬁcation of group A rotavi- ruses.",OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
BMC Microbiol 2009; 9:238; PMID:19930627; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"Real- world impact of rotavirus vaccinatio n. Pediatr Infect Dis J 2011; 30:S1-5; PMID:21183833; http://dx.doi.org/ 10.1097/INF.0b013e3181fefa1f [8] Clark HF, Hoshino Y, Bell LM, Groff J, Hess G, Bachman P, Of ﬁt PA. Rotavirus isolate WI61 representing a presumptive new humanserotype.",OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"Microbiol Immunol 1990; 34:77-82; PMID:1691433;http://dx.doi.org/10.1111/j.1348-0421.1990.tb00994.x [10] Gentsch JR, Laird AR, Bielfelt B, Grif ﬁn DD, Banyai K, Ramachan- dran M, Jain V, Cunliffe NA, Nakagomi O, Kirkwood CD, et al.HUMAN VACCINES & IMMUNOTHERAPEUTICS 715",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"JInfect Dis 2005; 192(Suppl 1):S146-59; PMID:16088798; http://dx.doi.org/10.1086/431499 [11] Santos N, Hoshino Y.",OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"Rev Med Virol 2005; 15:29-56; PMID:15484186; http://dx.doi.org/10.1002/rmv.448 [12] Kang G, Arora R, Chitambar SD, Deshpande J, Gupte MD, Kul- karni M, Naik TN, Mukherji D, Venkatasubramaniam S, GentschJR, et al.",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"J Infect Dis 2009; 200(Suppl 1):S147-53; PMID:19817593; http://dx.doi.org/10.1086/605031 [13] Saluja T, Sharma SD, Gupta M, Kundu R, Kar S, Dutta A, Silveira M, Singh JV, Kamath VG, Chaudhary A, et al.",OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"Vaccine 2014; 32(Suppl 1):A13-9; PMID:25091667; http://dx.doi.org/ 10.1016/j.vaccine.2014.03.030 [14] Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al.",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"Safety and ef ﬁcacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.N Engl J Med 2006; 354(1):23-33; PMID:16394299; http://dx.doi.org/10.1056/NEJMoa052664 [15] Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al.",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
N Engl J Med 2006; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434 [16] WHO.,OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"Clin Infect Dis 2006; 43:312-4; PMID:16804845; http://dx.doi.org/10.1086/505493 [18] Iturriza-Gomara M, Green J, Brown DW, Ramsay M, Desselberger U, Gray JJ.",OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"J Med Virol2000; 61:150-4; PMID:10745248; http://dx.doi.org/10.1002/(SICI)1096-9071(200005)61:1%3c150::AID-JMV24%3e3.0.CO;2-W [20] Wardana OP, Athiyyah AF, Budiono, Soedirham O, Soegijanto S. The role of rotavirus genotype in the severity of acute diarrhea inchildren under 5 years old at Surabaya, Indonesia.",OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"Arch Virol 1997; 142:2065-71;PMID:9413515; http://dx.doi.org/10.1007/s007050050224 [22] Clark HF, Lawley DA, Schaffer A, Patacsil JM, Marcello AE, Glass RI, Jain V, Gentsch J.",OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"J Clin Microbiol 2004; 42:1434-8; PMID:15070985; http://dx.doi.org/10.1128/JCM.42.4.1434-1438.2004 [23] Ruuska T, Vesikari T. A prospective study of acute diarrhoea in Finnish children from birth to 2 1/2 years of age.",OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
"Acta Paediatr Scand1991; 80:500-7; PMID:1872172; http://dx.doi.org/10.1111/j.1651-2227.1991.tb11893.x [24] Iturriza-Gomara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses.",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
J Clin Virol2004; 31:259-65; PMID:15494266; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6e/0b/khvi-13-03-1238994.PMC5360167.pdf
", 2001, 22, 931; ( b) ADF2013, SCM, Theoretical Chemistry , Vrije Universiteit, Amsterdam, The Netherlands, http://www.scm.com.",Non-OADS,/arxiv_data1/oa_pdf/cc/96/SC-008-C6SC03482A.PMC5360170.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.017 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
34 (1):23 –29.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
80 (1):45 –58.http://dx.doi.org/10.1111/j.1467-8624.2008.01245.x .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.1249/mss.0b013e31823b1dc7 .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.1088/0967-3334/ 33/11/1887 .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.1542/peds.2008-2498 .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://www.ericdigests.org/2001-3/children.htm .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.3390/ijerph9041326 .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.1037/ a0027899 .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
30 (1):84 –90.http://dx.doi.org/10.1037/ a0021586 .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
:161 –166http://dx.doi.org/10.1097/00003677 –200410000-00007 .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
Prev Med Rep. 3:53 –57.http://dx.doi.org/ 10.1016/j.pmedr.2015.12.004 .,OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.1249/mss.0b013e318233763b .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.1111/j.1467-789x.2011.00973.x .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
10. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
Prev Med Rep. 3:14 –20.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.1016/s0140-6736(03)15331-7 .,OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
"http://dx.doi.org/ 10.1186/s12889-015-2335-13 .Vanderloo, L., Tucker, P., Johnson, A., van Zandvoort, M., Burke, S., Irwin, J., 2014.",Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.1080/02701367.2015.1053105 .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
http://dx.doi.org/10.5993/ajhb.32.4.5 .,Non-OADS,/arxiv_data1/oa_pdf/be/04/main.PMC5360221.pdf
PPI  data were downloaded from the Biological General Repository  for Interaction Datasets (BioGRID; http://www.thebiogrid.,OADS,/arxiv_data1/oa_pdf/46/be/ijmm-39-03-0579.PMC5360351.pdf
"org) interaction database (17) and Human Protein Reference  Database (HPRD; http://www.hprd.org) (18), and merged  into the background PPI network.",OADS,/arxiv_data1/oa_pdf/46/be/ijmm-39-03-0579.PMC5360351.pdf
The PPI network was visualized  using Cytoscape  (http://cytoscape.org)  (19).,OADS,/arxiv_data1/oa_pdf/46/be/ijmm-39-03-0579.PMC5360351.pdf
"To further investigate the  functional pathways regulated by these important genes, the  Kyoto Encyclopedia of Genes and Genomes (KEGG, http:// www.genome.jp/kegg) pathway (21) enrichment analysis was  performed with the important upregulated and downregulated  genes, respectively, using online tools from the Database for  Annotation, Visualization and Integrated Discovery  (DAVID;  http://david.abcc.ncifcrf.gov) (22).",OADS,/arxiv_data1/oa_pdf/46/be/ijmm-39-03-0579.PMC5360351.pdf
"Finally, hierarchical clustering was performed on both samples  and pathways using the software Cluster 3.0 (http://bonsai.ims.u- tokyo.ac.jp/~mdehoon/software/cluster/)  (23).",OADS,/arxiv_data1/oa_pdf/46/be/ijmm-39-03-0579.PMC5360351.pdf
The clustering results were visualized via the  Java plugin TreeView (http://jtreeviewsourceforge.net/) (24).,OADS,/arxiv_data1/oa_pdf/46/be/ijmm-39-03-0579.PMC5360351.pdf
Available  from: http://globocan.iarc.fr.2014.,Non-OADS,/arxiv_data1/oa_pdf/46/be/ijmm-39-03-0579.PMC5360351.pdf
J Neuroendocrinol 28:  2016. http://dx.doi.org/10.1111/jne.12379.,OADS,/arxiv_data1/oa_pdf/1a/29/ijmm-39-03-0487.PMC5360360.pdf
"Cambridge University Press, Cambridge,  2006. http://dx.doi.org/10.1017/CBO9780511817540.",Non-OADS,/arxiv_data1/oa_pdf/1a/29/ijmm-39-03-0487.PMC5360360.pdf
The RNA-seq data set of AML was downloaded  from TCGA  (https://tcga-data.nci.nih.gov/).,OADS,/arxiv_data1/oa_pdf/e9/d1/ijmm-39-03-0663.PMC5360362.pdf
http://www.sigmaaldrich.com/life-science/cell- culture/learning-center/media-expert/calcium.html.,Non-OADS,/arxiv_data1/oa_pdf/b5/c8/ijmm-39-03-0587.PMC5360363.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/05/79/prbm-10-079.PMC5360394.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/05/79/prbm-10-079.PMC5360394.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2017:10 79–84Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 79 ORiginal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S101727 improving urban environment through public  commitment toward the implementation of   clean and healthy living behaviors nurul hartini atika Dian ariana Triana Kesuma Dewi afif Kurniawan Faculty of Psychology, Universitas  airlangga, surabaya, indonesiaBackground: Some parts of northern Surabaya are slum areas with dense populations, and  the majority of the inhabitants are from low-income families.",Non-OADS,/arxiv_data1/oa_pdf/05/79/prbm-10-079.PMC5360394.pdf
"airlangga 4-6, surabaya 60586, indonesiaemail nurul.hartini@psikologi.unair.ac.idJournal name: Psychology Research and Behavior Management Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Hartini et alRunning head recto: Improving urban environment through public commitmentDOI: http://dx.doi.org/10.2147/PRBM.S101727",Non-OADS,/arxiv_data1/oa_pdf/05/79/prbm-10-079.PMC5360394.pdf
"Psychology Research and Behavior Management 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/05/79/prbm-10-079.PMC5360394.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/42/a4/ott-10-1637.PMC5360395.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1637–1643OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1637Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11556 8 Evaluation of efficacy of transcatheter arterial  chemoembolization for hepatocellular carcinoma  using magnetic resonance diffusion-weighted  imaging Xiao-Ming Wu1 Jun-Feng Wang1 Jian-song Ji2 Ming-gao chen1 Jian-gang song1 1Department of radiology, Jinhua  People’s hospital, Jinhua, 2Department  of radiology, lishui Municipal  center hospital, lishui, People’s  republic of chinaAbstract:  Although the efficacy of transcatheter arterial chemoembolization (TACE) has  been recommended as first-line therapy for nonsurgical patients with hepatocellular carci - noma (HCC), it is difficult to accurately predict the efficacy of TACE.",Non-OADS,/arxiv_data1/oa_pdf/42/a4/ott-10-1637.PMC5360395.pdf
"Keywords:  magnetic resonance imaging, diffusion-weighted imaging, hepatocellular carcinoma,  transcatheter arterial chemoembolization, apparent diffusion coefficient Introduction Hepatocellular carcinoma (HCC) is a common malignancy in the People’s Republic  of China with characteristics of high malignancy, fast-growing progress, and poor  prognosis.1 The GLOBOCAN 2012 shows that the estimated age-standardized rates  (ASRs) of liver cancer incidence and mortality in a Chinese standard population (ASR  China) rank the second and third highest cancer incidence and mortality and accounts  for 12.9% of all new cancer cases and 17.4% of all cancer deaths in the People’s  Republic of China in 2012.2 The incidence rate of HCC ranks fifth in males and ninth  in females, and the mortality rate ranks second worldwide.3 The early diagnosis of this  disease is difficult due to the absence of specific symptoms in its early stage, and there - fore, the majority of patients are diagnosed at an advanced stage, losing their chance  for radical surgery.4 Factors resulting in HCC are complicated, including hepatitis B  virus infection, hepatitis  C virus infection, aflatoxin exposure, obesity, alcohol-related correspondence: Xiao-Ming Wu Department of radiology, Jinhua  People’s hospital, no 228, Xinhua  street, Wucheng District, Jinhua 321000,  Zhejiang Province, People’s republic  of china Tel +86 579 8913 8589 email drwuxiaoming@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Wu et al Running head recto: MR-DWI in evaluating the efficacy of TACE for HCC DOI: http://dx.doi.org/10.2147/OTT.S115568",Non-OADS,/arxiv_data1/oa_pdf/42/a4/ott-10-1637.PMC5360395.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/42/a4/ott-10-1637.PMC5360395.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/a4/ott-10-1637.PMC5360395.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ff/41/ott-10-1645.PMC5360396.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1645–1653OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1645Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S13091 0 Sonidegib: mechanism of action, pharmacology, and  clinical utility for advanced basal cell carcinomas Sachin Jain1 Ruolan Song2 Jingwu Xie2 1indiana University School of  Medicine, 2Department of Pediatrics,   Herman B wells Center for Pediatric  Research, indianapolis, iN, USAAbstract:  The Hedgehog (Hh) pathway is critical for cell differentiation, tissue polarity,  and stem cell maintenance during embryonic development, but is silent in adult tissues under  normal conditions.",Non-OADS,/arxiv_data1/oa_pdf/ff/41/ott-10-1645.PMC5360396.pdf
"Any mutation in these pathways may lead to abnormal fetal development as well as  malignant disease in adults.Correspondence: Jingwu Xie Department of Pediatrics, Herman B  wells Center for Pediatric Research,  1044 w. walnut St., Rm 327,  indianapolis, iN 46202, USA email via jinxie@iu.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Jain et al Running head recto: Sonidegib in BCC treatment DOI: http://dx.doi.org/10.2147/OTT.S130910",Non-OADS,/arxiv_data1/oa_pdf/ff/41/ott-10-1645.PMC5360396.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ff/41/ott-10-1645.PMC5360396.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/41/ott-10-1645.PMC5360396.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8c/c0/tcrm-13-335.PMC5360397.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 335–340Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  335ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12961 0 Clinical characteristics of zinc phosphide poisoning  in Thailand satariya Trakulsrichai1,2 natcha Kosanyawat1 Pongsakorn atiksawedparit1 Charuwan sriapha2 achara T ongpoo2 Umaporn Udomsubpayakul3 Panee Rittilert2 Winai Wananukul2 1Department of emergency Medicine,   2Ramathibodi Poison Center, 3section  for Clinical epidemiology and  Biostatistics, Research Center, Faculty  of Medicine, Ramathibodi hospital,   Mahidol University, Bangkok, ThailandObjective:  The objectives of this study were to describe the clinical characteristics and outcomes  of poisoning by zinc phosphide, a common rodenticide in Thailand, and to evaluate whether  these outcomes can be prognosticated by the clinical presentation.",Non-OADS,/arxiv_data1/oa_pdf/8c/c0/tcrm-13-335.PMC5360397.pdf
"Phosphine is a highly toxic gas in  humans and exerts its effects by many proposed mechanisms, including inhibition of  cytochrome C oxidase and oxidative respiration.1,2 Phosphine mainly affects the car - diovascular, respiratory, gastrointestinal (GI), hepatobiliary, and hematologic systems  and causes electrolyte and metabolic abnormalities.1,2 The severe clinical symptoms Correspondence: satariya Trakulsrichai Department of emergency Medicine,  Faculty of Medicine, Ramathibodi  hospital, Mahidol University, Rama Vi  Road, Bangkok 10400, Thailand Tel +66 2 201 1484 Fax +66 2 201 2404 email satariya.tra@mahidol.ac.t h Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Trakulsrichai et al Running head recto: Clinical characteristics of zinc phosphide poisoning DOI: http://dx.doi.org/10.2147/TCRM.S129610",Non-OADS,/arxiv_data1/oa_pdf/8c/c0/tcrm-13-335.PMC5360397.pdf
The poster’s abstract was published in “Poster  Abstracts” in Clinical Toxicology : http://www.eapcct2016.,Non-OADS,/arxiv_data1/oa_pdf/8c/c0/tcrm-13-335.PMC5360397.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/8c/c0/tcrm-13-335.PMC5360397.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/c0/tcrm-13-335.PMC5360397.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/02/ed/ott-10-1613.PMC5360398.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1613–1624OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1613Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13301 4 cDKl1 promotes tumor proliferation and  invasion in colorectal cancer chunzhi Qin1,* li ren1,* Meiling Ji1,* shixu lv2,* Ye Wei1 Dexiang Zhu1 Qi lin1 Pingping Xu1 Wenju chang1 Jianmin Xu1 1Department of general surgery,   Zhongshan hospital, Fudan University,   shanghai, 2Department of surgical  Oncology, First affiliated hospital  of Wenzhou Medical University,   Wenzhou, People’s republic of china *These authors contributed equally  to this workBackground:  CDKL1 is a member of the cell division cycle 2 (CDC2)-related serine threonine  protein kinase family and is overexpressed in malignant tumors such as melanoma, breast  cancer, and gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/02/ed/ott-10-1613.PMC5360398.pdf
"The mammalian  CDKL1 is predominantly expressed in the brain, lungs, kidneys, and ovaries.3,4  Zebrafish CDKL1, sharing a high degree of homology with the mammalian ortholog, correspondence: Jianmin Xu Department of general surgery,  Zhongshan hospital, Fudan University,  180 Fenglin road, shanghai 200032,  People’s republic of china Tel +86 135 0198 4869 email xu.jianmin1@zs-hospital.sh.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Qin et al Running head recto: CDKL1 promotes tumor progression in CRC  DOI: http://dx.doi.org/10.2147/OTT.S133014",Non-OADS,/arxiv_data1/oa_pdf/02/ed/ott-10-1613.PMC5360398.pdf
"Available from:  http://www.proteinatlas.org/about/assays +annotatio n. Accessed  January 16, 2015.",OADS,/arxiv_data1/oa_pdf/02/ed/ott-10-1613.PMC5360398.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/02/ed/ott-10-1613.PMC5360398.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/ed/ott-10-1613.PMC5360398.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/be/5b/ijn-12-2109.PMC5360399.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2109–2115International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2109OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13060 8 lipase degradation of plasticized polyvinyl  chloride endotracheal tube surfaces to create  nanoscale features Mary c Machado1 Thomas J Webster2 1center for Biomedical engineering,   Division of engineering Brown  University, Providence, rI,   2Department of chemical engineering,   Northeastern University, Boston,   Ma, UsaAbstract:  Polyvinyl chloride (PVC) endotracheal tubes (ETTs) nanoetched with a fungal lipase  have been shown to reduce bacterial growth and biofilm formation and could be an inexpensive  solution to the complex problem of ventilator-associated pneumonia (VAP).",Non-OADS,/arxiv_data1/oa_pdf/be/5b/ijn-12-2109.PMC5360399.pdf
"ETTs used today are composed primarily of polyvinyl  chloride (PVC) combined with a plasticizer, usually an organic acid ester, to increase  the flexibility of the material.9 Plasticized polyvinyl chloride (pPVC) tubes with correspondence: Thomas J Webster Department of chemical engineering,  Northeastern University, 360 huntington  avenue, Boston, Ma 02715, Usa Tel +1 617 373 6585 email th.webster@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Machado and Webster Running head recto: Lipase degradation of plasticized PVC endotracheal tube DOI: http://dx.doi.org/10.2147/IJN.S130608 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/be/5b/ijn-12-2109.PMC5360399.pdf
Or use: http://youtu.be/vUnf-PqbvF 4Video abstract,Non-OADS,/arxiv_data1/oa_pdf/be/5b/ijn-12-2109.PMC5360399.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/be/5b/ijn-12-2109.PMC5360399.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/5b/ijn-12-2109.PMC5360399.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/59/4f/ott-10-1625.PMC5360400.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1625–1635OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1625Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11839 1 Micro rna-145 inhibits the activation of the mTO r  signaling pathway to suppress the proliferation  and invasion of invasive pituitary adenoma cells by  targeting aKT3 in vivo and in vitro Kai Zhou Yan-Dong Fan Peng-Fei Wu serick Duysenbi Zhao-hai Feng guo-Jia Du Ting-rong Zhang Department of neurosurgery, The  First affiliated hospital of Xinjiang  Medical University, Urumqi, People’s  republic of chinaPurpose:  This study was designed to explore how miR-145 regulates the mTOR signaling  pathway in invasive pituitary adenoma (IPA) by targeting AKT3.",Non-OADS,/arxiv_data1/oa_pdf/59/4f/ott-10-1625.PMC5360400.pdf
"IPA infiltrates adjacent tissues and grows in several directions: superiorly, permeating  the diaphragma sellae and reaching the suprasellar cistern; laterally, disrupting the medial  wall of the cavernous sinus, obliterating the venous structures or even encasing the correspondence: Ting-rong Zhang Department of neurosurgery, The First  Affiliated Hospital of Xinjiang Medical  University, no 137, liyu Mountain south  road, new Downtown District, Urumqi  830054, People’s republic of china Tel +86 137 0991 6396 email Zhangtingrong999@sohu.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Zhou et al Running head recto: Role of miR-145 and mTOR pathway in IPA DOI: http://dx.doi.org/10.2147/OTT.S118391",Non-OADS,/arxiv_data1/oa_pdf/59/4f/ott-10-1625.PMC5360400.pdf
"Bioinformatics software on http://www.targetscan.or g  was adopted to predict the targeted correlation between  miR-145 and AKT3, which was further verified by dual- luciferase reporter gene assay system.",OADS,/arxiv_data1/oa_pdf/59/4f/ott-10-1625.PMC5360400.pdf
mir-145 targets aKT3 AKT3 was predicted to be the target gene of miR-145  by bioinformatics software http://www.targetscan.or g  (Figure 9A).,Non-OADS,/arxiv_data1/oa_pdf/59/4f/ott-10-1625.PMC5360400.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/59/4f/ott-10-1625.PMC5360400.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/4f/ott-10-1625.PMC5360400.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/ea/ndt-13-815.PMC5360401.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 815–826Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  815Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/NDT .S13099 7 Neuropsychiatric symptoms in untreated  Parkinson’s disease Szabolcs Szatmari1–3 Ben Min-w oo illigens4 Timo Siepmann5,6 Alexandra Pinter5,7 Annamaria Takats8 Daniel Bereczki8 1Department of Neurology, Sibiu  County emergency Hospital, Sibiu,   22nd Department of Neurology, Targu  Mures emergency Clinical County  Hospital, Targu Mures, Romania;   3János Szentágothai Doctoral School  of Neurosciences, Semmelweis  University, Budapest, Hungary;   4Department of Neurology, Beth  israel Deaconess Medical Center,   Harvard Medical School, Boston,   MA, USA; 5Center for Clinical  Research and Management education,   Division of Health Care Sciences,   Dresden international University,   6Department of Neurology, University  Hospital Carl Gustav Carus,   T echnical University of Dresden,   Dresden, Germany; 7Department of  Family Medicine, 8Department of  Neurology, Semmelweis University,   Budapest, HungaryAbstract:  Neuropsychiatric and cognitive symptoms are common in Parkinson’s disease (PD)  and may precede and exceed motor symptoms as major factors impacting disease course  and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/69/ea/ndt-13-815.PMC5360401.pdf
"The phenotypic variants are as follows: park cogni - tive (predominantly presents with cognitive impairment at an early stage), park apathy  (high scores on apathy scales), park depression/anxiety (early manifestation of these  symptoms), park sleep (characterized by excessive daytime sleepiness or rapid eye  movement behavior disorder), park pain (different pain syndromes dominate the clini - cal picture), park fatigue (exhibited as an independent and severe symptom), and  park autonomic (gastrointestinal, genitourinary symptom dominant, and adrenergic  dysfunction dominant) subtypes.2 A recent study found that the prevalence of neurop - sychiatric symptoms (NPS) in early, untreated PD patients was up to 56%.3 Several  prior studies have shown these symptoms to have an adverse impact on patient’s  everyday activities, quality of life, as well as the burden of their caregivers and the  health services.4–12 Previous research has also suggested that these symptoms are fre - quently unrecognized and untreated due to several factors such as the incomplete  understanding of mental health problems, illness-specific concerns among patients, Correspondence: Timo Siepmann Department of Neurology, University  Hospital Carl Gustav Carus, Technical  University of Dresden, 74 Fetscher  Street, 01307 Dresden, Germany Tel +49 351 458 3565 Fax +49 351 458 4365 email timo.siepmann@uniklinikum- dresden.d eJournal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Szatmari et al Running head recto: NPS in untreated PD DOI: http://dx.doi.org/10.2147/NDT.S130997",Non-OADS,/arxiv_data1/oa_pdf/69/ea/ndt-13-815.PMC5360401.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/69/ea/ndt-13-815.PMC5360401.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/ea/ndt-13-815.PMC5360401.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/76/20/ppa-11-571.PMC5360404.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 571–577Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  571Study Protocolopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S12461 5 mHealth intervention to support asthma self- management in adolescents: the Ad APt study richelle c Kosse,1 Marcel  l Bouvy,1 tjalling W de  Vries,2 Ad A Kaptein,3 Harm  cJ Geers,1 liset van dijk,4  Ellen S Koster1 1division of Pharmacoepidemiology  and clinical Pharmacology, utrecht  Institute for Pharmaceutical  Sciences, Faculty of Science, utrecht  university, utrecht, 2department  of Paediatrics, Medical center  leeuwarden, leeuwarden, 3Medical  Psychology, leiden university  Medical center, leiden, 4NIVEl,   the Netherlands Institute for  Health Services research, utrecht,   the NetherlandsPurpose:  Poor medication adherence in adolescents with asthma results in poorly controlled  disease and increased morbidity.",Non-OADS,/arxiv_data1/oa_pdf/76/20/ppa-11-571.PMC5360404.pdf
"Keywords:  adherence, adolescents, asthma, intervention, mHealth, pharmacist Introduction The estimated adherence rates with inhaled corticosteroids (ICSs) vary between 30%  and 70%.1 These low adherence rates result in uncontrolled asthma and unnecessary  hospitalizations, associated with decreased quality of life and school and work  absenteeism.2–4 Poor adherence is a complex problem that can be divided into inten - tional (consciously deciding) and unintentional (forgetting or not being able to use  medicines) non-adherence behaviors.5 Adherence rates decline during adolescence; studies report adherence rates of 50%  at age 12, while rates ,20% are found at age 17.6,7 During this life phase, adolescents  become more responsible for their own medication use, which can affect their medica - tion intake behavior.7 As adolescents perceive low necessity toward their medication  use,8 positively affecting adolescents’ beliefs toward illness and treatment might result  in increased adherence rates.9–12 The Common Sense Model of Self-Regulation (CSM) describes that illness percep - tions and medication beliefs can affect adherence.13 This model has been extensively correspondence: Ellen S Koster division of Pharmacoepidemiology and  clinical Pharmacology, utrecht Institute  for Pharmaceutical Sciences, Faculty of  Science, utrecht university, Po Box  80082, 3508 tB utrecht, the Netherlands tel +31 30 253 7324 Fax +31 30 253 9166 Email e.koster@uu.n l Journal name: Patient Preference and Adherence Article Designation: Study Protocol Y ear: 2017 Volume: 11 Running head verso: Kosse et al Running head recto: Rationale and design of the ADAPT study DOI: http://dx.doi.org/10.2147/PPA.S124615 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/76/20/ppa-11-571.PMC5360404.pdf
Or use: http://youtu.be/CHnkrWHtD6 YVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/76/20/ppa-11-571.PMC5360404.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/76/20/ppa-11-571.PMC5360404.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/78/09/hmer-9-013.PMC5360405.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/78/09/hmer-9-013.PMC5360405.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hepatic Medicine: Evidence and Research 2017:9 13–16Hepatic Medicine: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  13 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HMER.S118063Decreasing racial disparity with the combination  of ledipasvir–sofosbuvir for the treatment of  chronic hepatitis C Paul H Naylor   Milton Mutchnick Department of Internal Medicine/ Gastroenterology, Wayne State University School of Medicine,  Detroit, MI, USAAbstract:  African Americans (AA) in the US are twice as likely to be infected with hepatitis  C virus (HCV) compared to the non-Hispanic-white US population (Cau).",Non-OADS,/arxiv_data1/oa_pdf/78/09/hmer-9-013.PMC5360405.pdf
"10 These  observations were recently confirmed in a study by Naylor et al12 in a “real world”  clinic setting, where the predominant population being treated was AA.Correspondence: Paul H Naylor   Division of Gastroenterology, 603  Hudson Building, Harper University Hospital, 3990 John R, Detroit, MI 48201, USA Tel +1 631 463 6102   Fax +1 313 745 8843   Email pnaylor@med.wayne.edu  Journal name: Hepatic Medicine: Evidence and Research Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Naylor and MutchnickRunning head recto: Decreasing racial disparity with the combination of ledipasvir–sofosbuvirDOI: http://dx.doi.org/10.2147/HMER.S118063",Non-OADS,/arxiv_data1/oa_pdf/78/09/hmer-9-013.PMC5360405.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23596274.,Non-OADS,/arxiv_data1/oa_pdf/78/09/hmer-9-013.PMC5360405.pdf
"Hepatic Medicine: Evidence and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hepatic-medicine-evidence-and-research-journalHepatic Medicine: Evidence and Research is an international, peer- reviewed, open access journal covering all aspects of adult and pediatric hepatology in the clinic and laboratory including the following topics: Pathology, pathophysiology of hepatic disease; Investigation and treat-ment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/78/09/hmer-9-013.PMC5360405.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 16 Naylor and Mutchnick  6.,Non-OADS,/arxiv_data1/oa_pdf/78/09/hmer-9-013.PMC5360405.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11454177.,Non-OADS,/arxiv_data1/oa_pdf/78/09/hmer-9-013.PMC5360405.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 67–74Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 67 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S124395The US Food and Drug Administration’s drug  safety recommendations and long-acting beta2- agonist dispensing pattern changes in adult asthma  patients: 2003–2012 Esther H Zhou1  Sally Seymour2  Margie R Goulding1  Elizabeth M Kang1  Jacqueline M Major1  Solomon Iyasu1 1Division of Epidemiology, Office of  Surveillance and Epidemiology, 2Office  of New Drugs, Center for Drug  Evaluation and Research, US Food and Drug Administration, Silver Spring,  MD, USABackground: Emerging safety issues associated with long-acting beta2-agonist (LABA) have  led to multiple regulatory activities by the US Food and Drug Administration (FDA) since  2003, including Drug Safety Communications (DSCs) in 2010.",Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
"The US Food and Drug Administration (FDA)-approved LABA products for asthma include 1) fixed-dose combination (FDC) inhaled corticosteroids (ICSs) and LABA Correspondence: Esther H Zhou   Division of Epidemiology, Office of  Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Building 22, Room 2462, Silver Spring, MD 20993, USA Tel +1 301 796 0550   Email Esther.Zhou@fda.hhs.govJournal name: Journal of Asthma and Allergy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Zhou et alRunning head recto: LABA dispensing changes in adult asthma patientsDOI: http://dx.doi.org/10.2147/JAA.S124395",Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
"This study also contributed to the “Joint Meeting of the Pulmonary Allergy Drugs Advi-sory  Committee (PADAC) and the Drug Safety and Risk  Management Advisory Committee (DSARM)”, March 19, 2015, and can be found at: http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM438379.pdf.",Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
Available from: http://ginasthma.org/wp-content/uploads/2016/01/GINA_Report_2015_Aug11-1.pdf.,OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
Avail-able from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
Available from: http://www.fda.gov/Drugs/InformationOnDrugs/ucm079436.htm#L.,Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
Available from: http://www.fda.gov/Drugs/   DrugSafety/ucm199082.htm.,Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
Available from: http://www.fda.gov/ohrms/dockets/ac/cder05.html#PulmonaryAllergy.,Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
Available from: http://www.fda.gov/ohrms/dockets/ac/cder08.html#PulmonaryAllergy.,Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm213836.htm.,Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
Available from: http://www.cdc.gov/nchs/data/nhis/earlyrelease/insur201409.pdf.,OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ucm251512.htm.,Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/5b/96/jaa-10-067.PMC5360406.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2c/f4/ndt-13-827.PMC5360407.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 827–833Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  827OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13166 1 some children with autism have latent social skills  that can be tested Michal hrdlicka1 T omas Urbanek2 Maria Vacova1 stepanka Beranova1 iva Dudova1 1Department of child Psychiatry,   charles University second Faculty  of Medicine and University  hospital Motol, Prague, 2institute  of Psychology, academy of sciences,   Brno, czech republicBackground:  The idea of latent social skills in autism emerged as a possible interpretation of the  rapid (but temporary) improvement of autistic subjects in oxytocin studies.",Non-OADS,/arxiv_data1/oa_pdf/2c/f4/ndt-13-827.PMC5360407.pdf
"In other correspondence: Michal hrdlicka Department of child Psychiatry, charles  University second Faculty of Medicine,  University hospital Motol, V Uvalu 84,  15006 Prague, czech republic Tel +420 2 2443 3400 Fax +420 2 2443 3420 email michal.hrdlicka@lfmotol.cuni.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Hrdlicka et al Running head recto: Latent social skills in autism DOI: http://dx.doi.org/10.2147/NDT.S131661",Non-OADS,/arxiv_data1/oa_pdf/2c/f4/ndt-13-827.PMC5360407.pdf
Available from: http://CRAN.R-project.org/ package=psych.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/ndt-13-827.PMC5360407.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/2c/f4/ndt-13-827.PMC5360407.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/ndt-13-827.PMC5360407.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/52/31/ijn-12-2117.PMC5360408.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2117–2127International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2117OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12342 2 angiopep-2-conjugated poly(ethylene glycol)- co-  poly( ε-caprolactone) polymersomes for dual- targeting drug delivery to glioma in rats Fei lu1,2 Zhiyong Pang2,3 Jingjing Zhao2 Kai Jin4 haichun li2 Qiang Pang2 long Zhang2 Zhiqing Pang2 1Department of Pharmacy, Xianju  People’s hospital, Xianju, Zhejiang,   2Department of Pharmaceutics, Key  laboratory of smart Drug Delivery,   Ministry of education and P la,   school of Pharmacy, Fudan University,   shanghai, 3chongyang center for  Disease control and Prevention,   Xianning, hubei, 4school of life  science, Fudan University, shanghai,   People’s republic of chinaAbstract:  The blood–brain barrier is a formidable obstacle for glioma chemotherapy due to its  compact structure and drug efflux ability.",Non-OADS,/arxiv_data1/oa_pdf/52/31/ijn-12-2117.PMC5360408.pdf
"However,  the blood–brain barrier (BBB) prevents most therapeutic agents from entering the  brain parenchyma.6 Another obstacle associated with chemotherapy is promoting drug  accumulation in the tumor sites while preventing therapeutic agents from accessing  surrounding healthy tissues.7 Many strategies based on different mechanisms have been proposed to solve these prob - lems, including osmotic BBB disruption,8 bradykinin receptor-mediated BBB opening,9 correspondence: Zhiqing Pang Department of Pharmaceutics, Key  laboratory of smart Drug Delivery,  Ministry of education and Pla, school  of Pharmacy, Fudan University, 826  N Zhangheng road, shanghai 201203,  People’s republic of china Tel +86 21 5198 0069 email zqpang@fudan.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Lu et al Running head recto: Polymersomes for glioma drug delivery DOI: http://dx.doi.org/10.2147/IJN.S123422",Non-OADS,/arxiv_data1/oa_pdf/52/31/ijn-12-2117.PMC5360408.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/52/31/ijn-12-2117.PMC5360408.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/31/ijn-12-2117.PMC5360408.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 167–178Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 167 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S106258 Chinese health care system and clinical  epidemiology Yuelian Sun1 Hans Gregersen2 Wei Yuan3 1Department of Clinical Epidemiology,   Aarhus University Hospital, Aarhus,   Denmark; 2GIOME, Department of  Surgery, Chinese University of Hong Kong, Hong Kong,  3Key Laboratory of  Reproduction Regulation of NPFPC,  SIPPR, IRD, Fudan University, Shanghai,  People’s Republic of ChinaAbstract:  China has gone through a comprehensive health care insurance reform since 2003  and achieved universal health insurance coverage in 2011.",Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
"We then focus on the construction  Correspondence: Yuelian Sun Department of Clinical Epidemiology, Olof Palmes Allé 43-45, DK-8200  Aarhus N, DenmarkTel +45 8716 8254Email ys@clin.au.dkJournal name: Clinical Epidemiology Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Sun et alRunning head recto: Chinese health care systemDOI: http://dx.doi.org/10.2147/CLEP .S106258",Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
https://openknowledge.worldbank.org/handle/10986/13303 License: CC BY 3.0 IGO.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Creative Commons license and disclaimer available from: http://creativecommons.org/licenses/by/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from http://www.cn.undp.org/content/dam/china/docs/Publications/UNDP-CH_2013%20NHDR_EN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from http://en.nhfpc.gov.cn/2014-05/16/c_46667.htm.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from: http://www.who.int/healthsystems/topics/financing/healthreport/37ChinaB_YFINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from: http://www.mohrss.gov.cn/SYrlzyhshbzb/shehuibaozhang/zcwj/yiliao/201605/t20160506_239541.html.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from: http://www.mof.gov.cn/zhengwuxinxi/zhengcefabu/201505/t20150511_1229616.htm.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Availalbe from: http://cerdi.org/uploads/sfCmsContent/html/333/PelissierHuang.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Avail-able from: http://www.mohrss.gov.cn/SYrlzyhshbzb/shehuibaozhang/zcwj/yiliao/201508/t20150804_216852.html.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from: http://www.china.org.cn/china/2015-02/06/content_34757261.htm.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from: http://www.gov.cn/zwgk/2013-03/01/content_2342656.htm.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from: http://www.mohrss.gov.cn/SYrlzyhshbzb/shehuibaozhang/zcwj/yiliao/201601/t20160112_231624.html.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from: http://english.gov.cn/policies/lat-est_releases/2014/08/23/content_281474983027052.htm.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from http://www.pacifichealthsum   mit.org/downloads/HITCaseStudies/Functional/CISDCP .pdf.,OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from: http://ghdx.healthdata.org/record/china-chronic-disease-and-risk-factor-surveillance-2010.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from: https://epi.grants.cancer.gov/Consortia/mem-bers/shanghai.html.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
Available from http://shebao.southmoney.com/yiliao/baoxiao/201402/29656.html.,Non-OADS,/arxiv_data1/oa_pdf/24/76/clep-9-167.PMC5360409.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f1/e8/tcrm-13-325.PMC5360410.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 325–334Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  325ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11206 2 an estimate of the cost of administering intravenous  biological agents in spanish day hospitals Correspondence: Joan Miquel nolla Rheumatology Department, hospital  Universitari de Bellvitge, Feixa llarga  s/n 08907, l’hospitalet de llobregat,  Barcelona, spain Tel +34 93 260 7500 Fax +34 93 260 7533 email jm.nolla@bellvitgehospital.ca t Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Nolla et al Running head recto: An estimate of the cost of administering intravenous biological agents DOI: http://dx.doi.org/10.2147/TCRM.S112062 Joan Miquel nolla1 esperanza Martín2 Pilar llamas3 Javier Manero4 arturo Rodríguez de la  serna5 Manuel Francisco  Fernández-Miera6 Mercedes Rodríguez6 José Manuel lópez7 alexandra ivanova8 Belén aragón9 1Rheumatology Department, iDiBell- hospital Universitari de Bellvitge,   Barcelona, 2hospital Universitario  de getafe, Madrid, 3hospital  Universitario Fundación Jiménez Díaz,   Madrid, 4hospital Universitario Miguel  servet, Zaragoza, 5hospital de la santa  Creu i sant Pau, Barcelona, 6hospital  Universitario Marqués de Valdecilla,   santander, 7hospital Universitario  Virgen del Rocío, sevilla, 8Max Weber  institute, Madrid, 9MsD, Madrid, spainObjective:  To estimate the unit costs of administering intravenous (IV) biological agents in  day hospitals (DHs) in the Spanish National Health System.",Non-OADS,/arxiv_data1/oa_pdf/f1/e8/tcrm-13-325.PMC5360410.pdf
"Available from:  http://www.msssi.gob.es/estadEstudios/estadisticas/estHospiInternado/ inforAnual/homeESCRI.ht m. Accessed September 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f1/e8/tcrm-13-325.PMC5360410.pdf
Available from: http://www.oblikue.com/ bddcostes /.,Non-OADS,/arxiv_data1/oa_pdf/f1/e8/tcrm-13-325.PMC5360410.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/f1/e8/tcrm-13-325.PMC5360410.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/e8/tcrm-13-325.PMC5360410.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/40/56/ijn-12-2081.PMC5360411.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2081–2108International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2081OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12879 0 co-delivery nanoparticles with characteristics  of intracellular precision release drugs for  overcoming multidrug resistance DanDan Zhang1 Yan Yan Kong1 Jia hui sun1 shao Jie huo1 Min Zhou2 Yi ling gui1 Xu Mu1 huan chen1 shu Qin Yu1 Qian Xu3 1Jiangsu Province Key laboratory for  Molecular and Medical Biotechnology,   college of life sciences, Nanjing  Normal University, Nanjing, 2school  of Pharmacy, Jiangsu Food and  Pharmaceutical science college,   huai’an, 3Ministry of education  Key laboratory of environmental  Medicine and engineering, school of  Public health, southeast University,   Nanjing, People’s republic of chinaAbstract:  Combination chemotherapy in clinical practice has been generally accepted as a  feasible strategy for overcoming multidrug resistance (MDR).",Non-OADS,/arxiv_data1/oa_pdf/40/56/ijn-12-2081.PMC5360411.pdf
"Therefore, single-drug chemotherapy cannot completely eradicate cancers.correspondence: shu Qin Yu Jiangsu Province Key laboratory for  Molecular and Medical Biotechnology,  college of life sciences, Nanjing Normal  University, No 1 WenYuan road, Nanjing  210046, People’s republic of china Tel/fax +86 25 8589 1265 email yushuqin@njnu.edu.c n  Qian Xu Ministry of education Key laboratory of  environmental Medicine and engineering,  school of Public health, southeast  University, No 1 DingJiaQiao, Nanjing  210009, People’s republic of china Tel/fax +86 25 8327 2563 email q_xu68@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhang et al Running head recto: Co-delivery nanoparticles for overcoming multidrug resistance DOI: http://dx.doi.org/10.2147/IJN.S128790",Non-OADS,/arxiv_data1/oa_pdf/40/56/ijn-12-2081.PMC5360411.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/40/56/ijn-12-2081.PMC5360411.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/56/ijn-12-2081.PMC5360411.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/1d/cia-12-535.PMC5360412.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 535–541Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  535OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12620 7 Is diabetes mellitus associated with clinical  outcomes in aging males treated with  transurethral resection of prostate for bladder  outlet obstruction: implications from Taiwan  nationwide Population-Based Cohort study Yu-hsiang lin1–3,* Chen-Pang hou1,2,* Tien-hsing Chen2,4 horng-heng Juang5 Phei-lang Chang1,2 Pei-shan Yang1,2 Yu-sheng lin2,6 Chien-lun Chen1,2 Ke-hung Tsui1,2 1Department of Urology, Chang  gung Memorial hospital – linkou,   2school of Medicine, 3graduate  Institute of Clinical Medical sciences,   College of Medicine, Chang gung  University, 4Division of Cardiology,   Department of Internal Medicine,   Chang gung Memorial hospital,   Keelung, 5Department of Anatomy,   school of Medicine, Chang gung  University, Kwei-shan, Tao-Yuan,   6Division of Cardiology, Department  of Internal Medicine, Chang gung  Memorial hospital, Chiayi, Taiwan,   republic of China *These authors contributed equally  to this workPurpose:  We assessed the lower urinary tract symptoms (LUTSs) and clinical outcomes between  diabetes mellitus (DM) patients and non-diabetic (non-DM) patients receiving transurethral  resection of prostate (TUR-P).",Non-OADS,/arxiv_data1/oa_pdf/37/1d/cia-12-535.PMC5360412.pdf
"It affects ~210 million men globally.1 In the coming decades, Correspondence: Ke-hung Tsui Department of Urology, Chang gung  Memorial hospital – linkou, 5 Fu-shing  street, Kweishan, Taoyuan 333, Taiwan,  republic of China Tel +886 3 328 1200 ext 2137 Fax +886 3 328 5818 email khtsui@yahoo.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Lin et al Running head recto: Is DM associated with clinical outcomes in aging males treated with TUR-P DOI: http://dx.doi.org/10.2147/CIA.S126207",Non-OADS,/arxiv_data1/oa_pdf/37/1d/cia-12-535.PMC5360412.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/37/1d/cia-12-535.PMC5360412.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/37/1d/cia-12-535.PMC5360412.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c3/50/jir-10-017.PMC5360413.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c3/50/jir-10-017.PMC5360413.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2017:10 17Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/c3/50/jir-10-017.PMC5360413.pdf
"Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 17 CORRIGENDUM open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S129757 Reduced butyrylcholinesterase activity is an early indicator of  trauma‑induced acute systemic inflammatory response [Corrigendum] Zivkovic AR, Bender J, Brenner T, et al.",Non-OADS,/arxiv_data1/oa_pdf/c3/50/jir-10-017.PMC5360413.pdf
"On page 227, Figure 4D, the y-axis label “LLactate (mg/dL)”  should be “Lactate (mg/dL)”.Journal name: Journal of Inflammation Research Article Designation: CORRIGENDUMY ear: 2017V olume: 10Running head verso: Zivkovic et alRunning head recto: Short TitleDOI: http://dx.doi.org/10.2147/JIR.S129757",Non-OADS,/arxiv_data1/oa_pdf/c3/50/jir-10-017.PMC5360413.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 85–96Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  85 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S127840nab-Paclitaxel for the treatment of pancreatic  cancer George Kim 21st Century Oncology, University of  Florida Health Oncology, Jacksonville,  FL, USABackground: Nanoparticle albumin-bound paclitaxel (nab -P) plus gemcitabine (Gem) became  a standard treatment option for metastatic pancreatic cancer (MPC) following positive results  from a global phase III trial (MPACT).",Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
"The treatment landscape for metastatic Correspondence: George Kim 21st Century Oncology, University of Florida Health Oncology, 7751 Baymeadows Road E, Ste 205, Jacksonville, FL 32256, USAEmail gmrpkim@gmail.comJournal name: Cancer Management and Research Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: KimRunning head recto: nab -Paclitaxel for the treatment of pancreatic cancer DOI: http://dx.doi.org/10.2147/CMAR.S127840",Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: http://seer.cancer.gov/statfacts/html/pancreas.html.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available form: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02436668.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02289898.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Avail-able from: https://clinicaltrials.gov/ct2/show/NCT02399137.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02125136?term= nab-pac litaxel+ AND+ pancreatic+ AND+ adenocarcinoma&rank= 55.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02243007?term= nab-paclitaxel+ AND+ pancreatic+ AND+ adeno carcinoma&rank=59.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01964287.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01964430?term= nab-paclitaxel+ AND+ pancreatic+ AN D+adenocarcinoma&rank=24.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02047513?term= nab-paclitaxel+ AND+ pancreatic+ AND+ adeno carcinoma&rank=34.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02506842?term= nab-pac litaxel+ AND+ pancreatic+ AND+ adenocarcinoma&rank= 42.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02106884?term= nab-paclitaxel+ AN D+pancreatic+AND+adenocarcinoma&rank=54.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02101021.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 96 Kim 76.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02715804.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02551991.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from:   https://clinicaltrials.gov/ct2/show/NCT02827201.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://www.clinicaltri-als.gov/ct2/show/NCT02504333.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01730222?term= nab-paclitaxel+ AN D+pancreatic+AND+adenocarcinoma&rank=12.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02109341.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02194829.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/NCT02301143.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02562716.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Avalable from: https://clinicaltrials.gov/ct2/show/NCT02562716.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02024009.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/cmar-9-085.PMC5360414.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d9/33/cia-12-531.PMC5360415.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 531–533Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  531Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S13509 2 evaluation of the association between  subconjunctival orbital fat prolapse and  thyroid-associated orbitopathy Sang Beom Han Department of Ophthalmology,   Kangwon National University  Hospital, Kangwon National  University Graduate School of  Medicine, Chuncheon, KoreaDear editor I read with interest the article entitled “Subconjunctival orbital fat prolapse and  thyroid associated orbitopathy: a clinical association” by Chatzistefanou et al.1 The  case-series study was undoubtedly well designed and conducted, in which the authors  successfully revealed that subconjunctival orbital fat prolapse may occasionally be a  predominant clinical manifestation of thyroid-associated orbitopathy (TAO) and sug - gested that the presence of subconjunctival orbital fat prolapse can alert the diagnosis  of thyroid orbitopathy.",Non-OADS,/arxiv_data1/oa_pdf/d9/33/cia-12-531.PMC5360415.pdf
"1987;   3(2):83–86.Correspondence: Sang Beom Han Department of Ophthalmology,  Kangwon National University Hospital,  156 Baengnyeong-ro, Chuncheon,  Kangwon 200-722, Korea tel +82 33 258 9210 Fax +82 33 258 2296 email m.sangbeom.han@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2017 Volume: 12 Running head verso: Han Running head recto: Association between subconjunctival orbital fat prolapse and TAO DOI: http://dx.doi.org/10.2147/CIA.S135092",Non-OADS,/arxiv_data1/oa_pdf/d9/33/cia-12-531.PMC5360415.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d9/33/cia-12-531.PMC5360415.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d9/33/cia-12-531.PMC5360415.pdf
"Analysis of potential microRNA  target sites was performed using the commonly used predic - tion algorithm, miRanda (http://www.microrna.org/microrna/ home.do).",OADS,/arxiv_data1/oa_pdf/2d/10/ijmm-39-04-0900.PMC5360436.pdf
The percentage  HLA‑DR‑positive area was determined using ImageJ soft - ware  (https://imagej.nih.gov/ij/) and normalized to the area  covered by tissue in the defect zone.,OADS,/arxiv_data1/oa_pdf/b1/a1/ijmm-39-04-0907.PMC5360440.pdf
"The success of this epigenetic modulation strategy  has evoked enormous enthusiasm across different medical  research fields; this enthusiasm has been manifested by a Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> Received 6 December 2016 | Accepted 18 March 2017 | Published 21 March 2017© 2017 Molecular Vision 149Epigenetic intervention with a BET inhibitor ameliorates acute  retinal ganglion cell death in mice Jun Li,1,2,3 Lei Zhao,3 Go Urabe,3 Yingmei Fu,3,4 Lian-Wang Guo3,5,6 1Department of Ophthalmology, The First Hospital of China Medical University, Shenyang, China; 2Department of  Ophthalmology, The 3rd People’ s Hospital of Dalian, Dalian, China; 3Department of Surgery, 5151 Wisconsin Institute for  Medical Research, University of Wisconsin-Madison, Madison, WI; 4Shanghai Key Laboratory of Psychotic Disorders, Shanghai  Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 5McPherson Eye Research Institute,  University of Wisconsin-Madison, Madison, WI; 6Department of Surgery and Department of Physiology & Cell Biology, Davis  Heart and Lung Research Institute, the Ohio State University, Columbus, OH Purpose:  The bromo and extraterminal (BET) epigenetic “reader” family is becoming an appealing new therapeutic  target for several common diseases, yet little is known of its role in retinal neurodegeneration.",Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> © 2017 Molecular Vision  150rapid increase of publications on the BET family.,Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> © 2017 Molecular Vision  151below) BRN3A-positive nuclei was performed following our  recent publication [ 18].,Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
"Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> © 2017 Molecular Vision  152layer are RGCs [ 21], DAPI staining of retinal cross-sections  could not distinguish RGCs from other cell types in the same  layer, including displaced amacrine cells, astrocytes, and  microglia.",Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> © 2017 Molecular Vision  153NMDA-induced cell loss or damage by a single intravitreal  co-injection of JQ1.,Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
"Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> © 2017 Molecular Vision  154JQ1 treatment inhibits the expression of inflammatory cyto - kines in the retina:  Recently, neuroinflammation has been  increasingly recognized as an important mechanism of RGC  neurodegeneration under various stress conditions [ 24,25].",Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> © 2017 Molecular Vision  155rat RGC death caused by elevated intraocular pressure [ 30].,Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> © 2017 Molecular Vision  156RGC-protective effect of JQ1 observed here is likely attribut - able to its inhibition of the BET family.,Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
"Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> © 2017 Molecular Vision  157Conclusions:  To the best of our knowledge, this is the first  in vivo investigation revealing an RGC-protective effect of  a BET inhibitor.",Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> © 2017 Molecular Vision  15815.,Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
"Molecular Vision  2017; 23:149-159 <http://www.molvis.org/molvis/v 23/149> © 2017 Molecular Vision  159Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/07/7f/mv-v23-149.PMC5360452.pdf
"in human and Molecular Vision  2017; 23:131-139 <http://www.molvis.org/molvis/v 23/131> Received 31 October 2016 | Accepted 16 March 2017 | Published 18 March 2017© 2017 Molecular Vision 131Novel splice-site mutation in TTLL5 causes cone dystrophy in a  consanguineous family Miguel de Sousa Dias,1 Christian P. Hamel,2,3,4 Isabelle Meunier,2,3,4 Juliette Varin,1 Steven Blanchard,5 Fiona  Boyard,1 José-Alain Sahel,1,6,7,8,9,10 Christina Zeitz1 1Sorbonne Universités, UPMC Univ Paris 06, INSERM  U968, CNRS  UMR 7210, Institut de la Vision, 17 rue Moreau, Paris,  France; 2INSERM U 1051, Institut des Neurosciences de Montpellier, Hôpital Saint-Eloi, Montpellier, France; 3Affections  Sensorielles Génétiques, CHU de Montpellier, 191 Avenue du Doyen Gaston Giraud, Montpellier, France; 4Université  Montpellier, 163 Avenue Auguste Broussonnet, Montpellier, France; 5IntegraGen SA, Genopole CAMPUS 1 bât, G8, EVRY, Paris,  France; 6CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DHOS CIC1423, 28 rue de Charenton, Paris, France; 7Institute  of Ophthalmology, University College of London, London EC1V 9EL, UK; 8Fondation Ophtalmologique Adolphe de Rothschild,  Paris, France; 9Academie des Sciences, Institut de France, Paris, France; 10Department of Ophthalmology, The University of  Pittsburghschool of Medicine, Pittsburg, P A Purpose:  To report the clinical and genetic findings of one family with autosomal recessive cone dystrophy (CD) and  to identify the causative mutation.",Non-OADS,/arxiv_data1/oa_pdf/3c/8a/mv-v23-131.PMC5360453.pdf
"Molecular Vision  2017; 23:131-139 <http://www.molvis.org/molvis/v 23/131> © 2017 Molecular Vision  132murine retinas placed TTLL5 in rods and cones, at the base  of the connecting cilium, between the basal body and the  ciliary axoneme (or outer segment).",Non-OADS,/arxiv_data1/oa_pdf/3c/8a/mv-v23-131.PMC5360453.pdf
"Molecular Vision  2017; 23:131-139 <http://www.molvis.org/molvis/v 23/131> © 2017 Molecular Vision  133fundoscopy, the Farnsworth D-15 color vision test, a full-field  electroretinogram (ERG) that incorporated the International  Society for Clinical Electrophysiology of Vision standards  and methodology previously described [ 21-23], fundus auto - fluorescence (FAF) and infrared (IR), and spectral-domain  optical coherence tomography (SD-OCT).",Non-OADS,/arxiv_data1/oa_pdf/3c/8a/mv-v23-131.PMC5360453.pdf
"Molecular Vision  2017; 23:131-139 <http://www.molvis.org/molvis/v 23/131> © 2017 Molecular Vision  134RESULTS Phenotype and clinical investigations of the affected  patient:  The index patient was a 9-year-old boy (Figure 2,  II-3), corrected for myopia since 3 years of age, who always  had difficulty watching television and reading.",Non-OADS,/arxiv_data1/oa_pdf/3c/8a/mv-v23-131.PMC5360453.pdf
Molecular Vision  2017; 23:131-139 <http://www.molvis.org/molvis/v 23/131> © 2017 Molecular Vision  135 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/3c/8a/mv-v23-131.PMC5360453.pdf
"Molecular Vision  2017; 23:131-139 <http://www.molvis.org/molvis/v 23/131> © 2017 Molecular Vision  136Thus, as the index patient is a boy who possesses a truncating  mutation, which is predicted to abolish all functional domains  when the mutant protein is formed, it is likely that he will  have reduced fertility.",Non-OADS,/arxiv_data1/oa_pdf/3c/8a/mv-v23-131.PMC5360453.pdf
Molecular Vision  2017; 23:131-139 <http://www.molvis.org/molvis/v 23/131> © 2017 Molecular Vision  137REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/8a/mv-v23-131.PMC5360453.pdf
Molecular Vision  2017; 23:131-139 <http://www.molvis.org/molvis/v 23/131> © 2017 Molecular Vision  13822.,Non-OADS,/arxiv_data1/oa_pdf/3c/8a/mv-v23-131.PMC5360453.pdf
Molecular Vision  2017; 23:131-139 <http://www.molvis.org/molvis/v 23/131> © 2017 Molecular Vision  13937.,Non-OADS,/arxiv_data1/oa_pdf/3c/8a/mv-v23-131.PMC5360453.pdf
"Molecular Vision  2017; 23:140-148 <http://www.molvis.org/molvis/v 23/140> Received 13 September 2016 | Accepted 16 March 2017 | Published 18 March 2017© 2017 Molecular Vision 140A mutagenesis-derived Lrp5  mouse mutant with abnormal retinal  vasculature and low bone mineral density Jeremy R. Charette,1 Sarah E. Earp,2,3 Brent A. Bell,3 Cheryl L. Ackert-Bicknell,1,4 Dana A. Godfrey,4 Sujata  Rao,2,3 Bela Anand-Apte,2,3 Patsy M. Nishina,1 Neal S. Peachey2,3,5 1The Jackson Laboratory, Bar Harbor, ME; 2Cleveland Clinic Lerner College of Medicine of Case Western Reserve University,  Cleveland, OH; 3Cole Eye Institute, Cleveland Clinic, Cleveland, OH; 4Center for Musculoskeletal Research, Department of  Orthopaedics, University of Rochester, Rochester, NY; 5Louis Stokes Cleveland VA Medical Center, Cleveland, OH Purpose:  Familial exudative vitreoretinopathy (FEVR) is caused by mutations in the genes encoding low-density lipo - protein receptor-related protein (LRP5) or its interacting partners, namely frizzled class receptor 4 (FZD4) and norrin  cystine knot growth factor (NDP).",Non-OADS,/arxiv_data1/oa_pdf/db/87/mv-v23-140.PMC5360454.pdf
"Molecular Vision  2017; 23:140-148 <http://www.molvis.org/molvis/v 23/140> © 2017 Molecular Vision  141Abnormal retinal vascular development has been described  in two mutant mouse lines that carry inactivating mutations  in Lrp5  due to ENU mutagenesis or gene targeting [ 5,15].",Non-OADS,/arxiv_data1/oa_pdf/db/87/mv-v23-140.PMC5360454.pdf
"Molecular Vision  2017; 23:140-148 <http://www.molvis.org/molvis/v 23/140> © 2017 Molecular Vision  142on a single lane of an Illumina (San Diego, CA) HiSeq 2000  using a 2×100-base (paired-end) sequencing protocol.",Non-OADS,/arxiv_data1/oa_pdf/db/87/mv-v23-140.PMC5360454.pdf
"Molecular Vision  2017; 23:140-148 <http://www.molvis.org/molvis/v 23/140> © 2017 Molecular Vision  143(10–20 mg/kg) via an intraperitoneal injection, and FA-SLO  images of the superficial and deep capillary plexus were  collected at 1, 2, 3, and 4 min postinjection [ 27].",Non-OADS,/arxiv_data1/oa_pdf/db/87/mv-v23-140.PMC5360454.pdf
Molecular Vision  2017; 23:140-148 <http://www.molvis.org/molvis/v 23/140> © 2017 Molecular Vision  144coding to visualize the vascular layers using Leica Applica - tion Suite software.,Non-OADS,/arxiv_data1/oa_pdf/db/87/mv-v23-140.PMC5360454.pdf
Molecular Vision  2017; 23:140-148 <http://www.molvis.org/molvis/v 23/140> © 2017 Molecular Vision  145variant ( Lrp5  c.4724_4725insG) is a single-nucleotide inser - tion in the final two PPPSPxS motifs at the C-terminal end  of the Lrp5  gene.,Non-OADS,/arxiv_data1/oa_pdf/db/87/mv-v23-140.PMC5360454.pdf
"Molecular Vision  2017; 23:140-148 <http://www.molvis.org/molvis/v 23/140> © 2017 Molecular Vision  146was noted; however, this was not statistically significant  (control=0.0657 versus Lrp5tvrm111B=0.0594 g/cm2, p=0.18).",Non-OADS,/arxiv_data1/oa_pdf/db/87/mv-v23-140.PMC5360454.pdf
"Molecular Vision  2017; 23:140-148 <http://www.molvis.org/molvis/v 23/140> © 2017 Molecular Vision  147Xie Y, Beutler B. Real-time resolution of point mutations that  cause phenovariance in mice.",Non-OADS,/arxiv_data1/oa_pdf/db/87/mv-v23-140.PMC5360454.pdf
Molecular Vision  2017; 23:140-148 <http://www.molvis.org/molvis/v 23/140> © 2017 Molecular Vision  148accuracy and precision.,Non-OADS,/arxiv_data1/oa_pdf/db/87/mv-v23-140.PMC5360454.pdf
"Opti - mizing the in vitro expansion of choroidal melanocytes is  essential to study their physiologic roles in the choroid and Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> Received 17 October 2016 | Accepted 10 March 2017 | Published 12 March 2017© 2017 Molecular Vision 103Differential responses of choroidal melanocytes and uveal  melanoma cells to low oxygen conditions Cindy Weidmann,1,2 Jade Pomerleau,1,2 Laurence Trudel-Vandal,1,2 Solange Landreville1,3 1Axe Médecine régénératrice and Centre Universitaire d’Ophtalmologie (CUO)-Recherche, Centre de recherche du CHU de  Québec, Quebec City, QC, Canada; 2Centre de recherche en organogénèse expérimentale de l’Université Laval/LOEX, Quebec  City, QC, Canada; 3Département d’ophtalmologie, Faculté de médecine, Université Laval, Quebec City, QC, Canada Purpose:  Tissue culture is traditionally performed at atmospheric oxygen concentration (21%), which induces hyperoxic  stress, as endogenous physiologic oxygen tension found in tissues varies between 2% and 9%.",Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
"Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  104pathologies, such as uveal melanoma (UM) and age-related  macular degeneration.",Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
"Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  105counterstained with 4',6-diamidino-2-phenylindole (DAPI)  nuclear stain (Life Technologies).",Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
"Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  106modulates the molecular and cellular behaviors of human  choroidal melanocytes, the cells were permanently cultured  under hyperoxic (21%) or physiologic (3%) oxygen conditions  after the cells were isolated from the choroid layer.",Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  107 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
"Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  108h, p = 0.003; M2:  85.5 versus 97.6 h, p = 0.003; M3:  85.0  versus 94.0 h, p = 0.019).",Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  109 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  110physiology.,Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
"Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  111parameters of melanocyte differentiation, such as melanin  synthesis and dendrite outgrowth [ 42,43].",Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
"Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  112survival, a feature that is modeled in vitro by colony forma - tion in agar or methylcellulose suspension [ 47].",Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
"Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  113G2/M transition, to scrutinize the cell’s DNA and make sure  it is structurally intact and properly replicated.",Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  1143.,Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
Molecular Vision  2017; 23:103-115 <http://www.molvis.org/molvis/v 23/103> © 2017 Molecular Vision  115in cultured microglial cells.,Non-OADS,/arxiv_data1/oa_pdf/bb/26/mv-v23-103.PMC5360455.pdf
"Although much work has been done  using immortalized cell lines created from several species,  including the rat, pig, and human [ 4-6], these RPE culture  models generally fail to preserve many of their specialized  characteristics and the ability to recapitulate functional Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> Received 20 June 2016 | Accepted 3 March 2017 | Published 5 March 2017© 2017 Molecular Vision 60Appropriately differentiated ARPE-19 cells regain phenotype and  gene expression profiles similar to those of native RPE cells William Samuel,1 Cynthia Jaworski,1 Olga.",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  61characteristics and gene expression patterns exhibited  by the RPE in vivo.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  62Scientific, Cat # 51–6100), and mouse anti-premelanosome  protein (PMEL, 1:40; Thermo Fisher Scientific, Cat #  MA5–13232).",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  63Western blot analysis:  The human RPE cells cultured for  either 4 days or 4 months were washed twice with PBS (1X;  155 mM NaCl, 1.06 mM KH2PO4, 2.97 mM Na2HPO4-7H20,  pH 7.4, #10010-023, Gibco, Thermo Fisher Scientific), and  cell extracts were prepared using cell lysis buffer according to  the manufacturer’s recommendation (Cell Signaling, Danvers,  MA).",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  64room temperature and washed once with PBS.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  651D), an important structural feature characteristic of native  RPE cells.",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  66barrier properties of the culture were measured via TER, and  a mean level of 126 ± 26 Ω × cm2 TER (n = 12) was observed  in the cells cultured for 4 months.",OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  67for 4 months) obtained from the pooled cultured cells.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  68B, decreased by more than 31-fold in the differentiated RPE  cells.",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  69Table  2. s ele CTed uPRegula Ted geNes iN The diffe ReNTiaTed RPe Cells.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  70Gene Gene Name Biological Function p-value 4 Days 4 Months FC 4M/4D BEST1 Bestrophin 1 Electron transport 3.41E-04 0.30 13.06 44.01 CST3 Cystatin c Protease inhibitor 1.35E-04 66.06 2013.58 30.48 CDH3 Cadherin 3, P-Cadherin Cell adhesion 1.44E-03 0.02 0.50 24.83 CDH1 Cadherin E Cell adhesion 8.79E-05 0.04 0.57 13.23 RPE-related Transcription Factor TFEC Transcription Factor Transcriptional regulation 1.91E-07 0.08 4.63 57.88 SOX9 SRY -Box 9 Transcriptional regulation 1.21E-03 4.90 21.77 4.44 OTX2 Orthodenticle Homeobox 2 Sensory organ development.",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  71Table  3. s ele CTed dow NRegula Ted geNes iN The diffe ReNTiaTed RPe Cells.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  72 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  73To assess the effect of these increases in the mRNA  expression of the visual cycle genes on their respective  protein expression in the differentiated cells, we performed  western blot analysis.",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  74 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  75 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  76 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  77 Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  78shown in Figure 8A, the ARPE-19 cells cultured for 4 months  showed high expression of miR-204-5p and miR-211-5p.",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  79Protein network visualization shows functional associa - tions of differentially expressed genes:  Potential interactions  between the selected up- and downregulated differentially  expressed genes from the RPE cells cultured for 4 months and  4 days were examined through STRING to determine asso - ciations between the differentially expressed genes.,OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  80MITF ), we found these genes were highly expressed and even  at levels similar to those of the native RPE cells (Figure 11B),  corroborating the validity of the ARPE-19 cell differentiation  phenotype.",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  81protein expression.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  82 Figure 11.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  83particular, the expression of E-cadherin ( CDH1 ), a critical  inducer of epithelial morphogenesis, was highly increased in  the RPE cells cultured for 4 months compared with the cells  cultured for 4 days.",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  84cultured for 4 months, and the increase was translated to a  corresponding increase in the protein.",Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  85and play a critical role in maintaining epithelial barrier func - tion and cell physiology.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  863.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  87transcriptome and functional analysis.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  8854.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
Molecular Vision  2017; 23:60-89 <http://www.molvis.org/molvis/v 23/60> © 2017 Molecular Vision  8980.,Non-OADS,/arxiv_data1/oa_pdf/db/1e/mv-v23-60.PMC5360456.pdf
"In experimental diabetic retinopathy,  high salt intake also aggravated diabetes-induced retinal Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> Received 25 August 2016 | Accepted 16 March 2017 | Published 18 March 2017© 2017 Molecular Vision 116Osmotic regulation of NFAT5  expression in RPE cells: The  involvement of purinergic receptor signaling Margrit Hollborn,1 Sarah Fischer,1 Heidrun Kuhrt,2 Peter Wiedemann,1 Andreas Bringmann,1 Leon Kohen1,3 (The first two authors contributed equally to the work.)",Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  117alterations independently of changes in blood pressure [ 19].,Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  118sufficient quality.,Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
"Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  119Prism (GraphPad Software, San Diego, CA).",Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  120 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
"Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  121induces a release of growth factors like VEGF, bFGF, and  transforming growth factor β1 (TGF-β1) from RPE cells  [20,21].",Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
"Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  122adenosine is also extracellularly formed by dephosphoryla - tion of ATP, we tested ARL-67156 (an ecto-ATPase inhibitor  that blocks the conversion of ATP to ADP/AMP) and AOPCP  (an ectonucleotidase inhibitor that blocks the conversion of  AMP to adenosine).",Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
"Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  123DISCUSSION Systemic hypertension increases the risks of age-related  retinal neovascular diseases, such as diabetic retinopathy and  AMD [ 6,7,10-12].",Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  124 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
"Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  125induction and activation of NFAT5 and that the inhibition  of one pathway alone is not sufficient to fully abrogate the  hyperosmotic induction of NFAT5 [ 22,39,41-43].",Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  126A major mechanism of the induction of calcium  responses in osmotic stress is autocrine/paracrine activation  of purinergic signaling mediated by the osmo-/mechanosensi - tive release of ATP and subsequent activation of purinergic  receptors.,Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  127ectonucleotidase (which hydrolyzes AMP to adenosine) [ 52].,Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
"Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  128pressure–lowering minerals [ 57], have beneficial effects in  preventing age-related retinal diseases.",Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  129mouse model of diabetic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
Molecular Vision  2017; 23:116-130 <http://www.molvis.org/molvis/v 23/116> © 2017 Molecular Vision  13050.,Non-OADS,/arxiv_data1/oa_pdf/ad/fe/mv-v23-116.PMC5360457.pdf
Obtaining more information on people who are“lost to follow-up ”would also help understand how these barriers affect peoples' decisions to leave care and what motivates people to re-engage.EBioMedicine 17 (2017) 18 –19 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.01.036 .,Non-OADS,/arxiv_data1/oa_pdf/d9/96/main.PMC5360563.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.005 2352-3964/© 2017 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/d9/96/main.PMC5360563.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/96/main.PMC5360563.pdf
"13, 742 –750.EBioMedicine 17 (2017) 15 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.01.033 .",OADS,/arxiv_data1/oa_pdf/3e/2e/main.PMC5360564.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.008 2352-3964/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/3e/2e/main.PMC5360564.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/2e/main.PMC5360564.pdf
Published by Elsevier B.V. Thi s is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AcylcarnitinesCarnitineEnvironmental enteric dysfunctionFatty acid oxidationHippuratePolyphenolsTryptophan Urea cycle 1.,Non-OADS,/arxiv_data1/oa_pdf/24/7c/main.PMC5360565.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.01.026 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/24/7c/main.PMC5360565.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/7c/main.PMC5360565.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HIVPublic healthInterventionQualitativeSystematic review 1.,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.01.036 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
Public Health 105 (1):85 –90.http://dx.doi.org/10.2105/AJPH.,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/ 10.1016/S1473-3099(11)70181-5 (PubMed PMID: 22030332; PubMed Central PMCID: PMC4250825).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1371/journal.pone.0097353 PubMed PMID: 24828585; PubMed Central PMCID: PMCPmc4020856.,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1016/j.childyouth.2014.03.030 (PubMed PMID: WOS:000342549400016).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
17. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.3399/096016407782604820 (PubMed Central PMCID: PMC18252073).,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1089/AID.2013.0208 (PubMed PMID: 24401107; PubMed Central PMCID: PMCPMC4010172).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1080/13548506.2011.582125 (PubMed PMID: 21745024).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
Available from: http://www.casp-uk.net/wp- content/uploads/2011/11/CASP_Qualitative_Appraisal_Checklist_14oct10.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1097/QAD.0b013e328359b89b (PubMed PMID: 22948271).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1371/journal.pone.0089764 (PubMed PMID: 24646492; PubMed Central PMCID: PMCPmc3960101.,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1177/ 1049732315573204 (PubMed PMID: 25721715).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1521/aeap.2011.23.3_supp.117 (PubMed PMID: 21689042).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1097/QAD.0b013e3283578b9b (PubMed PMID: 22781227).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
17:19032. http://dx.doi.org/10.7448/IAS.17.1.19032 (PubMed PMID: 25095831; PubMed Central PMCID: PMC4122816).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
"Available from: http://cerqual.org/ whatisthecerqualapproach/ Hall, H.I., Frazier, E.L., Rhodes, P., Holtgrave, D.R., Furlow-Parmley, C., Tang, T., et al., 2013.",Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/ 10.1001/jamainternmed.2013.6841 (PubMed PMID: 23780395).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1080/ 17290376.2011.9725001 (PubMed PMID: WOS:000305254600002).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1080/15381501.2012.678132 (PubMed PMID: 2011557850.,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1371/ journal.pmed.1001895 (PubMed PMID: 26506244; PubMed Central PMCID: PMCPMC4624425).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
19 (1):21166. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1016/ j.cbpra.2013.10.002 (PubMed PMID: 25419102; PubMed Central PMCID: PMC4238929).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1111/j.1365-3156.2008.02170.x (PubMed PMID: 19000156).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
Health 15:48 –54.http://dx.doi.org/10.1111/j.1365-3156.2010.02514.x (PubMed PMID: WOS:000277205500004).,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1371/ journal.pmed.0030438 (PubMed PMID: 17121449; PubMed Central PMCID: PMC1637123).170 J.D.,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1007/s11524-010-9496-7 (PubMed PMID: 21046470; PubMed Central PMCID: PMC3005089).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1007/s11904-014-0233-9 (PubMed PMID: 25323298).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1007/s10461-011-9942-x (PubMed PMID: 21468660).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
Lancet http://dx.doi.org/10.1016/S0140- 6736(15)60658-4 (PubMed PMID: 26117719).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1080/15381501.,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
"http://dx.doi.org/10.1177/1545109712469686 (PubMed PMID: 23418205).Shrou ﬁ, A., Mafara, E., Saint-Sauveur, J.F., Taziwa, F., Vinoles, M.C., 2013.",Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1097/01.aids.0000327637.59672.02 (PubMed PMID: 18664948).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
8:45. http://dx.doi.org/10.1186/1471- 2288-8-45 .,Non-OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
12:181. http://dx.doi.org/10.1186/1471-2288-12-181 (PubMed PMID: 23185978; PubMed Central PMCID: PMC3552766).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1186/s12939-014-0060-z (PubMed PMID: 25078612; PubMed Central PMCID: PMCPMC4448289).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
"AIDS(London, England) http://dx.doi.org/10.1097/QAD.0000000000001101 (PubMed PMID: 27058350).",OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1080/13548500500159430 (PubMed PMID: 17129905).,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
http://dx.doi.org/10.1007/s10508-015-0501-9 (PubMed PMID: 25917411).171 J.D.,OADS,/arxiv_data1/oa_pdf/f9/e8/main.PMC5360566.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Zika virus vaccineFlavivirus NS1Flavivirus assembly 1.,Non-OADS,/arxiv_data1/oa_pdf/7e/ac/main.PMC5360567.pdf
The World Health organization ( http://www.who.int/emergencies/ zika-virus/situation-report/6-october-2016/en/ ) has reported over 73 countries and territories with active ZIKV outbreaks/epidemics.,Non-OADS,/arxiv_data1/oa_pdf/7e/ac/main.PMC5360567.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.003 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/ac/main.PMC5360567.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/ac/main.PMC5360567.pdf
These frontrunners are currently in phase I clinical trial ( https://clinicaltrials.gov ).,Non-OADS,/arxiv_data1/oa_pdf/7e/ac/main.PMC5360567.pdf
currently in phase I clinical trials ( https://clinicaltrials.gov ).,Non-OADS,/arxiv_data1/oa_pdf/7e/ac/main.PMC5360567.pdf
"A PIV using ZIKV strain PRVABC59 completely protects rhesus macaques from ZIKV challenge (Abbink et al., 2016 ), and is currently undergoing a phase I clinical trial ( https://clinicaltrials.gov ).",Non-OADS,/arxiv_data1/oa_pdf/7e/ac/main.PMC5360567.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Febrile seizuresTransgenerationSeizure susceptibility DNA methylation 1.,Non-OADS,/arxiv_data1/oa_pdf/45/ad/main.PMC5360568.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.006 2352-3964/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/45/ad/main.PMC5360568.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/ad/main.PMC5360568.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Diphtheria-tetanus-pertussis vaccineDTPMeasles vaccineNon-speci ﬁc effects of vaccines Oral polio vaccine 1.,Non-OADS,/arxiv_data1/oa_pdf/36/a1/main.PMC5360569.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.01.041 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/36/a1/main.PMC5360569.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/a1/main.PMC5360569.pdf
"http://www.who.int/ immunization/sage/meetings/2014/april (accessed June 1, 2014).",Non-OADS,/arxiv_data1/oa_pdf/36/a1/main.PMC5360569.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Idiopathic fatal pulmonary embolismWhole exome sequencingSevere thrombophilia Natural anticoagulant de ﬁciency 1.,Non-OADS,/arxiv_data1/oa_pdf/da/0a/main.PMC5360570.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.01.037 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/da/0a/main.PMC5360570.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/0a/main.PMC5360570.pdf
"Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA (URL: http://evs.gs.washington.edu/EVS/ ) [December, 2016 accessed].",OADS,/arxiv_data1/oa_pdf/da/0a/main.PMC5360570.pdf
https://www.ncbi.nlm.nih.gov/clinvar/variation/18010/ .,OADS,/arxiv_data1/oa_pdf/da/0a/main.PMC5360570.pdf
https://www.ncbi.nlm.nih.gov/clinvar/variation/188092/ .,Non-OADS,/arxiv_data1/oa_pdf/da/0a/main.PMC5360570.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AllergyAsthma Immunoadsorption IgEnioIgEEBioMedicine 17 (2017) 119 –133 Abbreviations: AUC, area under the curve; AV, visit of apheresis group; BAT, basophil activation-testing; CV, visit of control group; IC, informed consent; IgE, imm unoglobulin E; pt./pts., patient/s; SD, standard deviation; VAS, visual analogue scale.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5360571.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.007 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5360571.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5360571.pdf
http://www.sign.ac.uk/pdf/sign101.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5360571.pdf
http://www.versorgungsleitlinien.de/themen/asthma .,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5360571.pdf
http://www.ema.europa.eu .,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5360571.pdf
https://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5360571.pdf
http://www.iso.org .,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5360571.pdf
http://www.ginasthma.com/ download.asp?intId=309 .,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5360571.pdf
http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5360571.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PR3-ANCA associated vasculitisGranulomatosis with Polyangiitis Glycosylation GlycopeptideImmunoglobulinMass spectrometry 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/78/main.PMC5360573.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.01.033 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/78/main.PMC5360573.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/78/main.PMC5360573.pdf
Available from: http://www.ccmo.nl/en/non- wmo-research .,Non-OADS,/arxiv_data1/oa_pdf/d8/78/main.PMC5360573.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: DietNutritionDepressionPsychosisMental disorder Neurodevelopment NeurodegenerativeNutraceuticalPreventionTreatment Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/b4/51/main.PMC5360575.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.020 2352-3964/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/b4/51/main.PMC5360575.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/51/main.PMC5360575.pdf
Neurosci.http://dx.doi.org/10.1179/1476830515y.0000000043 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/b4/51/main.PMC5360575.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.018 2352-3964/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/04/0f/main.PMC5360576.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/0f/main.PMC5360576.pdf
"There is great interest in seeing if the observed association of secondary carnitine de ﬁciency with EED receives independent con ﬁrmation using other geographically distinct populations, and ideally, with a longitudinal study that also evaluatesEBioMedicine 17 (2017) 9 –10 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.01.026 .",Non-OADS,/arxiv_data1/oa_pdf/02/ec/main.PMC5360577.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.014 2352-3964/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/02/ec/main.PMC5360577.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/ec/main.PMC5360577.pdf
:1 –9http://dx.doi.org/10.1038/srep28009 .,OADS,/arxiv_data1/oa_pdf/02/ec/main.PMC5360577.pdf
http://dx.doi.org/10.1097/MPG.,Non-OADS,/arxiv_data1/oa_pdf/02/ec/main.PMC5360577.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Infectious diseaseInﬂuenza Human rhinovirusProteomicsDiagnostic biomarker 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/2d/main.PMC5360578.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.015 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/2d/main.PMC5360578.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/2d/main.PMC5360578.pdf
Compu- tational scripts were written in MATLAB using the GLmnet toolbox (web.stanford.edu/~hastie/glmnet_matlab/ ) and can be accessed at https://bitbucket.org/rhenao/npl_ebm .,OADS,/arxiv_data1/oa_pdf/6d/2d/main.PMC5360578.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PharmacogeneticsCYP450Genetic diversityDrug metabolismAfricaDrug development 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
"Single nucleotide polymorphisms (SNPs) in CYPgenes have been extensively reported (Fujikara et al., 2015 ) with over 400 allelic variants recorded across the CYP1, CYP2, and CYP3 sub-families (The human cytochrome P450 allele nomenclature database http://cypalleles.ki.se/ accessed 28 October 2016).",OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.017 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
"CYP2B6*6 CYP2B6 is involved in the metabolism of numerous therapeutic drugs including antiretrovirals (efavirenz, nevirapine), chemotherapeu- tics (cyclophosphamide), antidepressants (bupropion), and analgesics (ketamine, methadone; Flockhart Table ™http://medicine.iupui.edu/ CLINPHARM/ddis/main-table accessed 28 October 2016 ).CYP2B6*6 is a decreased function allele and has been reported at very high frequen- cies of 66 –68% in Uganda and Zimbabwe (Supplemental Table 1, Table 2), which is approximately tenfold higher than the reported frequency in South Africa (mixed ancestry; 9%; Supplemental Table 1, Table 2 ).",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
"Sub-Saharan Africa accounts for two-thirds of the global total of new HIV infections, with 25.6 million individuals living with HIV in 2015 (World Health Organization HIV/ AIDS Fact Sheet http://www.who.int/mediacentre/factsheets/fs360/en/ accessed 28 October 2016).",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
"amodiaquine; Li et al., 2002 ), the anti-cancer drug paclitaxel, and the anti-tuberculosis drug rifampicin (Flockhart Table ™http://medicine.iupui.edu/ CLINPHARM/ddis/main-table accessed 28 October 2016).",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
"CYP2D6*3, CYP2D6*17 and CYP2D6*29 CYP2D6 is involved in the metabolism of N25% of registered drugs; the major classes are antidepressants, β-blockers, antipsychotics, and antiarrhythmics (Flockhart Table ™ http://medicine.iupui.edu/ CLINPHARM/ddis/main-table accessed 28 October 2016).",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
CPIC guidelines and dosage guidelines published by the Royal Dutch Association for the Advancement of Pharmacy – Pharmacogenetics Working Group are freely available and can be accessed via The Pharmacogenomic Knowledgebase (PharmGKB; https://www.pharmgkb.org/view/dosing-guidelines.do?source=CPICaccessed 15 December 2016).,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
"CYP3A5*6 and CYP3A5*7 CYP3A5 is involved in the metabolism of antimalarials, antiretrovirals, and immunosuppressants (Flockhart Table ™http://medicine.iupui.edu/ CLINPHARM/ddis/main-table accessed 28 October 2016).",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
http://dx.doi.org/10.1002/cpt.,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
http://dx.doi.org/10.1038/gim.2016.87 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
"National Center for Biotechnology Information (US); 2012, Bethesda (MD) Internet.Available from: https://www.ncbi.nlm.nih.gov/books/NBK61999/ .",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
http://dx.doi.org/10.1002/cpt.597 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
http://dx.doi.org/ 10.1038/gim.2016.33 .,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
http://dx.doi.org/10.1038/gim.2016.105 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
Pharmacogenomics J. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/main.PMC5360579.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: Plasmalogen ScallopAlzheimer's diseaseMild cognitive impairmentCognitive function 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/c9/main.PMC5360580.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.012 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/c9/main.PMC5360580.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/c9/main.PMC5360580.pdf
"Alzheimer's Disease International, London Avail- able from: https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf .",Non-OADS,/arxiv_data1/oa_pdf/6f/c9/main.PMC5360580.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Antithrombin III Acute kidney injury Contrast induced nephropathyInﬂammation 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/80/main.PMC5360582.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.009 2352-3964/© 2017 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/9f/80/main.PMC5360582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/80/main.PMC5360582.pdf
http://dx.doi.org/10.1042/CS20160669 (epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/9f/80/main.PMC5360582.pdf
There are otherEBioMedicine 17 (2017) 13 –14 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.01.037 .,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.016 2352-3964/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
http://dx.doi.org/10.1016/j.ebiom.,OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
http://dx.doi.org/10.1182/blood-2008- 10-184879 (Epub 2009 Jan 12).,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
http://dx.doi.org/10.1182/blood-2012-01-406207 .,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
http://dx.doi.org/10.1111/jth.13372 .,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
http://dx.doi.org/10.1111/j.1538-7836.2009.03394.x.,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
http://dx.doi.org/10.1371/journal.pone.0154751 .,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
http://dx.doi.org/10.1161/circulationaha.110.976134 .14 I. Martínez-Martínez / EBioMedicine 17 (2017) 13 –14,Non-OADS,/arxiv_data1/oa_pdf/3c/49/main.PMC5360584.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cancer-associated ﬁbroblast Cytokines Intermediate metaboliteAutophagyTumor relapseRadiation therapy 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/a2/main.PMC5360585.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.019 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/a2/main.PMC5360585.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/a2/main.PMC5360585.pdf
The choice of a limited number of seed regions is both a weaknessEBioMedicine 17 (2017) 20 –21 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.02.010 .,Non-OADS,/arxiv_data1/oa_pdf/7f/87/main.PMC5360586.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.028 2352-3964/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/7f/87/main.PMC5360586.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/87/main.PMC5360586.pdf
address by a different approach the limit of too high total IgE levels or body massEBioMedicine 17 (2017) 16 –17 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.02.007 .,Non-OADS,/arxiv_data1/oa_pdf/5d/ad/main.PMC5360587.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.023 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/ad/main.PMC5360587.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/ad/main.PMC5360587.pdf
"It is hoped that a multi-center consortium approach will allow researchers not only to image thehealthy brain to arrive at a “gold standard ”—another factor sorely lacking when compared to, say, a normal range of hemoglobin A1c levels inEBioMedicine 17 (2017) 1 –2 http://dx.doi.org/10.1016/j.ebiom.2017.03.015 2352-3964/© 2017 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/94/fe/main.PMC5360588.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Zika virus Dengue virusFlavivirus diagnosisSerologic assayNeutralization assay 1.,Non-OADS,/arxiv_data1/oa_pdf/04/48/main.PMC5360589.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.03.006 2352-3964/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/04/48/main.PMC5360589.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/48/main.PMC5360589.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Inﬂuenza A virus Human monoclonal antibody HA stemBroadly reactive 1.,Non-OADS,/arxiv_data1/oa_pdf/4a/cd/main.PMC5360590.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.03.007 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/cd/main.PMC5360590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/cd/main.PMC5360590.pdf
Determined nu- cleotide sequences were analyzed and compared to sequences in the National Center for Biotechnology Information (NCBI) database by using the IgBlast software ( http://www.ncbi.nlm.nih.gov/igblast/ ).,OADS,/arxiv_data1/oa_pdf/4a/cd/main.PMC5360590.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Head and neck squamous cell carcinoma etiological subtypesCpG island methylator phenotypeMulti-omics data analysisantiviral gene signature 1.,Non-OADS,/arxiv_data1/oa_pdf/38/3b/main.PMC5360591.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.025 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/3b/main.PMC5360591.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/3b/main.PMC5360591.pdf
:1 –9http://dx.doi.org/10.1136/annrheumdis-2014-205303 .,Non-OADS,/arxiv_data1/oa_pdf/38/3b/main.PMC5360591.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/3b/main.PMC5360591.pdf
http://dx.doi.org/10.1002/0471142905.hg1011s57 .,Non-OADS,/arxiv_data1/oa_pdf/38/3b/main.PMC5360591.pdf
:1 –13http://dx.doi.org/10.1186/ s13059-014-0579-8 .,Non-OADS,/arxiv_data1/oa_pdf/38/3b/main.PMC5360591.pdf
:1 –11http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/3b/main.PMC5360591.pdf
Methods:1 –10http://dx.doi.org/10.1038/nmeth.3337 .,OADS,/arxiv_data1/oa_pdf/38/3b/main.PMC5360591.pdf
Here we introduce the camcAPP ( http://bioinformatics.cruk.cam.ac.,Non-OADS,/arxiv_data1/oa_pdf/d3/44/main.PMC5360593.pdf
"The interface was created with Shiny ( https://www.rstudio.com/products/shiny/ ), and allows the non- specialist Bioinformatician to create publication-ready ﬁgures and ta- bles through an intuitive interface to the underlying computer code.",OADS,/arxiv_data1/oa_pdf/d3/44/main.PMC5360593.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.022 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/44/main.PMC5360593.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/44/main.PMC5360593.pdf
The Scientist http://www.the-scientist.com/?articles.,Non-OADS,/arxiv_data1/oa_pdf/d3/44/main.PMC5360593.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.022 .,OADS,/arxiv_data1/oa_pdf/d3/44/main.PMC5360593.pdf
http://dx.doi.org/10.1016/j.ebiom.,OADS,/arxiv_data1/oa_pdf/d3/44/main.PMC5360593.pdf
"This is in line with previous studies demonstrating a down-regulation of NPRA mRNA and protein level in fat tissue and skeletal muscle in obesity and T2D both in humans and mice ( Coue et al., 2015; Ryden et al.,EBioMedicine 17 (2017) 11 –12 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.02.026 .",Non-OADS,/arxiv_data1/oa_pdf/59/22/main.PMC5360594.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.03.005 2352-3964/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/59/22/main.PMC5360594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/22/main.PMC5360594.pdf
"More- over, the addition of vitamin C, a required co-factor for TET enzyme based DNA demethylation provides a synergistic effect of 5-Aza-CdREBioMedicine 17 (2017) 22 –23 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.02.025 .",Non-OADS,/arxiv_data1/oa_pdf/30/b6/main.PMC5360595.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.03.008 2352-3964/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/30/b6/main.PMC5360595.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/b6/main.PMC5360595.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ProANP Insulin resistanceMetabolismHyperglycemiaPrediabetes 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/43/main.PMC5360596.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.026 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/43/main.PMC5360596.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/43/main.PMC5360596.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Amphiregulin Epithelial growth factor Experimental myopiaAxial elongationMyopia 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/36/main.PMC5360597.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.02.021 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/36/main.PMC5360597.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/36/main.PMC5360597.pdf
Retina http://dx.doi.org/10.1097/IAE.,Non-OADS,/arxiv_data1/oa_pdf/ff/36/main.PMC5360597.pdf
http://dx.doi.org/10.1136/ bjophthalmol-2015-307724 (pii: bjophthalmol-2015-307724; Epub ahead of print; 2016 Jan 22).,Non-OADS,/arxiv_data1/oa_pdf/ff/36/main.PMC5360597.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Sandro Contini, MD, Professor,  Department  of Surgical Sciences, University of Parma, Strada S. Eurosia 45/B,  43123 Parma, Italy.",Non-OADS,/arxiv_data1/oa_pdf/de/aa/WJG-23-1925.PMC5360633.pdf
"The most serious complication is typhoid  intestinal perforation (TIP), observed in 0.8% to 39%,  with a striking rate difference between high-income and EDITORIAL 1925 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.1925World J Gastroenterol   2017 March 21; 23(11): 1925-1931  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/de/aa/WJG-23-1925.PMC5360633.pdf
World J Gastroenterol  2017;  23(11): 1925-1931  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/de/aa/WJG-23-1925.PMC5360633.pdf
com/1007-9327/full/v23/i11/1925.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/aa/WJG-23-1925.PMC5360633.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/de/aa/WJG-23-1925.PMC5360633.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Gary C Chen, MD,  Comprehensive  Digestive Institute of Nevada, 8530 West Sunset Road, Suite 230,  Las Vegas, NV 89113,  United States.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"garychen@nevadagastro.com Telephone:  +1-702-4834483 Fax:  +1-702-4834493 Received:  November 23, 2016 Peer-review started:  November 25, 2016 First decision:  December 19, 2016 Revised:  January 5, 2017 Accepted:  February 17, 2017 Article in press:  February 17, 2017 Published online: March 21, 2017 Abstract Biologic therapy, such as those that target tumor REVIEW 1932 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.1932World J Gastroenterol   2017 March 21; 23(11): 1932-1943  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
World J Gastroenterol  2017; 23(11): 1932-1943  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i11/1932.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i11.1932 INTRODUCTION There are two conditions that mainly characterize  inflammatory bowel disease (IBD): ulcerative colitis  (UC) and Crohn’s disease (CD).,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
CCFA 2016 [cited  2016-11-15]; Available from: URL: http://www.ccfa.org/news/ Stelara.html 14 European Medicines Agency .,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"Available from: URL: http://www.fda.gov/downloads/ DrugsGuidanceComplianceRegulatoryInformation/Guidances/ UCM291128.pdf 16 Kuhlmann M , Covic A.",OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"Janssen Biotech, Inc.2016 [cited 2016-04-02];  Available from: URL: http://www.remicade.com/hcp/crohns- disease/dosing 21 Committee for Medicinal Products for Human Use .",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
Available from: URL: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2015/01/WC500180219.,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"2009 Available from: URL: http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/ ucm216146.pdf 23 Alten R , Cronstein BN.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"Heal Gastroenterol  2016  Available from: URL: http://www.healio.com/gastroenterology/ inflammatory-bowel-disease/news/print/healio-gastroenterology/ {f37035aa-1129-42cd-beff-eeb8b3b220e5}/the-arrival-of-biosimilar-therapies 25 Al-Sabbagh A , Olech E, Mcclellan JE, Kirchhoff CF.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
2003: 1-14 Available from: URL: http://users.wfu.edu/mcfallta/ DIR0/pharma_patents.pdf 28 U.S. Food and Drug Administration .,OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"2016 Available  from: URL: http://www.amgen.com/media/news-releases/2016/09/ fda-approves-amgens-amjevita-adalimumabatto-for-treatment-of- seven-inflammatory-diseases/ 30 Shih DQ , Targan SR.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
2013 Available from: URL: http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Summary_for_the_public/ human/002576/WC500150872.pdf 36 Le J .,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"Merck Man  2016 Available  from: URL: http://www.merckmanuals.com/professional/clinical- pharmacology/pharmacokinetics/overview-of-pharmacokinetics 37 Zhao L , Ren TH, Wang DD.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
ASPE  Issue Br  2016 1-16 Available from: URL: https://aspe.hhs.gov/ sites/default/files/pdf/187586/Drugspending.pdf 48 Abo T .,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
IMS Heal  2011; 1-7 Available from: URL:  http://weinberggroup.com/pdfs/Shaping_the_biosimiliars_opportu nity_A_global_perspective_on_the_evolving_biosimiliars_landsca pe.pdf 53 U.S. Food and Drug Administration .,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
Forbes   2014 Available from: URL: http://www.forbes.com/sites/ realspin/2014/08/08/biosimilars-can-save-lives-and-cost-less/ #149e456d3b2f 55 Miller S .,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"Express  Scripts  2013: 1-3 Available from: URL: http://lab.express- scripts.com/speciality-medications/the-250-billion-potential-of- biosimilars/n 56 Putrik P , Ramiro S, Kvien TK, Sokka T, Pavlova M, Uhlig T,  Boonen A. Inequities in access to biologic and synthetic DMARDs  across 46 European countries.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
Heal Canada  2015 Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/ prodpharma/sbd-smd/drug-med/sbd_smd_2014_remsima_160195- eng.php 65 U.S. Food and Drug Administration .,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
2016 Available from: URL: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
2009: 19-23  Available from: URL: http://www.who.int/biologicals/areas/ biological_therapeutics/BIOTHERAPEUTICS_FOR_WEB_22AP RIL2010.pdf 67 Biosimilar switching not suitable for all patients.,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"London,  United Kingdom: 2016 Available from: URL: http://www.eular.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
2016 Available from:  URL: http://www.prnewswire.com/news-releases/prometheus- diagnostic-test-validated-in-anticipation-of-us-healthcare-provider-Zheng MK et al.,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"Genet Eng News  2006; 26: 9-10 Available  from: URL: http://www.sutherland.com/portalresource/ lookup/poid/Z1tOl9NPluKPtDNIqLMRV56Pab6TfzcRXnc  KbDtRr9tObDdEuSpCp0!/fileUpload.name=/UPDATEDGEN  legal-warren-final21.pdf 72 Wang J , Chow SC.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
RAND Corp   2014 Available from: URL: https://www.rand.org/content/dam/ rand/pubs/perspectives/PE100/PE127/RAND_PE127.pdf 74 U.S. Food and Drug Administration .,OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"Available from: URL: http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/HowDrugsareDevelopedand  Approved/ApprovalApplications/TherapeuticBiologic  Applications/Biosimilars/ucm241719.htm 75 Blackstone EA , Fuhr JP.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"Natl Conf State Legis   2016 Available from: URL: http://www.ncsl.org/research/health/ state-laws-and-legislation-related-to-biologic-medications-and- substitution-of-biosimilars.aspx 77 Reinisch W , Smolen J. Biosimilar safety factors in clinical  practice.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
2013 Available from: URL: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"Bus Wire  2015 Available from: URL:  http://www.businesswire.com/news/home/20150518006521/en/ Celltrion-Healthcare-Patients-feel-benefit-biosimilar-infliximab 84 Jahnsen J , Detlie TE, Vatn S, Ricanek P. Biosimilar infliximab  (CT-P13) in the treatment of inflammatory bowel disease: A  Norwegian observational study.",OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
Bus Wire  2016  Available from: URL: http://www.businesswire.com/news/ home/20161114005543/en/Celltrion-Healthcare-Showcases-Data- Supporting-Efficacy-Safety 90 Biogen .,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"2016 Available  from: URL: http://media.biogen.com/press-release/biosimilars/ flixabi-biogens-infliximab-biosimilar-referencing-remicade- approved-europe 91 Choe JY , Prodanovic N, Niebrzydowski J, Staykov I, Dokoupilova  E, Baranauskaite A, Yatsyshyn R, Mekic M, Porawska W, Ciferska  H, Jedrychowicz-Rosiak K, Zielinska A, Choi J, Rho YH, Smolen  JS.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"Novartis  2016 Available  from: URL: https://www.novartis.com/news/media-releases/ sandoz-strengthens-its-biosimilars-portfolio-acquisition-pfizers- biosimilar 93 Udata C , Hua SY , Yin D, Salts S, Meng X, Rehman MI.",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
2014 Available from: URL:  http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol- newsArticle&ID=1975377 100 PR Newswire .,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
2014 Available from: URL: http://www.prnewswire.,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT02660580 103 Silver S .,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
Available from: URL: https://securingalpha.files.wordpress.,Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/17/b3/WJG-23-1932.PMC5360634.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Hiroshi Nakase,  Department of  Gastroenterology and Hepatology, Sapporo Medical University  School of Medicine, Minami 1-jo Nishi 16-chome, Chuo-ku,  Sapporo, Hokkaido 060-8556, Japan.",Non-OADS,/arxiv_data1/oa_pdf/7c/56/WJG-23-1944.PMC5360635.pdf
"REVIEW 1944 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.1944World J Gastroenterol   2017 March 21; 23(11): 1944-1953  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/7c/56/WJG-23-1944.PMC5360635.pdf
"World J  Gastroenterol  2017; 23(11): 1944-1953  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i11/1944.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i11.1944 INTRODUCTION Inflammatory bowel disease (IBD) is a chronic in­ flammatory disease involving idiopathic inflammation,  mainly in the gastrointestinal tract; defined more  specifically, it comprises ulcerative colitis (UC) and  Crohn’s disease (CD).",Non-OADS,/arxiv_data1/oa_pdf/7c/56/WJG-23-1944.PMC5360635.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/7c/56/WJG-23-1944.PMC5360635.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Wai K Leung, MD,  Department of  Medicine, The University of Hong Kong, Queen Mary Hospital,  102 Pokfulam Road, Hong Kong, China.",Non-OADS,/arxiv_data1/oa_pdf/b3/06/WJG-23-1954.PMC5360636.pdf
"waikleung@hku.h k Telephone:  +852-22553348 Fax:  +852-28162863 Received:  December 13, 2016 Peer-review started:  December 14, 2016 First decision:  December 28, 2016 Revised:  January 18, 2017 Accepted:  March 2, 2017 Article in press:  March 2, 2017 Published online: March 21, 2017REVIEW 1954 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.1954World J Gastroenterol   2017 March 21; 23(11): 1954-1963  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/b3/06/WJG-23-1954.PMC5360636.pdf
"World J Gastroenterol  2017; 23(11): 1954-1963  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i11/1954.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i11.1954 INTRODUCTION Novel oral anticoagulants (NOACs) include direct  thrombin inhibitor (dabigatran) and direct factor Xa  inhibitors (rivaroxaban, apixaban and edoxaban)  are increasingly favored over conventional oral anti­ coagulants such as warfarin.",Non-OADS,/arxiv_data1/oa_pdf/b3/06/WJG-23-1954.PMC5360636.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/b3/06/WJG-23-1954.PMC5360636.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Pei-Yuan Li, Associate Professor,   Division of Gastroenterology, Tongji Hospital, Tongji Medical  College, Huazhong University of Science and Technology, 1095  Jiefang Ave, Wuhan 430030, Hubei Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/8d/fc/WJG-23-1964.PMC5360637.pdf
"pyli@tjh.tjmu.edu.c n  Telephone:  +86­27­83663661 Fax:  +86­27­83663661  Received:  November 14, 2016 Peer-review started:  November 17, 2016 First decision:  December 2, 2016 Revised:  December 23, 2016 Accepted:  January 18, 2017 Article in press:  January 18, 2017 Published online: March 21, 2017REVIEW 1964 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.1964World J Gastroenterol   2017 March 21; 23(11): 1964-1973  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/8d/fc/WJG-23-1964.PMC5360637.pdf
World J Gastroenterol  2017;  23(11): 1964 ­1973  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/8d/fc/WJG-23-1964.PMC5360637.pdf
com/1007 ­9327/full/v23/i11/1964.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/fc/WJG-23-1964.PMC5360637.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/8d/fc/WJG-23-1964.PMC5360637.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Toshio Miki, MD, PhD, Assistant  Professor  of Research, Department of Surgery, Keck School of  Medicine, University of Southern California 2011 Zonal Avenue,  HMR 509A, Los Angeles, CA 90033,  United States.",Non-OADS,/arxiv_data1/oa_pdf/2b/7d/WJG-23-1974.PMC5360638.pdf
"toshiomi@usc.edu Telephone:  +1-323-4427703 Fax:  +1-323-4424040 Received:  August 4, 2016 Peer­review started:  August 5, 2016 First decision:  November 21, 2016 Revised:  December 2, 2016 Accepted:  January 11, 2017 Article in press:  January 11, 2017MINIREVIEWS 1974 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.1974World J Gastroenterol   2017 March 21; 23(11): 1974-1979  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/2b/7d/WJG-23-1974.PMC5360638.pdf
World J Gastroenterol  2017; 23(11): 1974-1979   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i11/1974.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/2b/7d/WJG-23-1974.PMC5360638.pdf
Available from: URL:  http://www.unos.org/data/ 5 Mito M .,OADS,/arxiv_data1/oa_pdf/2b/7d/WJG-23-1974.PMC5360638.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/2b/7d/WJG-23-1974.PMC5360638.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to: Javier Andres Bustamante-Rengifo,  MSc, PhD,  Department of Microbiology, School of Basic  Science, Universidad del Valle, Street 4B N 0 36-00, Building 116,  Floor 5, Cali 760043,  Colombia.",Non-OADS,/arxiv_data1/oa_pdf/2e/bb/WJG-23-1980.PMC5360639.pdf
"Of the par - 1980 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Effect of treatment failure on the CagA EPIYA motif in  Helicobacter pylori  strains from Colombian subjectsBasic Study Javier Andres Bustamante-Rengifo, Andres Jenuer Matta, Alvaro Jairo Pazos, Luis Eduardo BravoSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.1980World J Gastroenterol   2017 March 21; 23(11): 1980-1989  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/2e/bb/WJG-23-1980.PMC5360639.pdf
wjgnet.com/1007-9327/full/v23/i11/1980.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/bb/WJG-23-1980.PMC5360639.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/2e/bb/WJG-23-1980.PMC5360639.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Yi Wang, MD,  Department of Radiology,  Peking University People’s Hospital, 11 Xizhimen South St.,  Beijing 100044, China.",Non-OADS,/arxiv_data1/oa_pdf/08/05/WJG-23-1990.PMC5360640.pdf
"1990 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Chemotherapy response evaluation in a mouse model of  gastric cancer using intravoxel incoherent motion diffusion- weighted MRI and histopathologyBasic Study Jin Cheng, Yi Wang, Chun-Fang Zhang, He Wang, Wei-Zhen Wu, Feng Pan, Nan Hong, Jie DengSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.1990World J Gastroenterol   2017 March 21; 23(11): 1990-2001  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/08/05/WJG-23-1990.PMC5360640.pdf
World J Gastroenterol  2017;  23(11): 1990-2001  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/08/05/WJG-23-1990.PMC5360640.pdf
com/1007-9327/full/v23/i11/1990.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/05/WJG-23-1990.PMC5360640.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/08/05/WJG-23-1990.PMC5360640.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Li-Juan Huo, MD,  Department of  Gastroenterology, First Hospital of Shanxi Medical University,  85 South JieFang Road, Taiyuan 030001, Shanxi Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/19/14/WJG-23-2002.PMC5360641.pdf
"Expression of Nrf2 nuclear protein was low in the   2002 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Antioxidant axis Nrf2-keap1-ARE in inhibition of alcoholic  liver fibrosis by IL-22Basic Study Ya-Hui Ni, Li-Juan Huo, Ting-Ting LiSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2002World J Gastroenterol   2017 March 21; 23(11): 2002-2011  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/19/14/WJG-23-2002.PMC5360641.pdf
"World J  Gastroenterol  2017; 23(11): 2002-2011  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i11/2002.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i11.2002 INTRODUCTION Alcoholic liver fibrosis (ALF) is a wound-healing  response to prolonged alcoholic liver injury, which  is characterized by excessive extracellular matrix  accumulation.",Non-OADS,/arxiv_data1/oa_pdf/19/14/WJG-23-2002.PMC5360641.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/19/14/WJG-23-2002.PMC5360641.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscriptCorrespondence to: Dr. Yao Lin, Professor,  College of Life  Sciences, Fujian Normal University, Qishan Campus, Fuzhou  350108, Fujian Province, China.",Non-OADS,/arxiv_data1/oa_pdf/6e/39/WJG-23-2012.PMC5360642.pdf
"RESULTS The expression of CRM1 was significantly related to  size of primary tumor ( P = 0.005), Borrmann type ( P  = 0.006), degree of differentiation ( P = 0.004), depth  of invasion ( P = 0.008), lymph node metastasis ( P =  0.013), TNM stage  (P = 0.002)  and distant metastasis   2012 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Expression of CRM1 and CDK5 shows high prognostic  accuracy for gastric cancerBasic Study Yu-Qin Sun, Jian-Wei Xie, Hong-Teng Xie, Peng-Chen Chen, Xiu-Li Zhang, Chao-Hui Zheng, Ping Li,  Jia-Bin Wang, Jian-Xian Lin, Long-Long Cao, Chang-Ming Huang, Yao LinSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2012World J Gastroenterol   2017 March 21; 23(11): 2012-2022  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/6e/39/WJG-23-2012.PMC5360642.pdf
World J Gastroenterol  2017; 23(11): 2012-2022   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i11/2012.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/6e/39/WJG-23-2012.PMC5360642.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/6e/39/WJG-23-2012.PMC5360642.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Animesh Jain, MD,  Division of Gastro - enterology and Hepatology, Department of Internal Medicine,  University of North Carolina Chapel Hill, 130 Mason Farm  Road, Campus Box 7080, Chapel Hill, NC 27599-7080,  United States.",Non-OADS,/arxiv_data1/oa_pdf/03/ce/WJG-23-2023.PMC5360643.pdf
"METHODS We retrospectively reviewed all patients at our center  2023 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Colonic ulcerations may predict steroid-refractory course in  patients with ipilimumab-mediated enterocolitisRetrospective Cohort Study Animesh Jain, Evan J Lipson, William H Sharfman, Steven R Brant, Mark G LazarevSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2023World J Gastroenterol   2017 March 21; 23(11): 2023-2028  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/03/ce/WJG-23-2023.PMC5360643.pdf
"World J  Gastroenterol  2017; 23(11): 2023-2028  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i11/2023.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i11.2023INTRODUCTION Ipilimumab (YervoyTM, Bristol-Myers Squibb, Princeton,  NJ, United States) is a first-in-class monoclonal  antibody that blocks the immune regulatory molecule  cytotoxic T-lymphocyte antigen-4 (CTLA-4), resulting  in T-cell activation.",Non-OADS,/arxiv_data1/oa_pdf/03/ce/WJG-23-2023.PMC5360643.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/03/ce/WJG-23-2023.PMC5360643.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Anne-Marie Leroi, MD, PhD,  INSERM  U1073, Service de Physiologie Digestive, CHU Rouen, 1 rue de  Germont, F-76000 Rouen, France.",Non-OADS,/arxiv_data1/oa_pdf/46/54/WJG-23-2029.PMC5360644.pdf
"Predictive factors of compliance with TAI  were based on pretreatment assessments and training  2029 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Predictive factors for compliance with transanal irrigation  for the treatment of defecation disordersRetrospective Cohort Study Clémence Bildstein, Chloé Melchior, Guillaume Gourcerol, Estelle Boueyre, Valérie Bridoux, Eric Vérin,  Anne-Marie LeroiSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2029World J Gastroenterol   2017 March 21; 23(11): 2029-2036  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/46/54/WJG-23-2029.PMC5360644.pdf
"World J Gastroenterol  2017; 23(11): 2029-2036  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i11/2029.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i11.2029 INTRODUCTION Chronic constipation and fecal incontinence (FI) are  common disorders with debilitating symptoms[1,2].",Non-OADS,/arxiv_data1/oa_pdf/46/54/WJG-23-2029.PMC5360644.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/46/54/WJG-23-2029.PMC5360644.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Hyung Wook Kim, MD, PhD,   Department of Internal Medicine, Pusan National University  School of Medicine and Research Institute for Convergence of  Biomedical Science and Technology, Pusan National University  Yangsan Hospital, Beomeo-ri, Mulgeum-eup, Yangsan-si,  Gyeongsangnam-do 626-770,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/a5/01/WJG-23-2037.PMC5360645.pdf
"All rectal NETs  2037 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Is endoscopic ultrasonography essential for endoscopic  resection of small rectal neuroendocrine tumors?Retrospective Study Su Bum Park, Dong Jun Kim, Hyung Wook Kim, Cheol Woong Choi, Dae Hwan Kang, Su Jin Kim,  Hyeong Seok NamSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2037World J Gastroenterol   2017 March 21; 23(11): 2037-2043  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/a5/01/WJG-23-2037.PMC5360645.pdf
"World J  Gastroenterol  2017; 23(11): 2037-2043  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i11/2037.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i11.2037 INTRODUCTION Rectal neuroendocrine tumors (NETs) have rapidly  increased in incidence, with more than a 10-fold  increase occurring over the last 30 years[1].",Non-OADS,/arxiv_data1/oa_pdf/a5/01/WJG-23-2037.PMC5360645.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/a5/01/WJG-23-2037.PMC5360645.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Moon Hyung Choi, MD, Clinical Assistant  Professor,  Department of Radiology, Seoul St. Mary’s Hospital,  College of Medicine, The Catholic University of Korea, 222  Banpo-daero, Seocho-gu, Seoul 06591,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/c9/3f/WJG-23-2044.PMC5360646.pdf
"The pancreatic hardness was also objectively  2044 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Pancreatic hardness: Correlation of surgeon’s palpation,  durometer measurement and preoperative magnetic  resonance imaging featuresRetrospective Study Tae Ho Hong, Joon-Il Choi, Michael Yong Park, Sung Eun Rha, Young Joon Lee, Young Kyoung You,  Moon Hyung ChoiSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2044World J Gastroenterol   2017 March 21; 23(11): 2044-2051  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/c9/3f/WJG-23-2044.PMC5360646.pdf
World J Gastroenterol  2017; 23(11): 2044-2051   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i11/2044.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/c9/3f/WJG-23-2044.PMC5360646.pdf
